Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",A1BG,Alpha-1B-glycoprotein,19703,139,1.15 [0.46-2.89],0.7638286863086959
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AAMDC,Mth938 domain-containing protein,19177,139,0.92 [0.68-1.25],0.5888313371251257
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AARSD1,Alanyl-tRNA editing protein Aarsd1,22505,169,1.04 [0.82-1.32],0.7533416864832855
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ABCA2,ATP-binding cassette sub-family A member 2,19073,136,0.90 [0.57-1.42],0.6437126411471812
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ABHD14B,Protein ABHD14B,22380,167,0.98 [0.77-1.23],0.8394985256844567
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ABL1,Tyrosine-protein kinase ABL1,22505,169,0.99 [0.81-1.21],0.8893944197786975
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ABO,Histo-blood group ABO system transferase,19678,139,0.96 [0.86-1.07],0.4841707681721316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ABRAXAS2,BRISC complex subunit Abraxas 2,19073,136,0.94 [0.73-1.21],0.6533194791499336
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22099,164,1.04 [0.88-1.23],0.6726340027027995
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19295,142,1.02 [0.82-1.26],0.8811535885528591
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19673,140,0.95 [0.79-1.14],0.5473826143410292
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACAN,Aggrecan core protein,22404,169,0.91 [0.56-1.48],0.7102366200297562
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACE,Angiotensin-converting enzyme,19678,139,0.83 [0.44-1.54],0.5474760775896366
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACE2,Angiotensin-converting enzyme 2,22202,165,0.99 [0.74-1.33],0.9611162740079188
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACHE,Acetylcholinesterase,19262,139,0.98 [0.59-1.63],0.9397089749020836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACOT13,Acyl-coenzyme A thioesterase 13,19573,142,0.95 [0.82-1.09],0.4758146788827991
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22609,170,1.13 [0.87-1.47],0.3427168281749328
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACP1,Low molecular weight phosphotyrosine protein phosphatase,19124,135,1.07 [0.75-1.53],0.7172478648354458
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACP5,Tartrate-resistant acid phosphatase type 5,22716,167,0.89 [0.58-1.37],0.5992466971845032
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACP6,Lysophosphatidic acid phosphatase type 6,22770,167,0.96 [0.78-1.17],0.659015185694308
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACRBP,Acrosin-binding protein,19568,141,1.13 [0.74-1.72],0.5708219135741497
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACRV1,Acrosomal protein SP-10,19124,135,0.93 [0.58-1.48],0.7508528140112318
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACSL1,Long-chain-fatty-acid--CoA ligase 1,19073,136,0.97 [0.62-1.51],0.8780101001482559
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACTA2,"Actin, aortic smooth muscle",22202,165,1.00 [0.73-1.38],0.9866961578661574
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACTN2,Alpha-actinin-2,19073,136,1.06 [0.79-1.42],0.7094091489922445
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACTN4,Alpha-actinin-4,22181,166,1.04 [0.68-1.59],0.8615242589707932
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACVRL1,Serine/threonine-protein kinase receptor R3,22424,168,1.01 [0.56-1.83],0.9639976976461616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACY1,Aminoacylase-1,22609,170,1.04 [0.83-1.30],0.7367203154406567
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19073,136,0.88 [0.65-1.19],0.4115445663367898
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ACYP1,Acylphosphatase-1,19179,139,0.92 [0.72-1.18],0.4951953435183523
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADA,Adenosine deaminase,22856,169,0.93 [0.63-1.39],0.736835359760552
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADA2,Adenosine deaminase 2,22451,165,0.77 [0.55-1.08],0.1336077009757957
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19124,135,1.14 [0.75-1.73],0.549192396707142
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22202,165,0.88 [0.56-1.39],0.5891834575962105
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22459,168,0.71 [0.48-1.05],0.0879957335352458
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22856,169,0.98 [0.66-1.44],0.9129126587686708
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22768,168,1.04 [0.64-1.70],0.8796360013583202
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19573,142,0.77 [0.45-1.34],0.3617067937246033
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19124,135,1.07 [0.64-1.78],0.8078482875549258
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22879,170,1.30 [0.71-2.37],0.3921969790562508
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22505,169,0.99 [0.73-1.33],0.9273674807499668
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22202,165,0.64 [0.38-1.09],0.1033682084741927
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19124,135,0.91 [0.57-1.45],0.6856762429316914
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22677,169,0.96 [0.71-1.29],0.7767982770143405
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTSL2,ADAMTS-like protein 2,19669,142,1.17 [0.70-1.95],0.5548047674759939
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTSL4,ADAMTS-like protein 4,19177,139,0.51 [0.25-1.04],0.0628331625809074
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADAMTSL5,ADAMTS-like protein 5,19673,140,0.82 [0.54-1.25],0.3561605767946743
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22099,164,1.05 [0.73-1.50],0.8084359429233938
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADD1,Alpha-adducin,19262,139,0.96 [0.76-1.22],0.7580560601389559
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRB3,Adhesion G protein-coupled receptor B3,22424,168,0.86 [0.57-1.31],0.4828042284425928
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRD1,Adhesion G-protein coupled receptor D1,19262,139,0.88 [0.56-1.39],0.5949867673836127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRE1,Adhesion G protein-coupled receptor E1,19573,142,0.98 [0.73-1.31],0.8682442610757064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRE2,Adhesion G protein-coupled receptor E2,22709,169,0.83 [0.51-1.36],0.4547323934919723
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRE5,Adhesion G protein-coupled receptor E5,22771,167,0.77 [0.48-1.24],0.2771403463270783
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRF5,Adhesion G protein-coupled receptor F5,19673,140,0.78 [0.46-1.35],0.3781701215254422
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRG1,Adhesion G-protein coupled receptor G1,22505,169,0.91 [0.69-1.19],0.4873077221984024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRG2,Adhesion G-protein coupled receptor G2,22609,170,1.04 [0.63-1.72],0.8769442131281128
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADGRV1,Adhesion G-protein coupled receptor V1,19065,134,0.72 [0.54-0.96],0.0273356586136925
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADH1B,All-trans-retinol dehydrogenase,19262,139,0.95 [0.76-1.18],0.622544871435772
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22202,165,1.01 [0.86-1.18],0.937217866491852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADIPOQ,Adiponectin,19703,139,1.05 [0.83-1.34],0.679054786647403
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADM,Pro-adrenomedullin,22809,167,0.75 [0.45-1.23],0.2508382620912485
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ADRA2A,Alpha-2A adrenergic receptor,19073,136,0.93 [0.73-1.19],0.5607521032921718
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AFAP1,Actin filament-associated protein 1,19262,139,0.95 [0.78-1.16],0.6154188522127848
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AFM,Afamin,19703,139,1.24 [0.52-2.92],0.6280017984921474
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AFP,Alpha-fetoprotein,22396,167,1.14 [0.94-1.38],0.1944744641424034
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGBL2,Cytosolic carboxypeptidase 2,19065,134,0.76 [0.67-0.87],8.383283106310296e-05
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGER,Advanced glycosylation end product-specific receptor,22557,169,1.16 [0.83-1.62],0.3953544656939957
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGR2,Anterior gradient protein 2 homolog,21850,163,0.95 [0.83-1.09],0.4486327167227153
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGR3,Anterior gradient protein 3,22059,164,0.91 [0.72-1.16],0.4609107929931006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGRN,Agrin,22709,169,0.94 [0.61-1.44],0.7708649929913974
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGRP,Agouti-related protein,22856,169,0.99 [0.77-1.27],0.9222813879367447
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGT,Angiotensinogen,19678,139,0.77 [0.44-1.35],0.3601172807250159
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AGXT,Serine--pyruvate aminotransferase,22609,170,1.16 [0.98-1.36],0.0863922356211761
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHCY,Adenosylhomocysteinase,22609,170,0.97 [0.79-1.18],0.7336409171974747
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHNAK,Neuroblast differentiation-associated protein AHNAK,19177,139,0.87 [0.51-1.48],0.6111065494387944
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHNAK2,Protein AHNAK2,19177,139,0.95 [0.53-1.69],0.8611395118159848
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19568,141,0.72 [0.54-0.97],0.0277742270887737
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHSG,Alpha-2-HS-glycoprotein,19678,139,0.99 [0.55-1.79],0.973902683056792
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AHSP,Alpha-hemoglobin-stabilizing protein,22579,164,1.00 [0.85-1.16],0.9491888547988572
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AIDA,"Axin interactor, dorsalization-associated protein",19126,138,0.91 [0.73-1.12],0.3610132576238881
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AIF1,Allograft inflammatory factor 1,22099,164,1.06 [0.82-1.38],0.6417595689183118
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AIF1L,Allograft inflammatory factor 1-like,19177,139,1.19 [0.94-1.50],0.1544484300840543
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22460,169,0.97 [0.85-1.10],0.6190757804266311
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AK1,Adenylate kinase isoenzyme 1,22609,170,1.02 [0.83-1.26],0.8377420317400791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AK2,"Adenylate kinase 2, mitochondrial",19633,140,0.91 [0.78-1.06],0.2068786655661642
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKAP12,A-kinase anchor protein 12,19262,139,1.04 [0.49-2.19],0.9237040838147874
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKR1B1,Aldo-keto reductase family 1 member B1,22099,164,0.95 [0.79-1.14],0.6022083460207137
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKR1B10,Aldo-keto reductase family 1 member B10,19126,138,0.94 [0.71-1.24],0.6479880292670379
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKR1C4,Aldo-keto reductase family 1 member C4,22202,165,0.90 [0.68-1.18],0.4383624332822631
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKR7L,Aflatoxin B1 aldehyde reductase member 4,19124,135,0.97 [0.76-1.23],0.7852472705575874
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKT1S1,Proline-rich AKT1 substrate 1,22047,163,0.90 [0.73-1.11],0.3440010813291526
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKT2,RAC-beta serine/threonine-protein kinase,19643,140,0.94 [0.83-1.07],0.3490116389750392
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AKT3,RAC-gamma serine/threonine-protein kinase,21989,162,0.93 [0.72-1.19],0.5492221895366564
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALCAM,CD166 antigen,22879,170,1.06 [0.53-2.16],0.862772269751768
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALDH1A1,Retinal dehydrogenase 1,22614,165,1.07 [0.84-1.37],0.5703128271353277
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALDH2,"Aldehyde dehydrogenase, mitochondrial",19568,141,0.85 [0.59-1.21],0.3611634493027933
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22536,167,0.97 [0.78-1.21],0.7944551119303217
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19643,140,1.01 [0.72-1.42],0.9525411905841276
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALMS1,Alstrom syndrome protein 1,19295,142,0.94 [0.65-1.35],0.7320503172070316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALPI,Intestinal-type alkaline phosphatase,19124,135,0.95 [0.83-1.10],0.5110969562811776
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ALPP,"Alkaline phosphatase, placental type",22505,169,1.01 [0.88-1.16],0.8558275049200913
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMBN,Ameloblastin,22181,166,1.06 [0.66-1.70],0.802621341798749
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMBP,Protein AMBP,22776,166,0.72 [0.36-1.44],0.3466944556771655
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19669,142,1.12 [0.59-2.10],0.7293840588988135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMFR,E3 ubiquitin-protein ligase AMFR,22047,163,1.16 [0.95-1.40],0.1392992771498788
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMIGO1,Amphoterin-induced protein 1,19126,138,0.69 [0.47-1.02],0.0653071560357992
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMIGO2,Amphoterin-induced protein 2,22505,169,1.00 [0.55-1.83],0.99767337405949
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMN,Protein amnionless,22181,166,0.99 [0.74-1.32],0.9402327904358732
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMOT,Angiomotin,19262,139,1.17 [0.80-1.71],0.4291606624529948
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMOTL2,Angiomotin-like protein 2,19511,141,0.79 [0.54-1.16],0.2290869595048989
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMPD3,AMP deaminase 3,19633,140,0.99 [0.79-1.23],0.9004261345736239
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18411,131,0.75 [0.52-1.08],0.1224078372600267
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMY2A,Pancreatic alpha-amylase,21711,162,0.72 [0.53-0.97],0.02974578231544
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AMY2B,Alpha-amylase 2B,21053,155,0.68 [0.50-0.93],0.0148438230234989
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANG,Angiogenin,22525,166,1.25 [0.85-1.83],0.2615381471668613
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPT1,Angiopoietin-1,22527,169,0.96 [0.82-1.12],0.5753332431687064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPT2,Angiopoietin-2,22809,167,1.02 [0.71-1.45],0.9174249525737316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPTL1,Angiopoietin-related protein 1,22305,170,0.89 [0.56-1.42],0.6285446633421652
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPTL2,Angiopoietin-related protein 2,22642,169,1.22 [0.87-1.71],0.2513398852033047
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPTL3,Angiopoietin-related protein 3,22594,169,0.95 [0.65-1.38],0.7817561662663646
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPTL4,Angiopoietin-related protein 4,22670,169,0.95 [0.71-1.28],0.7505900692490493
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANGPTL7,Angiopoietin-related protein 7,22809,167,0.79 [0.54-1.14],0.2089119340223606
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANK2,Ankyrin-2,19073,136,1.12 [0.92-1.37],0.2604194411384254
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19124,135,0.93 [0.75-1.15],0.4977223734760886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANKRA2,Ankyrin repeat family A protein 2,18980,139,0.97 [0.72-1.30],0.8421465038951577
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANKRD54,Ankyrin repeat domain-containing protein 54,22099,164,0.88 [0.68-1.13],0.3187219428442094
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19177,139,0.60 [0.35-1.02],0.058746857232866
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANPEP,Aminopeptidase N,22630,169,1.11 [0.69-1.79],0.6693934898214654
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA1,Annexin A1,19137,139,1.07 [0.75-1.52],0.6989511521576488
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA10,Annexin A10,22047,163,0.92 [0.77-1.10],0.3623523064670976
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA11,Annexin A11,22540,167,1.00 [0.82-1.23],0.98344204283904
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA2,Annexin A2,18887,139,1.01 [0.80-1.28],0.9043229396798188
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA3,Annexin A3,22768,168,1.00 [0.82-1.21],0.9851170821566986
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA4,Annexin A4,22492,169,0.94 [0.78-1.14],0.5350172598240446
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ANXA5,Annexin A5,21987,163,1.07 [0.68-1.68],0.7595370695101662
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AOC1,Amiloride-sensitive amine oxidase [copper-containing],22181,166,0.87 [0.67-1.14],0.3265190254128168
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AOC3,Membrane primary amine oxidase,22671,169,1.38 [0.88-2.16],0.1605094482978895
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AP1G2,AP-1 complex subunit gamma-like 2,19568,141,0.88 [0.72-1.08],0.2213658523205359
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AP2B1,AP-2 complex subunit beta,19126,138,0.82 [0.57-1.17],0.270521314908979
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AP3B1,AP-3 complex subunit beta-1,19573,142,0.99 [0.81-1.23],0.9587057202745236
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AP3S2,AP-3 complex subunit sigma-2,19633,140,0.84 [0.59-1.21],0.3513959581172636
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22505,169,0.96 [0.71-1.31],0.8036241396202283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APCS,Serum amyloid P-component,19521,135,1.60 [1.00-2.55],0.0489349552020397
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22736,167,1.05 [0.83-1.31],0.7004487882852706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APLP1,Amyloid-like protein 1,22609,170,1.12 [0.86-1.44],0.4087034141542822
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOA1,Apolipoprotein A-I,19703,139,1.11 [0.64-1.95],0.7056734122234921
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOA2,Apolipoprotein A-II,19678,139,1.01 [0.72-1.42],0.95432292555666
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOA4,Apolipoprotein A-IV,19703,139,0.96 [0.62-1.50],0.8661031478472082
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOB,Apolipoprotein B-100,19678,139,0.66 [0.34-1.32],0.2415548423914299
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOBR,Apolipoprotein B receptor,19177,139,0.93 [0.63-1.35],0.693020123477899
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOC1,Apolipoprotein C-I,19659,137,1.19 [0.78-1.83],0.4170053041913818
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOD,Apolipoprotein D,18789,129,1.01 [0.69-1.48],0.9550802622913264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOE,Apolipoprotein E,19703,139,0.90 [0.70-1.16],0.4028461624658969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOF,Apolipoprotein F,19678,139,0.73 [0.44-1.20],0.2101729564804813
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOH,Beta-2-glycoprotein 1,22614,165,1.33 [0.93-1.91],0.1183239242689923
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOL1,Apolipoprotein L1,19678,139,1.11 [0.89-1.40],0.3459714648314042
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APOM,Apolipoprotein M,22634,169,1.29 [0.77-2.15],0.3351108627221638
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APP,Amyloid-beta precursor protein,22580,165,0.97 [0.79-1.19],0.7545182239816735
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APPL2,DCC-interacting protein 13-beta,19262,139,0.95 [0.82-1.10],0.5215323809530179
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",APRT,Adenine phosphoribosyltransferase,22429,168,0.93 [0.71-1.24],0.6352654598263431
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARAF,Serine/threonine-protein kinase A-Raf,19295,142,0.97 [0.76-1.23],0.8079652253213606
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AREG,Amphiregulin,22505,169,1.32 [1.02-1.70],0.0333407500195386
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARF6,ADP-ribosylation factor 6,19573,142,1.04 [0.89-1.21],0.5952122776018027
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARFIP1,Arfaptin-1,19643,140,0.98 [0.77-1.24],0.8634242759974274
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARG1,Arginase-1,22514,164,0.98 [0.76-1.27],0.9002285819543496
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARG2,"Arginase-2, mitochondrial",19568,141,1.06 [0.75-1.50],0.7483813739705425
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGAP1,Rho GTPase-activating protein 1,22099,164,1.04 [0.77-1.40],0.8158767157996822
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGAP25,Rho GTPase-activating protein 25,22099,164,1.10 [0.88-1.37],0.4183253236346327
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGAP30,Rho GTPase-activating protein 30,19295,142,0.74 [0.45-1.22],0.237517517389164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGAP45,Rho GTPase-activating protein 45,19262,139,0.94 [0.77-1.15],0.5268863429866144
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGAP5,Rho GTPase-activating protein 5,18980,139,0.90 [0.71-1.12],0.3426497923262896
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGEF1,Rho guanine nucleotide exchange factor 1,19633,140,0.93 [0.78-1.12],0.4520605917438153
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGEF10,Rho guanine nucleotide exchange factor 10,19643,140,0.92 [0.77-1.09],0.3349448318751759
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGEF12,Rho guanine nucleotide exchange factor 12,22569,167,0.95 [0.83-1.09],0.4702020798432893
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARHGEF5,Rho guanine nucleotide exchange factor 5,19065,134,0.92 [0.73-1.16],0.4882698802434969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARID3A,AT-rich interactive domain-containing protein 3A,19065,134,0.89 [0.58-1.37],0.5936430523315215
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARID4B,AT-rich interactive domain-containing protein 4B,22047,163,1.04 [0.76-1.42],0.7991389116320282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARL13B,ADP-ribosylation factor-like protein 13B,19073,136,0.99 [0.78-1.25],0.9119128086655028
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19073,136,0.81 [0.54-1.23],0.3230120954236559
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARMCX2,Armadillo repeat-containing X-linked protein 2,19065,134,0.99 [0.76-1.28],0.921025977551204
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARNT,Aryl hydrocarbon receptor nuclear translocator,22181,166,0.53 [0.34-0.82],0.0048178138417828
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19073,136,1.07 [0.80-1.42],0.6702359201830554
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARSA,Arylsulfatase A,22614,165,0.99 [0.73-1.34],0.9375948235848282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARSB,Arylsulfatase B,22505,169,0.95 [0.74-1.22],0.6962342535815106
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ART3,Ecto-ADP-ribosyltransferase 3,22671,169,1.03 [0.68-1.56],0.9012183834021216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ART5,Ecto-ADP-ribosyltransferase 5,19065,134,0.80 [0.59-1.10],0.1772466400623536
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ARTN,Artemin,22181,166,0.85 [0.60-1.20],0.3579197470099443
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASAH1,Acid ceramidase,19486,142,0.96 [0.68-1.36],0.8292139734845211
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASAH2,Neutral ceramidase,22459,168,1.37 [1.03-1.83],0.0297577398270309
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASGR1,Asialoglycoprotein receptor 1,22459,168,0.73 [0.45-1.18],0.1961698680543764
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASGR2,Asialoglycoprotein receptor 2,19678,139,1.19 [0.64-2.21],0.5787939889129012
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASPN,Asporin,19673,140,0.91 [0.49-1.67],0.7573837725997483
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASPSCR1,Tether containing UBX domain for GLUT4,19643,140,0.87 [0.68-1.10],0.2457383556085891
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASRGL1,Isoaspartyl peptidase/L-asparaginase,19177,139,0.93 [0.79-1.09],0.3629675901361299
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ASS1,Argininosuccinate synthase,19073,136,1.00 [0.81-1.23],0.9776336901033092
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATF2,Cyclic AMP-dependent transcription factor ATF-2,22047,163,0.98 [0.80-1.21],0.8774400327887234
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATF4,Cyclic AMP-dependent transcription factor ATF-4,18980,139,0.89 [0.55-1.46],0.6501831158445406
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATG16L1,Autophagy-related protein 16-1,19573,142,0.98 [0.81-1.18],0.818156954842823
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATG4A,Cysteine protease ATG4A,22099,164,0.98 [0.78-1.24],0.8623490297755058
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATOX1,Copper transport protein ATOX1,22677,169,0.96 [0.79-1.15],0.640589975187206
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19073,136,0.88 [0.60-1.27],0.489927889392259
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19073,136,0.93 [0.55-1.58],0.7842530931707414
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19073,136,0.99 [0.66-1.48],0.948405522774338
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP1B4,Protein ATP1B4,18980,139,0.71 [0.46-1.10],0.1211153305199729
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP2B4,Plasma membrane calcium-transporting ATPase 4,19073,136,0.87 [0.65-1.17],0.3511949942020981
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP5F1D,"ATP synthase subunit delta, mitochondrial",19073,136,0.90 [0.64-1.26],0.5285040429798653
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP5IF1,"ATPase inhibitor, mitochondrial",22709,169,0.94 [0.83-1.06],0.3173633763452356
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP5PO,"ATP synthase subunit O, mitochondrial",22047,163,0.79 [0.55-1.12],0.1789112839447711
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP6AP2,Renin receptor,22099,164,1.15 [0.85-1.54],0.3600297496220773
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP6V1D,V-type proton ATPase subunit D,22505,169,0.51 [0.29-0.89],0.017949798885093
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP6V1F,V-type proton ATPase subunit F,21999,163,1.04 [0.84-1.28],0.7473574174869717
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP6V1G1,V-type proton ATPase subunit G 1,19177,139,1.01 [0.80-1.26],0.9545209199309546
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATP6V1G2,V-type proton ATPase subunit G 2,19073,136,1.08 [0.93-1.26],0.2998598292231367
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATRAID,All-trans retinoic acid-induced differentiation factor,19573,142,1.14 [0.70-1.85],0.5992218713348462
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATRN,"Attractin, Isoform 2",19703,139,1.37 [0.51-3.66],0.5292947370180973
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATXN10,Ataxin-10,22047,163,1.11 [0.91-1.35],0.2976274329152646
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATXN2,Ataxin-2,19065,134,1.00 [0.87-1.15],0.9990378451676312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATXN2L,Ataxin-2-like protein,19643,140,0.83 [0.57-1.19],0.3081430604393608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ATXN3,Ataxin-3,19633,140,0.95 [0.73-1.22],0.6778163081525961
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AXIN1,Axin-1,22569,167,0.95 [0.82-1.10],0.50467683692909
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AXL,Tyrosine-protein kinase receptor UFO,22671,169,1.15 [0.70-1.90],0.5721128061068326
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AZI2,5-azacytidine-induced protein 2,19643,140,0.82 [0.61-1.11],0.2073108310018969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",AZU1,Azurocidin,21888,161,1.13 [0.97-1.33],0.1254218108926659
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",B2M,Beta-2-microglobulin,19703,139,0.98 [0.58-1.64],0.9309669402170012
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19073,136,0.76 [0.33-1.75],0.5205999662636278
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19177,139,0.73 [0.47-1.14],0.1623454024893664
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",B4GALT1,"Beta-1,4-galactosyltransferase 1",22709,169,1.19 [0.72-1.96],0.4977091386124014
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",B4GAT1,"Beta-1,4-glucuronyltransferase 1",22614,165,0.89 [0.50-1.58],0.6979157638092583
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BABAM1,BRISC and BRCA1-A complex member 1,19124,135,0.62 [0.33-1.17],0.1431400136416738
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BACH1,Transcription regulator protein BACH1,22569,167,0.95 [0.78-1.15],0.5883487337582863
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAG3,BAG family molecular chaperone regulator 3,22424,168,1.01 [0.72-1.43],0.9375337926536796
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAG4,BAG family molecular chaperone regulator 4,19124,135,1.04 [0.75-1.45],0.7985219107401973
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAG6,Large proline-rich protein BAG6,22202,165,1.12 [0.76-1.63],0.5746836419130859
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22099,164,1.00 [0.80-1.25],0.9920183161850836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAMBI,BMP and activin membrane-bound inhibitor homolog,22099,164,0.72 [0.44-1.18],0.1969818735767071
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BANK1,B-cell scaffold protein with ankyrin repeats,22569,167,1.00 [0.88-1.14],0.992784037546817
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAP18,Chromatin complexes subunit BAP18,19633,140,1.08 [0.86-1.34],0.5156783072283292
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BATF,Basic leucine zipper transcriptional factor ATF-like,19126,138,1.06 [0.89-1.26],0.54379960773923
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BAX,Apoptosis regulator BAX,22017,163,0.94 [0.80-1.10],0.4224685039949549
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCAM,Basal cell adhesion molecule,22614,165,0.83 [0.46-1.50],0.5326699226593574
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCAN,Brevican core protein,22459,168,1.06 [0.70-1.59],0.7847542727773806
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19673,140,0.96 [0.56-1.64],0.8670779075214999
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19065,134,1.05 [0.79-1.40],0.7442816077523171
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCHE,Cholinesterase,19303,134,1.79 [0.98-3.28],0.0580636131752868
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL2,Apoptosis regulator Bcl-2,19573,142,1.22 [0.96-1.56],0.1097242646350974
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL2L1,Bcl-2-like protein 1,19633,140,0.93 [0.79-1.09],0.3630350014768109
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22569,167,0.96 [0.71-1.29],0.7874872173054026
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL2L15,Bcl-2-like protein 15,19124,135,0.87 [0.64-1.17],0.3513883700449195
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL7A,B-cell CLL/lymphoma 7 protein family member A,18980,139,0.74 [0.55-1.00],0.050313763198418
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCL7B,B-cell CLL/lymphoma 7 protein family member B,19568,141,0.94 [0.65-1.35],0.7238938114672612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BCR,Breakpoint cluster region protein,22569,167,0.94 [0.81-1.09],0.4294291771056615
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BDNF,Brain-derived neurotrophic factor,19669,142,0.86 [0.72-1.04],0.1136437137971846
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BECN1,Beclin-1,19177,139,0.94 [0.72-1.23],0.644868570891552
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BEX3,Protein BEX3,18980,139,0.79 [0.54-1.18],0.254499248022896
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BGLAP,Osteocalcin,19669,142,0.88 [0.75-1.05],0.1622857716124878
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BGN,Biglycan,22060,163,1.08 [0.96-1.21],0.1799561583770136
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BHLHE40,Class E basic helix-loop-helix protein 40,19065,134,1.03 [0.82-1.29],0.7880886490515026
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19073,136,0.67 [0.36-1.26],0.2136933717597576
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BID,BH3-interacting domain death agonist,22569,167,0.87 [0.71-1.08],0.2046920379702189
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BIN2,Bridging integrator 2,22614,165,1.02 [0.88-1.19],0.7840210127573254
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BIRC2,Baculoviral IAP repeat-containing protein 2,22099,164,0.96 [0.77-1.20],0.7236326347994684
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BLMH,Bleomycin hydrolase,22879,170,0.92 [0.61-1.40],0.6959711475562705
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BLNK,B-cell linker protein,19124,135,1.08 [0.70-1.65],0.7361303665039869
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19065,134,0.85 [0.66-1.10],0.2148704363173942
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19633,140,0.87 [0.58-1.32],0.5220407374627642
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BLVRB,Flavin reductase,22614,165,1.04 [0.85-1.26],0.723391720594263
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BMP10,Bone morphogenetic protein 10,19262,139,1.26 [0.71-2.25],0.4319232482549632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BMP4,Bone morphogenetic protein 4,22424,168,0.94 [0.69-1.28],0.6953248578205585
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BMP6,Bone morphogenetic protein 6,22166,163,0.96 [0.69-1.33],0.8005748768829797
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BMPER,BMP-binding endothelial regulator protein,19262,139,1.27 [0.62-2.60],0.5183768355201688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19673,140,0.85 [0.52-1.39],0.5201285784714688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19124,135,1.02 [0.70-1.48],0.925159076951826
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BOC,Brother of CDO,22202,165,1.25 [0.70-2.24],0.4538409467099866
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BOLA1,BolA-like protein 1,19065,134,0.75 [0.54-1.05],0.0918934202001394
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BOLA2_BOLA2B,BolA-like protein 2,19177,139,1.00 [0.75-1.34],0.9964338482447104
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BPIFA2,BPI fold-containing family A member 2,18496,134,0.96 [0.82-1.11],0.5617169307148567
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BPIFB1,BPI fold-containing family B member 1,22548,165,1.05 [0.84-1.31],0.6792858185185273
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BPIFB2,BPI fold-containing family B member 2,19639,140,1.08 [0.86-1.36],0.514239340519161
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRAP,BRCA1-associated protein,19402,140,1.02 [0.88-1.19],0.7783011246860689
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRD1,Bromodomain-containing protein 1,19295,142,0.78 [0.44-1.37],0.3804671288308587
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRD2,Bromodomain-containing protein 2,19065,134,0.83 [0.50-1.40],0.4967248617557183
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRD3,Bromodomain-containing protein 3,19073,136,1.07 [0.78-1.46],0.6905104213887918
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRDT,Bromodomain testis-specific protein,19073,136,0.79 [0.50-1.25],0.3118968131529008
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRK1,Protein BRICK1,22047,163,1.00 [0.72-1.37],0.9756699468262716
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRME1,Break repair meiotic recombinase recruitment factor 1,19065,134,0.82 [0.53-1.27],0.3701689005924496
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BRSK2,Serine/threonine-protein kinase BRSK2,19643,140,0.57 [0.36-0.91],0.0187116120290885
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BSG,Basigin,22816,168,1.11 [0.55-2.24],0.7775874559234135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BSND,Barttin,18980,139,0.89 [0.53-1.48],0.6446680370826128
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22808,168,0.84 [0.65-1.07],0.154079655468138
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BST2,Bone marrow stromal antigen 2,22808,168,0.83 [0.62-1.10],0.1985813151331331
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTC,Probetacellulin,22099,164,1.00 [0.83-1.20],0.9911242104595795
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTD,Biotinidase,19703,139,1.79 [0.81-3.95],0.1510340517531239
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTLA,B- and T-lymphocyte attenuator,18980,139,0.95 [0.77-1.16],0.6079524130273886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTN1A1,Butyrophilin subfamily 1 member A1,19533,141,0.53 [0.32-0.88],0.0143916835498649
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTN2A1,Butyrophilin subfamily 2 member A1,22709,169,0.96 [0.56-1.65],0.8737817530077023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTN3A2,Butyrophilin subfamily 3 member A2,22569,167,0.92 [0.63-1.32],0.637901063760046
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",BTNL10,Butyrophilin-like protein 10,18980,139,0.50 [0.29-0.87],0.0143822789531148
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C19orf12,Protein C19orf12,22047,163,0.98 [0.79-1.23],0.8954810782413902
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1GALT1C1,C1GALT1-specific chaperone 1,19073,136,0.78 [0.45-1.35],0.3752142190340307
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QA,Complement C1q subcomponent subunit A,22739,168,0.56 [0.31-1.01],0.0533236150185353
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19643,140,0.96 [0.76-1.23],0.7680626647929361
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QL2,Complement C1q-like protein 2,19124,135,0.89 [0.60-1.32],0.563849659981333
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22671,169,1.24 [0.91-1.69],0.1757227296569574
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19262,139,1.25 [0.81-1.93],0.3145281791952266
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19643,140,0.84 [0.50-1.42],0.5180376838975214
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19220,139,1.08 [0.77-1.53],0.6413213321183497
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1R,Complement C1r subcomponent,19703,139,1.13 [0.51-2.49],0.7691906760415721
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1RL,Complement C1r subcomponent-like protein,19671,139,1.03 [0.45-2.36],0.9463843468560098
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C1S,Complement C1s subcomponent,19703,139,1.40 [0.65-3.01],0.39316071997123
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C2,Complement C2,22634,169,2.01 [1.04-3.87],0.0375316600775606
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C2CD2L,Phospholipid transfer protein C2CD2L,21999,163,0.88 [0.63-1.23],0.4481456670685216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C2orf69,UPF0565 protein C2orf69,19126,138,0.81 [0.59-1.12],0.2025062051457737
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C3,Complement C3,18696,128,1.04 [0.72-1.48],0.8489133673766424
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C4BPB,C4b-binding protein beta chain,22677,169,0.96 [0.69-1.34],0.8129835603688741
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C5,Complement C5,19703,139,0.53 [0.18-1.61],0.2665004601977843
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C7,Complement component C7,19224,132,0.93 [0.55-1.59],0.7903394233050193
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C7orf50,Uncharacterized protein C7orf50,19633,140,0.90 [0.43-1.88],0.7769056346997707
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C8B,Complement component C8 beta chain,19703,139,1.04 [0.62-1.77],0.8701414669294365
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C9,Complement component C9,19678,139,0.96 [0.69-1.33],0.789010018538104
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",C9orf40,Uncharacterized protein C9orf40,19573,142,1.01 [0.84-1.23],0.880536513406505
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA1,Carbonic anhydrase 1,22071,157,1.06 [0.85-1.33],0.5792752050435742
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA11,Carbonic anhydrase-related protein 11,22099,164,0.91 [0.58-1.43],0.686666294257055
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA12,Carbonic anhydrase 12,22505,169,1.04 [0.68-1.59],0.8586098151272807
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA13,Carbonic anhydrase 13,22370,168,0.97 [0.85-1.11],0.6514448641695185
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA14,Carbonic anhydrase 14,22809,167,1.15 [0.77-1.72],0.48434235221679
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA2,Carbonic anhydrase 2,22538,164,1.05 [0.87-1.26],0.6316349633949434
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA3,Carbonic anhydrase 3,22839,168,1.13 [0.92-1.40],0.2564658169685774
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA4,Carbonic anhydrase 4,22879,170,0.72 [0.40-1.28],0.2596113504987251
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA5A,"Carbonic anhydrase 5A, mitochondrial",22202,165,1.09 [0.95-1.27],0.2264773347918866
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA6,Carbonic anhydrase 6,22543,164,1.13 [0.91-1.40],0.2806808839872938
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA7,Carbonic anhydrase 7,19295,142,0.74 [0.45-1.24],0.255098905701724
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA8,Carbonic anhydrase-related protein,19124,135,1.07 [0.60-1.91],0.8067325362412822
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CA9,Carbonic anhydrase 9,22809,167,1.12 [0.83-1.51],0.4522109825179835
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CABP2,Calcium-binding protein 2,19126,138,0.81 [0.62-1.07],0.1437991830116151
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19065,134,0.65 [0.37-1.16],0.1476262453087068
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19073,136,0.99 [0.75-1.31],0.9361149100440936
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19065,134,1.00 [0.76-1.32],0.9908986398574396
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19643,140,0.87 [0.72-1.06],0.1659451190865502
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CACYBP,Calcyclin-binding protein,19219,139,0.97 [0.82-1.13],0.6609082253624672
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CADPS,Calcium-dependent secretion activator 1,19126,138,0.78 [0.51-1.20],0.2619690866807642
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALB1,Calbindin,22505,169,1.00 [0.72-1.39],0.989438611396945
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALB2,Calretinin,22047,163,0.88 [0.56-1.41],0.6064539891378082
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALCA,Calcitonin,22411,168,1.13 [0.89-1.44],0.3020008517351177
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALCB,Calcitonin gene-related peptide 2,19633,140,0.80 [0.50-1.26],0.3319352447520218
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22736,167,0.96 [0.84-1.10],0.5402345736141773
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19177,139,1.00 [0.81-1.24],0.9936956983517424
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CALY,Neuron-specific vesicular protein calcyon,19073,136,0.64 [0.38-1.08],0.0972882530960237
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22099,164,0.78 [0.56-1.08],0.1370937515639636
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19126,138,0.84 [0.61-1.16],0.2834144199588955
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19643,140,0.90 [0.77-1.05],0.1681285444835557
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CANT1,Soluble calcium-activated nucleotidase 1,22543,170,1.21 [0.62-2.37],0.5733008699568682
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAPG,Macrophage-capping protein,22456,165,1.19 [0.95-1.49],0.1371757111992893
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAPN3,Calpain-3,19568,141,1.04 [0.68-1.58],0.8599550209547238
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAPS,Calcyphosin,19633,140,0.99 [0.83-1.17],0.8846968918910639
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CARHSP1,Calcium-regulated heat-stable protein 1,22047,163,0.97 [0.75-1.26],0.8437821734661639
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASC3,Protein CASC3,19126,138,0.85 [0.57-1.28],0.4390982677645146
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP1,Caspase-1,22047,163,0.92 [0.75-1.14],0.4509152251667028
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP10,Caspase-10,22047,163,1.02 [0.84-1.24],0.839664254208356
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP2,Caspase-2,22569,167,1.07 [0.88-1.31],0.4797630340538308
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP3,Caspase-3,22879,170,0.95 [0.81-1.11],0.5035659510162855
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP4,Caspase-4,19295,142,0.98 [0.89-1.08],0.6314537782251637
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP7,Caspase-7,19633,140,0.95 [0.78-1.15],0.5852445031969511
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP8,Caspase-8,22737,166,1.02 [0.82-1.26],0.8741403378851825
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASP9,Caspase-9,19124,135,1.03 [0.79-1.34],0.819809204894458
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CASQ2,Calsequestrin-2,19073,136,0.99 [0.71-1.39],0.9704151563051864
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CAT,Catalase,19377,138,1.09 [0.82-1.45],0.5657448225469441
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CBLIF,Cobalamin binding intrinsic factor,22575,170,1.23 [1.01-1.48],0.0350872671324291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CBLN1,Cerebellin-1,19065,134,0.82 [0.66-1.01],0.0671806238601761
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CBLN4,Cerebellin-4,22809,167,1.33 [0.88-2.02],0.1776123619801582
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CBS,Cystathionine beta-synthase,19177,139,1.13 [0.84-1.54],0.4134844711600114
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CBX2,Chromobox protein homolog 2,19073,136,0.97 [0.65-1.46],0.8892154832094701
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22459,168,1.02 [0.85-1.22],0.8553321963864327
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCAR2,Cell cycle and apoptosis regulator protein 2,19633,140,0.96 [0.71-1.29],0.7667262235138017
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCDC134,Coiled-coil domain-containing protein 134,19568,141,0.75 [0.53-1.07],0.1100154133544729
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCDC28A,Coiled-coil domain-containing protein 28A,19126,138,0.68 [0.39-1.20],0.1834623033253684
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCDC50,Coiled-coil domain-containing protein 50,19643,140,0.95 [0.76-1.17],0.6064151851338129
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCDC80,Coiled-coil domain-containing protein 80,22609,170,0.94 [0.63-1.39],0.756290768658049
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19177,139,0.88 [0.67-1.16],0.359502716775559
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL11,Eotaxin,22856,169,0.82 [0.57-1.17],0.2620410237402877
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL13,C-C motif chemokine 13,22816,169,0.97 [0.80-1.18],0.77650250590859
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL14,C-C motif chemokine 14,22525,166,1.04 [0.73-1.47],0.8397061571274802
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL15,C-C motif chemokine 15,22879,170,1.17 [0.87-1.58],0.2906047415267121
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL16,C-C motif chemokine 16,22879,170,0.89 [0.70-1.13],0.3416233066760672
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL17,C-C motif chemokine 17,22573,166,0.92 [0.79-1.08],0.3121922350713671
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL18,C-C motif chemokine 18,22260,164,0.95 [0.78-1.17],0.6490977960811876
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL19,C-C motif chemokine 19,22808,168,1.04 [0.94-1.14],0.4636569559553526
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL2,C-C motif chemokine 2,22424,168,1.12 [0.87-1.44],0.3624543049559738
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL20,C-C motif chemokine 20,22856,169,1.07 [0.93-1.24],0.3416857065718071
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL21,C-C motif chemokine 21,22709,169,0.80 [0.57-1.14],0.2138203749442718
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL22,C-C motif chemokine 22,22381,165,0.93 [0.71-1.22],0.5931642097090979
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL23,C-C motif chemokine 23,22709,169,0.80 [0.58-1.12],0.1958921187838408
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL24,C-C motif chemokine 24,22670,169,1.01 [0.86-1.19],0.8824968431837767
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL25,C-C motif chemokine 25,22856,169,1.00 [0.76-1.32],0.994582525009704
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL26,C-C motif chemokine 26,22569,167,0.94 [0.81-1.11],0.4713408023620022
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL27,C-C motif chemokine 27,22609,170,0.86 [0.68-1.07],0.1738277901463001
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL28,C-C motif chemokine 28,22494,167,0.96 [0.76-1.22],0.7474688928746533
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL3,C-C motif chemokine 3,22569,167,0.98 [0.78-1.23],0.8599222872804819
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL4,C-C motif chemokine 4,22640,166,0.92 [0.74-1.15],0.4706475453169512
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL5,C-C motif chemokine 5,22671,169,0.94 [0.82-1.08],0.3906620937826895
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL7,C-C motif chemokine 7,22569,167,0.93 [0.73-1.18],0.5576209036495338
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCL8,C-C motif chemokine 8,22776,166,1.00 [0.80-1.25],0.9897514277351132
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCN1,CCN family member 1,22465,168,0.97 [0.81-1.15],0.695509285731606
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCN2,CCN family member 2,22597,169,0.81 [0.64-1.03],0.0814625316198788
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCN3,CCN family member 3,22846,170,1.07 [0.71-1.61],0.744055386410306
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCN4,CCN family member 4,22809,167,1.05 [0.76-1.46],0.7546530575230135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCN5,CCN family member 5,22614,165,1.16 [0.82-1.64],0.4003227567964998
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCND2,G1/S-specific cyclin-D2,19295,142,1.01 [0.66-1.56],0.9552561389671976
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCNE1,G1/S-specific cyclin-E1,19124,135,0.96 [0.80-1.16],0.6748978931021925
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCS,Copper chaperone for superoxide dismutase,22459,168,0.95 [0.72-1.26],0.7208617021128942
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CCT5,T-complex protein 1 subunit epsilon,22099,164,0.95 [0.70-1.30],0.7540571016521502
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD101,Immunoglobulin superfamily member 2,19573,142,0.79 [0.54-1.13],0.1951729087507442
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD109,CD109 antigen,22614,165,0.63 [0.43-0.94],0.0226421295408857
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD14,Monocyte differentiation antigen CD14,22105,162,1.04 [0.74-1.46],0.8311802295487333
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD160,CD160 antigen,22856,169,0.89 [0.66-1.20],0.4517445048744237
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD163,Scavenger receptor cysteine-rich type 1 protein M130,22671,169,0.99 [0.72-1.36],0.9473057085857082
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD164,Sialomucin core protein 24,22614,165,1.50 [1.05-2.14],0.0264983671841017
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD164L2,CD164 sialomucin-like 2 protein,19126,138,0.90 [0.57-1.41],0.6329556283350476
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD177,CD177 antigen,22585,165,1.05 [0.94-1.17],0.4111198462446315
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD1C,T-cell surface glycoprotein CD1c,22677,169,1.22 [0.68-2.19],0.4950850533134233
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD2,T-cell surface antigen CD2,19073,136,1.13 [0.78-1.65],0.5247570095364728
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD200,OX-2 membrane glycoprotein,22569,167,0.81 [0.47-1.38],0.4311549722208678
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD200R1,Cell surface glycoprotein CD200 receptor 1,22501,167,1.15 [0.77-1.70],0.4997562434672862
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD207,C-type lectin domain family 4 member K,22111,167,0.92 [0.64-1.32],0.6449664770997958
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD209,CD209 antigen,22656,168,1.28 [0.91-1.81],0.1552491105276486
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD22,B-cell receptor CD22,22856,169,0.78 [0.55-1.10],0.155838137259578
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD226,CD226 antigen,19124,135,0.71 [0.48-1.07],0.1014048833224551
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD244,Natural killer cell receptor 2B4,22856,169,0.87 [0.52-1.45],0.6013697652965914
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD248,Endosialin,19669,142,1.14 [0.77-1.71],0.51284557230579
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD27,CD27 antigen,22677,169,0.99 [0.70-1.40],0.9512481001242332
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD274,Programmed cell death 1 ligand 1,22459,168,1.28 [0.88-1.86],0.1992104269501721
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD276,CD276 antigen,22600,169,1.01 [0.69-1.47],0.9747179549134932
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD28,T-cell-specific surface glycoprotein CD28,22099,164,0.85 [0.57-1.26],0.4132502719606615
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD2AP,CD2-associated protein,22609,170,0.92 [0.74-1.14],0.4473159821936996
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD300A,CMRF35-like molecule 8,19262,139,0.72 [0.41-1.25],0.240161037724611
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD300C,CMRF35-like molecule 6,22808,168,0.88 [0.59-1.31],0.527375124787524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD300E,CMRF35-like molecule 2,22730,167,0.79 [0.56-1.14],0.2058212605586689
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD300LF,CMRF35-like molecule 1,22809,167,1.07 [0.85-1.35],0.5457633199942709
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD300LG,CMRF35-like molecule 9,22614,165,1.06 [0.73-1.53],0.7755586638933161
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD302,CD302 antigen,22505,169,0.80 [0.50-1.28],0.3516573299456805
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD33,Myeloid cell surface antigen CD33,22677,169,0.95 [0.80-1.12],0.5065706715058593
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD34,Hematopoietic progenitor cell antigen CD34,22725,167,0.85 [0.48-1.51],0.5875524414608202
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD36,Platelet glycoprotein 4,19124,135,0.68 [0.47-1.01],0.0545942332932702
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22505,169,0.92 [0.58-1.44],0.7081379551170636
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD3D,T-cell surface glycoprotein CD3 delta chain,19065,134,1.01 [0.63-1.64],0.9593720886435698
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD3E,T-cell surface glycoprotein CD3 epsilon chain,19295,142,1.10 [0.73-1.65],0.659734609711
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD3G,T-cell surface glycoprotein CD3 gamma chain,19124,135,0.88 [0.71-1.09],0.2290526763461261
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD4,T-cell surface glycoprotein CD4,22527,167,0.78 [0.48-1.27],0.3121199119267356
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD40,Tumor necrosis factor receptor superfamily member 5,22601,166,0.95 [0.72-1.25],0.7028956788771313
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD40LG,CD40 ligand,22856,169,0.89 [0.75-1.06],0.1993739146320433
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD46,Membrane cofactor protein,22444,165,1.08 [0.66-1.76],0.7646551443182141
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD48,CD48 antigen,22670,169,0.81 [0.51-1.30],0.3901855914563764
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD5,T-cell surface glycoprotein CD5,22776,166,0.87 [0.57-1.34],0.5381967619881438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD55,Complement decay-accelerating factor,21795,157,1.01 [0.58-1.78],0.9669122276350278
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD58,Lymphocyte function-associated antigen 3,22566,169,0.75 [0.35-1.60],0.4545718770715446
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD59,CD59 glycoprotein,21772,161,0.83 [0.42-1.64],0.5930831961360534
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD5L,CD5 antigen-like,19585,136,0.77 [0.54-1.10],0.1483091223236349
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD6,T-cell differentiation antigen CD6,22816,168,0.97 [0.75-1.25],0.7957458218746136
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD63,CD63 antigen,22424,168,0.98 [0.75-1.27],0.8499205339061919
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD69,Early activation antigen CD69,22510,166,0.93 [0.80-1.09],0.370723613409503
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD7,T-cell antigen CD7,19085,135,0.96 [0.65-1.42],0.8290516856980761
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD70,CD70 antigen,22569,167,1.20 [0.87-1.67],0.2720311273150699
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD72,B-cell differentiation antigen CD72,19262,139,0.85 [0.57-1.27],0.4176385491767166
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD74,HLA class II histocompatibility antigen gamma chain,22808,168,0.84 [0.56-1.26],0.4077254753215739
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD79B,B-cell antigen receptor complex-associated protein beta chain,22856,169,0.95 [0.69-1.32],0.7813786288810936
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD80,T-lymphocyte activation antigen CD80,19673,140,0.87 [0.53-1.42],0.5707160818398644
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD82,CD82 antigen,19295,142,1.12 [0.79-1.59],0.5105781701404151
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD83,CD83 antigen,22569,167,0.81 [0.53-1.24],0.3274072942511769
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD84,SLAM family member 5,22569,167,0.82 [0.53-1.27],0.3773236327766355
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD86,T-lymphocyte activation antigen CD86,19573,142,0.92 [0.54-1.60],0.7769924360006834
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD8A,T-cell surface glycoprotein CD8 alpha chain,22808,168,1.25 [0.95-1.64],0.1120518166557646
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD93,Complement component C1q receptor,21721,157,1.20 [0.75-1.89],0.447507221225733
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD99,CD99 antigen,22614,165,1.14 [0.55-2.34],0.7258383248592831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CD99L2,CD99 antigen-like protein 2,22614,165,0.88 [0.49-1.58],0.6672549058238106
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDA,Cytidine deaminase,19632,140,1.12 [0.80-1.55],0.5096666756203263
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDAN1,Codanin-1,19633,140,1.48 [0.91-2.39],0.1128864802124226
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC123,Cell division cycle protein 123 homolog,18980,139,0.92 [0.70-1.20],0.5213449980013807
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC25A,M-phase inducer phosphatase 1,18980,139,0.72 [0.46-1.13],0.1567586749951411
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC26,Anaphase-promoting complex subunit CDC26,19545,142,1.03 [0.82-1.29],0.816673033311907
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC27,Cell division cycle protein 27 homolog,22099,164,0.83 [0.65-1.06],0.1363359976431441
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC37,Hsp90 co-chaperone Cdc37,22677,169,0.98 [0.84-1.16],0.8545914933522547
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDC42BPB,Serine/threonine-protein kinase MRCK beta,19573,142,0.92 [0.78-1.08],0.2884500048147108
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDCP1,CUB domain-containing protein 1,22459,168,0.90 [0.67-1.20],0.4739125430467309
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH1,Cadherin-1,21823,160,1.15 [0.83-1.60],0.3980829396488816
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH15,Cadherin-15,22760,168,1.07 [0.79-1.44],0.6786376901311861
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH17,Cadherin-17,22609,170,0.95 [0.77-1.16],0.5865466467917911
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH2,Cadherin-2,22609,170,1.34 [0.91-1.96],0.1364904607063144
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH22,Cadherin-22,19295,142,0.87 [0.49-1.55],0.6449355778704315
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH23,Cadherin-23,19633,140,0.78 [0.42-1.47],0.4422445900251076
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH3,Cadherin-3,22808,168,1.12 [0.76-1.64],0.5680606551702873
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH4,Cadherin-4,19065,134,0.86 [0.60-1.25],0.4413666125439908
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH5,Cadherin-5,22879,170,0.90 [0.57-1.40],0.6306202047609659
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDH6,Cadherin-6,22609,170,1.27 [0.89-1.82],0.1842853146223937
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDHR1,Cadherin-related family member 1,22047,163,1.21 [0.91-1.63],0.1930413419551863
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDHR2,Cadherin-related family member 2,22505,169,1.06 [0.89-1.26],0.5356587268726632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDHR5,Cadherin-related family member 5,22609,170,1.05 [0.74-1.49],0.7713942902765889
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDK1,Cyclin-dependent kinase 1,18980,139,0.93 [0.60-1.44],0.7312550255228575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19643,140,0.87 [0.65-1.16],0.3525755985069492
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDKL5,Cyclin-dependent kinase-like 5,19065,134,0.90 [0.65-1.25],0.5480760665064928
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDKN1A,Cyclin-dependent kinase inhibitor 1,22505,169,0.95 [0.83-1.08],0.4281844358100433
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22505,169,0.98 [0.85-1.14],0.8263705811112101
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDNF,Cerebral dopamine neurotrophic factor,22505,169,0.75 [0.49-1.17],0.2097136630168972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22642,169,0.97 [0.58-1.61],0.8934977782111218
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CDSN,Corneodesmosin,22775,168,0.94 [0.68-1.29],0.6966685489777534
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22639,169,0.98 [0.56-1.74],0.9529130669205
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19573,142,1.13 [0.92-1.39],0.2356423707127127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19295,142,1.02 [0.82-1.28],0.8396514384354972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19573,142,1.08 [0.72-1.62],0.6977877461557411
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19295,142,0.85 [0.57-1.25],0.4079764876303118
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22569,167,1.06 [0.91-1.24],0.462560284603666
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22099,164,1.04 [0.79-1.38],0.7711298669291831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21796,163,0.78 [0.62-0.98],0.0357960753132409
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19669,142,0.98 [0.63-1.52],0.9173237636666796
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22202,165,0.98 [0.74-1.30],0.888336765869512
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEBPA,CCAAT/enhancer-binding protein alpha,19124,135,0.98 [0.64-1.50],0.9250710576821995
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEBPB,CCAAT/enhancer-binding protein beta,22202,165,0.90 [0.62-1.30],0.5690746225828872
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CELA2A,Chymotrypsin-like elastase family member 2A,19669,142,0.88 [0.67-1.15],0.3526263529052575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CELA3A,Chymotrypsin-like elastase family member 3A,22842,170,0.92 [0.72-1.17],0.4886947393314244
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19262,139,0.73 [0.41-1.32],0.2993245733229575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEMIP2,Cell surface hyaluronidase,19124,135,0.74 [0.41-1.33],0.3128970730175667
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEND1,Cell cycle exit and neuronal differentiation protein 1,19065,134,0.95 [0.71-1.27],0.7215162174150325
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CENPF,Centromere protein F,19295,142,0.86 [0.64-1.17],0.3340446799189141
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CENPJ,Centromere protein J,19295,142,1.19 [0.99-1.43],0.0678711049518079
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP112,Centrosomal protein of 112 kDa,19073,136,0.95 [0.65-1.39],0.7932394033624943
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP152,Centrosomal protein of 152 kDa,18980,139,0.77 [0.50-1.17],0.2210926648292258
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP164,Centrosomal protein of 164 kDa,22181,166,0.97 [0.77-1.22],0.7913451864907567
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP170,Centrosomal protein of 170 kDa,19177,139,0.90 [0.72-1.12],0.3264378826053836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP20,Centrosomal protein 20,22099,164,0.98 [0.81-1.18],0.8217889060063632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP290,Centrosomal protein of 290 kDa,19295,142,1.00 [0.74-1.35],0.9914776421226192
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP350,Centrosome-associated protein 350,18980,139,1.20 [0.80-1.79],0.3819829051463667
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP43,Centrosomal protein 43,22026,163,0.95 [0.78-1.17],0.6333375929298485
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CEP85,Centrosomal protein of 85 kDa,22099,164,0.88 [0.70-1.10],0.2638409982096258
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CERT,Ceramide transfer protein,22047,163,1.17 [0.94-1.47],0.1680971505739673
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CES1,Liver carboxylesterase 1,22656,170,1.02 [0.86-1.21],0.8399324624615623
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CES2,Cocaine esterase,22505,169,1.00 [0.77-1.28],0.9720582590174496
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CES3,Carboxylesterase 3,22505,169,0.84 [0.68-1.04],0.1099757479529349
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CETN2,Centrin-2,22047,163,1.10 [0.90-1.35],0.3416034044691335
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CETN3,Centrin-3,19573,142,0.98 [0.80-1.21],0.8529938686980283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFB,Complement factor B,19327,135,1.46 [0.89-2.41],0.1364136304197931
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFC1,Cryptic protein,22099,164,1.04 [0.77-1.40],0.7945985231560607
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFD,Complement factor D,19703,139,1.02 [0.44-2.39],0.959905857192453
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFH,Complement factor H,18537,127,1.53 [0.74-3.17],0.2534671318312133
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFHR2,Complement factor H-related protein 2,19559,137,0.85 [0.65-1.11],0.2216588984101979
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFHR4,Complement factor H-related protein 4,19672,139,1.09 [0.87-1.37],0.4450271785943569
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFHR5,Complement factor H-related protein 5,19412,135,1.10 [0.74-1.65],0.6258622785300608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFI,Complement factor I,19703,139,1.12 [0.50-2.49],0.785201800686106
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CFP,Properdin,19703,139,1.42 [0.83-2.44],0.1989528799660738
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CGA,Glycoprotein hormones alpha chain,22614,165,0.92 [0.79-1.08],0.3059890388792673
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19678,139,1.08 [0.80-1.45],0.6119062117893601
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CGN,Cingulin,19126,138,0.63 [0.39-1.03],0.0628987735465515
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CGREF1,Cell growth regulator with EF hand domain protein 1,22609,170,0.90 [0.65-1.25],0.5280931159501395
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22099,164,0.95 [0.76-1.20],0.6842595816025535
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHAD,Chondroadherin,19262,139,0.84 [0.62-1.14],0.2632789615617048
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19633,140,0.76 [0.49-1.19],0.2345339935935723
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHCHD6,MICOS complex subunit MIC25,19568,141,0.89 [0.49-1.60],0.6895368725383431
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHEK2,Serine/threonine-protein kinase Chk2,22202,165,1.15 [0.78-1.70],0.4688931224735132
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHGA,Chromogranin-A,19669,142,0.98 [0.82-1.18],0.8436752032418322
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHGB,Secretogranin-1,22717,167,0.85 [0.60-1.20],0.3500748285127925
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHI3L1,Chitinase-3-like protein 1,22080,161,0.98 [0.81-1.18],0.8112939451121864
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHIT1,Chitotriosidase-1,22699,167,1.06 [0.96-1.18],0.2570811299541962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHL1,Neural cell adhesion molecule L1-like protein,22634,169,1.05 [0.68-1.61],0.8284502864753794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHM,Rab proteins geranylgeranyltransferase component A 1,19126,138,0.78 [0.59-1.03],0.0783535812909205
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHMP1A,Charged multivesicular body protein 1a,22459,168,1.04 [0.88-1.24],0.6483897378438462
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHMP6,Charged multivesicular body protein 6,19673,140,0.82 [0.62-1.10],0.1885969225036579
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHP1,Calcineurin B homologous protein 1,19065,134,0.89 [0.70-1.14],0.3515479486454476
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHRDL1,Chordin-like protein 1,22670,169,1.09 [0.69-1.71],0.7083488267912685
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHRDL2,Chordin-like protein 2,22609,170,1.08 [0.85-1.36],0.5271864644522153
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CHRM1,Muscarinic acetylcholine receptor M1,19126,138,0.53 [0.31-0.91],0.0207572820893283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CIAPIN1,Anamorsin,22677,169,1.00 [0.81-1.24],0.9964458484031916
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CILP,Cartilage intermediate layer protein 1,19669,142,0.91 [0.68-1.22],0.5200082095507387
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CINP,Cyclin-dependent kinase 2-interacting protein,19295,142,0.74 [0.48-1.13],0.1571882470077282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CIRBP,Cold-inducible RNA-binding protein,19573,142,0.96 [0.81-1.14],0.6506239814380936
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CIT,Citron Rho-interacting kinase,19126,138,0.94 [0.65-1.35],0.7386163020448454
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CKAP4,Cytoskeleton-associated protein 4,22747,165,0.86 [0.50-1.49],0.5972028114917239
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CKB,Creatine kinase B-type,19669,142,0.81 [0.62-1.06],0.1217357371537396
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22525,166,0.98 [0.81-1.18],0.8108065928970806
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLASP1,CLIP-associating protein 1,18980,139,0.93 [0.74-1.18],0.5601463858632976
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLC,Galectin-10,22574,170,0.87 [0.71-1.08],0.2144879424341461
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC10A,C-type lectin domain family 10 member A,22459,168,1.23 [0.84-1.80],0.2902727209709885
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC11A,C-type lectin domain family 11 member A,22566,165,1.17 [0.87-1.56],0.2989232225953734
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC12A,C-type lectin domain family 12 member A,19124,135,0.79 [0.34-1.82],0.5770187090978767
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC14A,C-type lectin domain family 14 member A,22614,165,0.95 [0.61-1.48],0.8147931716771966
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC1A,C-type lectin domain family 1 member A,22202,165,1.07 [0.70-1.64],0.7591839854049002
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC1B,C-type lectin domain family 1 member B,22808,168,0.93 [0.81-1.07],0.3016834336901522
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC2L,C-type lectin domain family 2 member L,19126,138,0.67 [0.44-1.02],0.059134425654831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC3B,Tetranectin,19228,133,1.58 [0.76-3.26],0.2183932874933868
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC4A,C-type lectin domain family 4 member A,22569,167,1.21 [0.81-1.80],0.3625358137447561
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC4C,C-type lectin domain family 4 member C,22569,167,0.84 [0.62-1.13],0.2470054862318298
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC4D,C-type lectin domain family 4 member D,22569,167,0.88 [0.71-1.11],0.2771356310795778
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC4G,C-type lectin domain family 4 member G,22569,167,1.31 [0.87-1.98],0.1915190788761737
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC4M,C-type lectin domain family 4 member M,19630,142,1.24 [0.89-1.72],0.2012080878915139
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC5A,C-type lectin domain family 5 member A,22541,167,1.21 [0.75-1.96],0.4309743943313687
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC6A,C-type lectin domain family 6 member A,22099,164,1.01 [0.75-1.36],0.9676241070478616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLEC7A,C-type lectin domain family 7 member A,22856,169,1.06 [0.83-1.35],0.655432445607441
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLGN,Calmegin,19126,138,0.95 [0.65-1.38],0.798341752343656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLIC5,Chloride intracellular channel protein 5,19126,138,0.77 [0.44-1.36],0.3713652003392563
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLINT1,Clathrin interactor 1,18980,139,0.96 [0.66-1.39],0.8373088253673884
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLIP2,CAP-Gly domain-containing linker protein 2,22569,167,0.95 [0.84-1.07],0.4223526499378863
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLMP,CXADR-like membrane protein,22809,167,0.85 [0.43-1.69],0.645946238026496
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLNS1A,Methylosome subunit pICln,19126,138,1.05 [0.65-1.69],0.8425804230190708
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22411,168,1.03 [0.90-1.19],0.6492125651316003
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLPS,Colipase,22579,164,1.04 [0.85-1.27],0.7319959419329543
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLSPN,Claspin,21999,163,0.80 [0.50-1.27],0.3437931509714496
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLSTN1,Calsyntenin-1,22047,163,1.09 [0.85-1.40],0.4869570363516542
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLSTN2,Calsyntenin-2,22856,169,1.14 [0.82-1.60],0.4324316025531923
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLSTN3,Calsyntenin-3,19633,140,1.35 [0.82-2.22],0.231080110852306
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLTA,Clathrin light chain A,22202,165,1.15 [0.88-1.51],0.3106893974918209
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLU,Clusterin,19703,139,1.07 [0.68-1.69],0.7678047397501279
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CLUL1,Clusterin-like protein 1,22577,169,1.17 [0.87-1.57],0.2961808536650383
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CMC1,COX assembly mitochondrial protein homolog,19673,140,0.97 [0.81-1.16],0.7622871383949169
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CMIP,C-Maf-inducing protein,19568,141,0.88 [0.72-1.07],0.2021468353216615
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNDP1,Beta-Ala-His dipeptidase,22671,169,1.21 [0.89-1.65],0.2224938329741544
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNGB3,Cyclic nucleotide-gated cation channel beta-3,19065,134,0.95 [0.69-1.30],0.732665105614419
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19140,139,1.02 [0.84-1.26],0.8169982632194924
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNPY2,Protein canopy homolog 2,22202,165,0.92 [0.72-1.17],0.4834534759891478
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNPY4,Protein canopy homolog 4,22505,169,1.00 [0.83-1.20],0.9841277343782716
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNST,Consortin,22609,170,0.93 [0.82-1.06],0.2918287618407681
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTF,Ciliary neurotrophic factor,19065,134,0.99 [0.61-1.60],0.960482382580258
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTN1,Contactin-1,22879,170,0.86 [0.52-1.40],0.5365648733726993
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTN2,Contactin-2,22809,167,0.88 [0.64-1.19],0.3934049878757969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTN3,Contactin-3,22614,165,1.13 [0.76-1.67],0.553274098471844
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTN4,Contactin-4,22614,165,1.53 [0.86-2.70],0.1462455506387493
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTN5,Contactin-5,22659,166,0.87 [0.60-1.27],0.4781810989411653
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTNAP2,Contactin-associated protein-like 2,22569,167,1.11 [0.79-1.56],0.5471671681628917
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CNTNAP4,Contactin-associated protein-like 4,19126,138,0.94 [0.79-1.11],0.4532347859832365
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COCH,Cochlin,19673,140,0.99 [0.70-1.39],0.9402161777043996
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL15A1,Collagen alpha-1(XV) chain,19669,142,1.68 [0.91-3.10],0.097385748924147
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL18A1,Collagen alpha-1(XVIII) chain,22701,166,0.80 [0.44-1.46],0.4714295213374084
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL1A1,Collagen alpha-1(I) chain,22879,170,0.83 [0.49-1.39],0.480080122339898
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL24A1,Collagen alpha-1(XXIV) chain,19573,142,1.01 [0.76-1.35],0.9291168346162768
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL28A1,Collagen alpha-1(XXVIII) chain,19126,138,1.00 [0.80-1.26],0.9734175743858886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL2A1,Collagen alpha-1(II) chain,19177,139,0.99 [0.81-1.21],0.909078326303286
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL3A1,Collagen alpha-1(III) chain,19669,142,1.32 [0.66-2.60],0.4307096506151109
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL4A1,Collagen alpha-1(IV) chain,22609,170,0.96 [0.68-1.36],0.8274207611483106
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL4A4,Collagen alpha-4(IV) chain,19264,142,0.92 [0.69-1.24],0.5936187147921792
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL5A1,Collagen alpha-1(V) chain,19262,139,0.85 [0.55-1.30],0.444919553167023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL6A3,Collagen alpha-3(VI) chain,22879,170,1.23 [0.82-1.84],0.3172974289212944
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL9A1,Collagen alpha-1(IX) chain,22569,167,1.10 [0.82-1.46],0.5313166123284953
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COL9A2,Collagen alpha-2(IX) chain,19295,142,1.04 [0.75-1.44],0.805967159150485
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COLEC12,Collectin-12,22600,169,0.98 [0.57-1.71],0.9531632648354634
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COMMD1,COMM domain-containing protein 1,19177,139,0.99 [0.76-1.29],0.9546085899985
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COMMD9,COMM domain-containing protein 9,19568,141,0.87 [0.57-1.34],0.5352250882967016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COMP,Cartilage oligomeric matrix protein,22341,163,0.97 [0.64-1.47],0.8920070164491392
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COMT,Catechol O-methyltransferase,21966,163,0.98 [0.83-1.16],0.8143673261732269
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COPB2,Coatomer subunit beta',19073,136,1.09 [0.74-1.59],0.6670027104243462
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COPE,Coatomer subunit epsilon,22047,163,0.70 [0.49-1.00],0.052788338478249
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19177,139,1.16 [0.83-1.62],0.3855845566772883
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CORO1A,Coronin-1A,22122,164,1.02 [0.88-1.19],0.7756512176309791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CORO6,Coronin-6,19065,134,0.99 [0.63-1.56],0.9540487859728428
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22505,169,1.03 [0.85-1.25],0.7737010063804258
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",COX6B1,Cytochrome c oxidase subunit 6B1,19673,140,1.08 [0.66-1.78],0.7484358720051388
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPA1,Carboxypeptidase A1,22879,170,0.85 [0.67-1.08],0.1942609456596286
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPA2,Carboxypeptidase A2,22722,168,0.83 [0.67-1.03],0.0932439291285698
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPA4,Carboxypeptidase A4,18873,138,0.85 [0.59-1.24],0.406784575643454
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPB1,Carboxypeptidase B,22879,170,0.88 [0.69-1.12],0.3093018709802661
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPB2,Carboxypeptidase B2,19659,137,2.20 [1.10-4.38],0.0251233618130276
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPE,Carboxypeptidase E,22647,165,1.03 [0.72-1.47],0.8894473696930185
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPLX2,Complexin-2,18980,139,1.02 [0.60-1.73],0.9443035691004514
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPM,Carboxypeptidase M,22701,167,0.86 [0.58-1.27],0.4354440675787711
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19124,135,0.91 [0.50-1.66],0.7614274345368247
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPPED1,Serine/threonine-protein phosphatase CPPED1,22808,168,1.07 [0.88-1.31],0.4914089121725743
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPQ,Carboxypeptidase Q,19627,142,1.01 [0.66-1.56],0.9611245589415208
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPTP,Ceramide-1-phosphate transfer protein,19073,136,1.00 [0.67-1.50],0.9913274830402216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPVL,Probable serine carboxypeptidase CPVL,22781,167,1.06 [0.76-1.49],0.7291355590419095
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPXM1,Probable carboxypeptidase X1,22677,169,0.94 [0.77-1.14],0.5320829094299407
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CPXM2,Inactive carboxypeptidase-like protein X2,19673,140,0.96 [0.50-1.84],0.9090930068586088
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CR1,Complement receptor type 1,19597,139,1.27 [0.81-2.02],0.2999499110116491
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CR2,Complement receptor type 2,22671,169,0.96 [0.72-1.30],0.81201821212337
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22099,164,0.97 [0.82-1.14],0.6714460611456373
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRADD,Death domain-containing protein CRADD,22411,168,0.97 [0.81-1.16],0.7107347780238576
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CREB3,Cyclic AMP-responsive element-binding protein 3,18980,139,0.92 [0.68-1.24],0.5759828055992448
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CREBZF,CREB/ATF bZIP transcription factor,18980,139,1.18 [0.65-2.12],0.5884313601246536
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CREG1,Protein CREG1,22308,162,1.19 [0.82-1.74],0.357911102715739
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRELD1,Protein disulfide isomerase CRELD1,19262,139,1.24 [0.81-1.91],0.3236110229480676
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRELD2,Protein disulfide isomerase CRELD2,22670,169,1.06 [0.82-1.38],0.636208495812711
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRH,Corticoliberin,22058,164,0.92 [0.78-1.08],0.2957467657995489
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRHBP,Corticotropin-releasing factor-binding protein,22600,169,1.16 [0.72-1.88],0.5464150333906361
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRHR1,Corticotropin-releasing factor receptor 1,22202,165,1.03 [0.83-1.27],0.7989695077802047
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRIM1,Cysteine-rich motor neuron 1 protein,22709,169,1.00 [0.51-1.96],0.9919980794695292
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRIP2,Cysteine-rich protein 2,22459,168,1.20 [0.84-1.70],0.322067982007833
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRISP2,Cysteine-rich secretory protein 2,22809,167,1.13 [0.90-1.42],0.2742478422485575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRISP3,Cysteine-rich secretory protein 3,19499,139,1.07 [0.59-1.96],0.8167619649538688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRKL,Crk-like protein,22636,169,0.96 [0.85-1.09],0.5400717422967574
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRLF1,Cytokine receptor-like factor 1,22709,169,1.69 [1.00-2.86],0.0508213398051597
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRNN,Cornulin,21965,161,0.95 [0.77-1.18],0.6583839827822677
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRTAC1,Cartilage acidic protein 1,22879,170,0.78 [0.50-1.22],0.2805971965157841
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRTAM,Cytotoxic and regulatory T-cell molecule,22459,168,0.77 [0.58-1.01],0.0624374121539591
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRTAP,Cartilage-associated protein,19126,138,0.79 [0.54-1.16],0.2225524969773457
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRX,Cone-rod homeobox protein,22202,165,0.94 [0.82-1.08],0.3569495033147658
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRYBB1,Beta-crystallin B1,19673,140,0.95 [0.74-1.22],0.6749518321098965
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRYBB2,Beta-crystallin B2,19633,140,1.01 [0.80-1.28],0.9336487436680312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRYGD,Gamma-crystallin D,19633,140,0.92 [0.78-1.09],0.3471665958228638
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRYM,Ketimine reductase mu-crystallin,19065,134,0.95 [0.76-1.20],0.6816378427312002
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CRYZL1,Quinone oxidoreductase-like protein 1,19177,139,0.99 [0.83-1.18],0.9193172709283464
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSDE1,Cold shock domain-containing protein E1,19073,136,0.97 [0.84-1.12],0.6403693355596529
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF1,Macrophage colony-stimulating factor 1,22709,169,0.86 [0.52-1.45],0.5782731956069653
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF1R,Macrophage colony-stimulating factor 1 receptor,19678,139,1.12 [0.74-1.70],0.5970457448512171
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF2,Granulocyte-macrophage colony-stimulating factor,19073,136,1.37 [0.92-2.06],0.1249091150348256
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22459,168,0.97 [0.78-1.21],0.7878047522928251
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF2RB,Cytokine receptor common subunit beta,19124,135,1.13 [0.78-1.65],0.5237055711313562
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF3,Granulocyte colony-stimulating factor,22181,166,0.96 [0.72-1.28],0.7898068541669678
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSF3R,Granulocyte colony-stimulating factor receptor,19124,135,0.74 [0.42-1.30],0.2910183469613482
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSH1,Chorionic somatomammotropin hormone 1,19678,139,0.71 [0.41-1.25],0.2399270001334735
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSNK1D,Casein kinase I isoform delta,19124,135,0.78 [0.59-1.04],0.0853650763881231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSNK2A1,Casein kinase II subunit alpha,19643,140,0.84 [0.58-1.20],0.3325020278933197
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSPG4,Chondroitin sulfate proteoglycan 4,19669,142,0.97 [0.59-1.58],0.8978246652729396
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSPG5,Chondroitin sulfate proteoglycan 5,19065,134,1.02 [0.73-1.42],0.9101506871406864
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSRP3,Cysteine and glycine-rich protein 3,19073,136,1.07 [0.91-1.26],0.3925023237986177
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CST1,Cystatin-SN,17069,125,0.99 [0.83-1.18],0.9087017512395078
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CST3,Cystatin-C,22638,169,1.33 [0.81-2.18],0.2566514900228195
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CST5,Cystatin-D,22228,168,1.25 [0.98-1.59],0.0718585459395487
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CST6,Cystatin-M,22034,163,1.13 [0.84-1.52],0.4178723608912166
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CST7,Cystatin-F,22640,166,0.92 [0.78-1.08],0.3036648230683867
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CSTB,Cystatin-B,22297,165,0.82 [0.59-1.14],0.2424101829120212
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTAG1A_CTAG1B,Cancer/testis antigen 1,19252,142,0.97 [0.70-1.33],0.8325043972012133
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTBS,Di-N-acetylchitobiase,19384,136,0.84 [0.47-1.51],0.5662852718459934
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTF1,Cardiotrophin-1,22202,165,0.92 [0.77-1.08],0.3002566993579528
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTHRC1,Collagen triple helix repeat-containing protein 1,19669,142,0.88 [0.49-1.59],0.6786180627765711
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTLA4,Cytotoxic T-lymphocyte protein 4,19669,142,0.81 [0.47-1.40],0.4550583417237606
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTNNA1,Catenin alpha-1,19065,134,0.96 [0.60-1.53],0.8688781287562132
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTRB1,Chymotrypsinogen B,22614,165,0.96 [0.74-1.25],0.7659249332952858
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTRC,Chymotrypsin-C,22609,169,0.87 [0.70-1.08],0.2098218981730647
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTRL,Chymotrypsin-like protease CTRL-1,19633,140,0.87 [0.68-1.11],0.2571157181053229
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSB,Cathepsin B,22626,167,1.01 [0.79-1.31],0.9091786301136306
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSC,Dipeptidyl peptidase 1,22565,169,0.81 [0.59-1.13],0.2141929559732561
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSD,Cathepsin D,21086,156,0.80 [0.54-1.18],0.2602483019253766
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSE,Cathepsin E,19262,139,1.07 [0.78-1.46],0.6679619521469949
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSF,Cathepsin F,22677,169,0.96 [0.68-1.34],0.8006374078295492
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSH,Pro-cathepsin H,22140,165,0.98 [0.81-1.18],0.8238100115691458
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSL,Cathepsin L1,22609,170,1.07 [0.61-1.89],0.8122850254073017
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSO,Cathepsin O,22856,169,0.90 [0.57-1.42],0.6635655732061618
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSS,Cathepsin S,17745,132,1.29 [0.65-2.59],0.4667270577503614
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSV,Cathepsin L2,22750,166,0.83 [0.60-1.15],0.2574333883330701
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CTSZ,Cathepsin Z,22592,169,1.18 [0.76-1.83],0.456837199840006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CUZD1,CUB and zona pellucida-like domain-containing protein 1,19126,138,0.81 [0.49-1.33],0.4018473888010127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CWC15,Spliceosome-associated protein CWC15 homolog,19455,142,0.99 [0.76-1.29],0.9391259741189356
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CX3CL1,Fractalkine,22459,168,1.03 [0.68-1.54],0.9007231370916362
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXADR,Coxsackievirus and adenovirus receptor,22569,167,0.83 [0.63-1.09],0.1753652016332768
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL1,Growth-regulated alpha protein,22564,165,1.03 [0.90-1.19],0.6365801889194767
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL10,C-X-C motif chemokine 10,22709,169,0.98 [0.80-1.20],0.8422740375493364
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL11,C-X-C motif chemokine 11,22808,168,0.90 [0.76-1.08],0.2663874604335067
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL12,Stromal cell-derived factor 1,22181,166,0.66 [0.46-0.93],0.0189429682382388
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL13,C-X-C motif chemokine 13,22808,168,0.92 [0.73-1.16],0.5043651531097193
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL14,C-X-C motif chemokine 14,22181,166,0.80 [0.61-1.04],0.0983729483595062
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL16,C-X-C motif chemokine 16,22840,168,1.17 [0.66-2.10],0.587127038461709
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL17,C-X-C motif chemokine 17,22856,169,1.17 [0.84-1.62],0.3629058168186803
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL3,C-X-C motif chemokine 3,22601,166,0.98 [0.85-1.14],0.8341095323459803
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL5,C-X-C motif chemokine 5,22536,170,0.96 [0.85-1.07],0.4436767126785346
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL6,C-X-C motif chemokine 6,22856,169,0.93 [0.78-1.11],0.4022005999901492
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL8,Interleukin-8,22433,165,0.97 [0.79-1.19],0.7995947288799533
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CXCL9,C-X-C motif chemokine 9,22709,169,0.91 [0.74-1.13],0.4042475242901979
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CYB5A,Cytochrome b5,18980,139,1.01 [0.81-1.25],0.9339452460331832
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CYB5R2,NADH-cytochrome b5 reductase 2,19330,141,1.20 [0.91-1.58],0.1957822906798975
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19073,136,0.77 [0.61-0.99],0.0383262003563896
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CYTH3,Cytohesin-3,18980,139,0.98 [0.78-1.22],0.8539890073503593
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",CYTL1,Cytokine-like protein 1,19669,142,1.32 [0.66-2.65],0.4319487481289437
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAAM1,Disheveled-associated activator of morphogenesis 1,19262,139,0.88 [0.72-1.08],0.2184806212816905
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAB2,Disabled homolog 2,22809,167,0.95 [0.84-1.07],0.4135496939500519
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAG1,Dystroglycan,22709,169,0.92 [0.69-1.22],0.5627387822197016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAND5,DAN domain family member 5,19124,135,0.76 [0.56-1.04],0.0856893846826804
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAPK2,Death-associated protein kinase 2,19124,135,1.12 [0.85-1.48],0.4203533922740253
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22569,167,0.97 [0.87-1.08],0.5838968621561631
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DARS1,"Aspartate--tRNA ligase, cytoplasmic",22411,168,1.02 [0.85-1.23],0.8107562975799242
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DBH,Dopamine beta-hydroxylase,19637,139,1.01 [0.87-1.18],0.8705040607624116
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DBI,Acyl-CoA-binding protein,22515,165,1.01 [0.84-1.20],0.9540655973841132
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DBN1,Drebrin,19124,135,0.79 [0.56-1.11],0.1764647635375265
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DBNL,Drebrin-like protein,22709,169,0.95 [0.82-1.09],0.4550391666034027
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22677,169,0.83 [0.56-1.23],0.3632670395385163
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCC,Netrin receptor DCC,19126,138,0.65 [0.29-1.48],0.3061739673355939
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCDC2C,Doublecortin domain-containing protein 2C,18980,139,0.93 [0.71-1.21],0.5693140455590939
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCLRE1C,Protein artemis,18980,139,0.69 [0.40-1.19],0.1854200312181044
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCN,Decorin,22202,165,0.64 [0.34-1.20],0.1634013569152414
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCTD,Deoxycytidylate deaminase,19262,139,0.96 [0.81-1.15],0.681726078688199
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCTN1,Dynactin subunit 1,22809,167,0.92 [0.75-1.13],0.4141062209050653
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCTN2,Dynactin subunit 2,22505,169,0.96 [0.83-1.11],0.5698203197944108
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCTN6,Dynactin subunit 6,22047,163,0.99 [0.81-1.20],0.9025228232057564
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCTPP1,dCTP pyrophosphatase 1,22609,170,1.17 [0.76-1.81],0.4752124365559838
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCUN1D1,DCN1-like protein 1,19065,134,0.87 [0.68-1.11],0.2649375273935738
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCUN1D2,DCN1-like protein 2,18980,139,1.01 [0.83-1.22],0.9424688583464016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DCXR,L-xylulose reductase,22677,169,1.13 [0.88-1.45],0.3394118555522092
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDA1,DET1- and DDB1-associated protein 1,19073,136,0.90 [0.59-1.37],0.6151657379459469
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22505,169,1.01 [0.75-1.37],0.9462875300509416
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDC,Aromatic-L-amino-acid decarboxylase,22575,170,1.06 [0.80-1.39],0.7002760225318314
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDHD2,Phospholipase DDHD2,19643,140,0.88 [0.69-1.12],0.3040830147351309
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDI2,Protein DDI1 homolog 2,19262,139,1.03 [0.84-1.26],0.8026559312236571
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDR1,Epithelial discoidin domain-containing receptor 1,22808,168,0.70 [0.38-1.31],0.2655033830136363
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDT,D-dopachrome decarboxylase,19669,142,0.98 [0.67-1.44],0.9241473283506362
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX1,ATP-dependent RNA helicase DDX1,19573,142,1.25 [0.96-1.63],0.0981138164755196
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX25,ATP-dependent RNA helicase DDX25,19126,138,0.67 [0.41-1.12],0.12642195004973
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX39A,ATP-dependent RNA helicase DDX39A,19124,135,0.98 [0.47-2.07],0.9643932992342588
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX4,Probable ATP-dependent RNA helicase DDX4,19124,135,1.16 [0.89-1.52],0.2610191746222765
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX53,Probable ATP-dependent RNA helicase DDX53,19126,138,1.13 [0.72-1.78],0.5867873163997117
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DDX58,Antiviral innate immune response receptor RIG-I,22099,164,1.00 [0.79-1.27],0.9694083601306052
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22569,167,1.03 [0.89-1.18],0.7035862919453506
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFA1_DEFA1B,Neutrophil defensin 1,22127,158,1.15 [0.89-1.48],0.2887635118010381
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFB103A_DEFB103B,Beta-defensin 103,18972,135,1.24 [0.91-1.71],0.1786108884671816
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFB104A_DEFB104B,Beta-defensin 104,19065,134,0.86 [0.62-1.19],0.3680151103470709
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFB116,Beta-defensin 116,19065,134,1.02 [0.83-1.26],0.836185047313316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFB118,Beta-defensin 118,19065,134,0.88 [0.63-1.22],0.4466708393286852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DEFB4A_DEFB4B,Beta-defensin 4A,22301,168,0.90 [0.82-0.99],0.0335423819793677
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DENND2B,DENN domain-containing protein 2B,19073,136,1.10 [0.83-1.45],0.5181225862206164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DENR,Density-regulated protein,19124,135,0.83 [0.61-1.12],0.220631196083528
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DFFA,DNA fragmentation factor subunit alpha,22856,169,1.02 [0.84-1.25],0.819022506273547
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DGCR6,Protein DGCR6,19065,134,0.83 [0.54-1.26],0.3730690266498279
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DGKA,Diacylglycerol kinase alpha,19124,135,0.89 [0.65-1.22],0.4601579014659814
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DGKZ,Diacylglycerol kinase zeta,22181,166,1.08 [0.73-1.59],0.7085547502888259
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DHODH,Dihydroorotate dehydrogenase,19073,136,1.03 [0.74-1.43],0.8517861350505678
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DHPS,Deoxyhypusine synthase,19568,141,1.16 [0.82-1.63],0.3966106848387357
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19633,140,0.99 [0.70-1.40],0.959206929444324
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DIABLO,"Diablo homolog, mitochondrial",22541,167,0.95 [0.84-1.08],0.4547034780244133
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DIPK1C,Divergent protein kinase domain 1C,19126,138,0.77 [0.51-1.18],0.2381792531344833
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DIPK2B,Divergent protein kinase domain 2B,19262,139,1.02 [0.55-1.88],0.9496869630138092
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DKK1,Dickkopf-related protein 1,22808,168,0.88 [0.71-1.11],0.2851155097159487
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DKK3,Dickkopf-related protein 3,22879,170,1.14 [0.72-1.80],0.5746009952562809
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DKK4,Dickkopf-related protein 4,22428,168,0.88 [0.65-1.20],0.4169287367333911
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DKKL1,Dickkopf-like protein 1,22505,169,1.02 [0.87-1.19],0.8167822989410288
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DLG4,Disks large homolog 4,19633,140,0.89 [0.70-1.12],0.3125443611895843
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DLGAP5,Disks large-associated protein 5,19643,140,0.83 [0.58-1.19],0.3048536713867495
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DLK1,Protein delta homolog 1,22879,170,1.04 [0.81-1.34],0.7474291164085964
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DLL1,Delta-like protein 1,22677,169,1.00 [0.62-1.61],0.9865962202079988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DLL4,Delta-like protein 4,19177,139,0.96 [0.78-1.19],0.7338480594822765
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DMD,Dystrophin,19177,139,0.93 [0.67-1.30],0.6888842362067149
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DMP1,Dentin matrix acidic phosphoprotein 1,19177,139,0.96 [0.75-1.24],0.7764964007964593
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJA1,DnaJ homolog subfamily A member 1,18980,139,1.02 [0.72-1.44],0.9151111871896206
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJA2,DnaJ homolog subfamily A member 2,22787,166,0.92 [0.78-1.08],0.3208377622908265
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJA4,DnaJ homolog subfamily A member 4,19633,140,0.92 [0.74-1.15],0.4777176192751657
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJB1,DnaJ homolog subfamily B member 1,22505,169,0.98 [0.84-1.14],0.7749322852823676
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJB14,DnaJ homolog subfamily B member 14,19573,142,0.94 [0.73-1.20],0.6027425711788343
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJB2,DnaJ homolog subfamily B member 2,19262,139,1.01 [0.75-1.36],0.9498571890887691
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJB6,DnaJ homolog subfamily B member 6,19071,139,0.96 [0.79-1.17],0.6758283026921872
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJB8,DnaJ homolog subfamily B member 8,22202,165,1.20 [0.99-1.46],0.064625880808196
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJC21,DnaJ homolog subfamily C member 21,19633,140,1.00 [0.65-1.52],0.985781274894518
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJC6,Putative tyrosine-protein phosphatase auxilin,19177,139,0.94 [0.77-1.14],0.5289417211501195
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNAJC9,DnaJ homolog subfamily C member 9,19573,142,1.01 [0.82-1.24],0.9167445523163216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNER,Delta and Notch-like epidermal growth factor-related receptor,22568,169,0.86 [0.50-1.50],0.6045339372764957
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNLZ,DNL-type zinc finger protein,19065,134,1.07 [0.91-1.25],0.4296101324321822
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNM1,Dynamin-1,19573,142,0.99 [0.86-1.13],0.8405421412383085
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNM3,Dynamin-3,19643,140,0.71 [0.51-0.99],0.0405226884246102
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNMBP,Dynamin-binding protein,22459,168,1.01 [0.81-1.26],0.9274477960029756
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNPEP,Aspartyl aminopeptidase,19633,140,0.93 [0.71-1.23],0.626121287842412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22675,169,1.05 [0.81-1.36],0.7041815489582375
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DOC2B,Double C2-like domain-containing protein beta,19126,138,0.65 [0.37-1.13],0.1264556651741543
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DOCK9,Dedicator of cytokinesis protein 9,19065,134,1.11 [0.98-1.25],0.0871295123311551
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DOK1,Docking protein 1,19633,140,0.94 [0.84-1.06],0.3347428338673827
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DOK2,Docking protein 2,22609,170,0.96 [0.86-1.07],0.4364711215829572
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPEP1,Dipeptidase 1,22411,168,0.99 [0.76-1.30],0.9697925185695856
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPEP2,Dipeptidase 2,22505,169,0.71 [0.44-1.15],0.1666174269179615
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPP10,Inactive dipeptidyl peptidase 10,22569,167,0.83 [0.55-1.27],0.3938689088496034
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPP4,Dipeptidyl peptidase 4,22161,163,0.93 [0.58-1.50],0.7654862452149651
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPP6,Dipeptidyl aminopeptidase-like protein 6,22505,169,0.69 [0.46-1.05],0.0808730945101289
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPP7,Dipeptidyl peptidase 2,22420,169,1.12 [0.89-1.41],0.3390860823638897
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPT,Dermatopontin,22879,170,0.65 [0.40-1.06],0.0818679749909289
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DPY30,Protein dpy-30 homolog,22736,167,1.04 [0.83-1.30],0.7535225209134153
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DRAXIN,Draxin,22459,168,1.01 [0.74-1.39],0.945603836109368
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DRG2,Developmentally-regulated GTP-binding protein 2,22505,169,0.95 [0.75-1.22],0.6998113928193244
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DSC2,Desmocollin-2,22370,162,1.01 [0.66-1.54],0.9651419477055376
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DSCAM,Down syndrome cell adhesion molecule,19643,140,0.76 [0.48-1.21],0.2515033716269105
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DSG2,Desmoglein-2,22614,165,0.94 [0.56-1.57],0.8179363583244477
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DSG3,Desmoglein-3,22741,167,0.81 [0.54-1.22],0.3180274289774829
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DSG4,Desmoglein-4,22426,169,0.95 [0.73-1.24],0.6970816360922341
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DTD1,D-aminoacyl-tRNA deacylase 1,19262,139,0.94 [0.78-1.13],0.4965792597007428
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DTNB,Dystrobrevin beta,19540,141,0.83 [0.56-1.24],0.3676389580803684
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DTX2,Probable E3 ubiquitin-protein ligase DTX2,19126,138,0.82 [0.62-1.08],0.1625075226936895
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DTX3,Probable E3 ubiquitin-protein ligase DTX3,22505,169,0.85 [0.47-1.54],0.6007266325916834
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DTYMK,Thymidylate kinase,19673,140,0.87 [0.69-1.10],0.2603962426237849
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DUOX2,Dual oxidase 2,22202,165,0.97 [0.80-1.18],0.786485777338891
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DUSP13,Dual specificity protein phosphatase 13 isoform A,19568,141,1.10 [0.75-1.61],0.63030607632178
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DUSP29,Dual specificity phosphatase 29,19126,138,0.94 [0.73-1.22],0.6614129934493265
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DUSP3,Dual specificity protein phosphatase 3,22047,163,0.94 [0.79-1.11],0.4411766647823524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19573,142,0.94 [0.80-1.10],0.4262607593235671
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DXO,Decapping and exoribonuclease protein,19633,140,1.01 [0.71-1.44],0.9484083809435752
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19568,141,0.90 [0.63-1.29],0.5720845773522916
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DYNLT1,Dynein light chain Tctex-type 1,19126,138,1.12 [0.93-1.35],0.2241636191003519
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",DYNLT3,Dynein light chain Tctex-type 3,19568,141,1.07 [0.75-1.54],0.6975751521645582
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22459,168,0.97 [0.84-1.13],0.7221958408414488
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EBI3_IL27,Interleukin-27,22770,167,0.83 [0.53-1.31],0.4225913826907015
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECE1,Endothelin-converting enzyme 1,22047,163,0.91 [0.61-1.36],0.6550451293370856
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19673,140,1.03 [0.83-1.28],0.7683730421846693
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECHS1,"Enoyl-CoA hydratase, mitochondrial",19177,139,0.97 [0.82-1.14],0.6866824281841559
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECI2,Enoyl-CoA delta isomerase 2,19073,136,0.81 [0.61-1.08],0.1576288314317167
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECM1,Extracellular matrix protein 1,19139,133,1.06 [0.67-1.67],0.8046506402649498
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ECSCR,Endothelial cell-specific chemotaxis regulator,19065,134,0.99 [0.72-1.36],0.9298345868669676
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDA2R,Tumor necrosis factor receptor superfamily member 27,22809,167,1.04 [0.69-1.56],0.8421650449294455
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDAR,Tumor necrosis factor receptor superfamily member EDAR,22569,167,0.91 [0.78-1.06],0.2119148852584461
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDDM3B,Epididymal secretory protein E3-beta,19568,141,1.16 [0.81-1.66],0.4281075756460042
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19073,136,0.84 [0.51-1.35],0.4652808590533823
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDF1,Endothelial differentiation-related factor 1,19643,140,0.96 [0.76-1.21],0.7240727786700314
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22202,165,1.15 [0.78-1.71],0.4780297442167946
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDN1,Endothelin-1,19177,139,1.05 [0.60-1.86],0.8552945020263912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EDNRB,Endothelin receptor type B,19124,135,0.86 [0.57-1.28],0.4496323271927033
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EEF1D,Elongation factor 1-delta,19673,140,0.95 [0.80-1.14],0.6037235407942867
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFCAB14,EF-hand calcium-binding domain-containing protein 14,19573,142,0.96 [0.53-1.75],0.8965388750079678
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFCAB2,Dynein regulatory complex protein 8,19295,142,0.99 [0.63-1.57],0.9698009139211556
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22632,167,1.00 [0.63-1.57],0.9861188459004804
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFHD1,EF-hand domain-containing protein D1,19643,140,0.68 [0.41-1.14],0.1434634968825926
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFNA1,Ephrin-A1,22580,165,0.90 [0.53-1.53],0.694054237840301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFNA4,Ephrin-A4,22424,168,0.83 [0.50-1.38],0.4759967223153337
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EFNB2,Ephrin-B2,19126,138,0.99 [0.75-1.31],0.9715721739904476
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EGF,Pro-epidermal growth factor,22570,169,0.94 [0.83-1.07],0.3552693613065374
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EGFL7,Epidermal growth factor-like protein 7,22099,164,0.90 [0.64-1.28],0.5574965711579895
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EGFLAM,Pikachurin,19573,142,1.01 [0.60-1.71],0.9580972861018412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EGFR,Epidermal growth factor receptor,22879,170,1.09 [0.47-2.50],0.8425439641396044
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EGLN1,Egl nine homolog 1,22569,167,1.01 [0.79-1.30],0.9166582529470436
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EHBP1,EH domain-binding protein 1,19673,140,0.92 [0.74-1.14],0.446751308668995
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EHD3,EH domain-containing protein 3,19177,139,0.99 [0.86-1.14],0.878605808679306
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19633,140,0.93 [0.68-1.26],0.6207509983812993
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19506,141,0.97 [0.83-1.12],0.6684640128908301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19073,136,0.83 [0.64-1.09],0.1799854631882163
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19177,139,0.79 [0.52-1.21],0.2819059924575272
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF4B,Eukaryotic translation initiation factor 4B,22459,168,0.94 [0.75-1.19],0.6079459027899872
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF4E,Eukaryotic translation initiation factor 4E,19124,135,0.98 [0.82-1.18],0.8709673377337679
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22609,170,1.00 [0.81-1.23],0.997728535035156
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22856,169,0.98 [0.86-1.13],0.8090057980765352
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19643,140,0.91 [0.71-1.17],0.4470166006941645
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF5,Eukaryotic translation initiation factor 5,19073,136,0.97 [0.67-1.41],0.8898072006466768
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EIF5A,Eukaryotic translation initiation factor 5A-1,22181,166,0.81 [0.49-1.32],0.3921112187542959
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ELAC1,Zinc phosphodiesterase ELAC protein 1,19643,140,0.92 [0.76-1.11],0.380256886606362
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ELAVL4,ELAV-like protein 4,19065,134,1.02 [0.84-1.23],0.8749607360713041
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ELN,Elastin,19673,140,0.78 [0.49-1.26],0.312320995662174
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ELOA,Elongin-A,22505,169,0.92 [0.71-1.21],0.5614547296510141
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ELOB,Elongin-B,19073,136,0.95 [0.63-1.45],0.8179084027589009
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENAH,Protein enabled homolog,22181,166,1.13 [0.86-1.50],0.3828200768110973
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENDOU,Poly(U)-specific endoribonuclease,18172,130,1.17 [0.85-1.62],0.3408197230355433
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENG,Endoglin,22879,170,0.89 [0.40-1.97],0.7708565942584588
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENO1,Alpha-enolase,22574,167,1.08 [0.91-1.29],0.3806947899838487
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENO2,Gamma-enolase,22808,168,0.99 [0.80-1.21],0.886547384393604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENO3,Beta-enolase,19177,139,1.04 [0.78-1.38],0.7960311120177433
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENOPH1,Enolase-phosphatase E1,19568,141,0.84 [0.60-1.17],0.3107524959812098
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19073,136,1.26 [0.73-2.16],0.4071134930762639
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENPEP,Glutamyl aminopeptidase,19073,136,0.82 [0.53-1.26],0.3576814289772678
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22879,170,0.69 [0.43-1.11],0.1300625364649667
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22709,169,1.08 [0.77-1.51],0.6574004232559832
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19177,139,1.34 [0.86-2.09],0.1924952279594166
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21909,164,1.06 [0.90-1.24],0.4961412414125972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENSA,Alpha-endosulfine,19568,141,0.85 [0.62-1.18],0.3390596601036504
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22099,164,0.87 [0.63-1.20],0.4026230384084887
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22202,165,1.05 [0.54-2.04],0.8786219688159451
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22202,165,0.82 [0.51-1.33],0.420848175838434
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ENTR1,Endosome-associated-trafficking regulator 1,19177,139,1.18 [0.91-1.55],0.2178477105284216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EP300,Histone acetyltransferase p300,19124,135,0.90 [0.52-1.56],0.7059057524954158
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPB41L5,Band 4.1-like protein 5,19126,138,0.90 [0.69-1.19],0.4743160405582893
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPCAM,Epithelial cell adhesion molecule,22604,169,0.96 [0.84-1.10],0.5313887004550228
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPGN,Epigen,19568,141,1.06 [0.77-1.44],0.7340629462052823
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHA1,Ephrin type-A receptor 1,22675,169,1.17 [0.78-1.75],0.4422258180278291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHA10,Ephrin type-A receptor 10,22047,163,1.01 [0.82-1.25],0.9170036914923796
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHA2,Ephrin type-A receptor 2,21799,162,0.82 [0.50-1.35],0.4365021705618254
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHA4,Ephrin type-A receptor 4,19262,139,0.76 [0.43-1.36],0.3581778103983909
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHB4,Ephrin type-B receptor 4,22879,170,0.88 [0.50-1.56],0.6620191961450678
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHB6,Ephrin type-B receptor 6,22411,168,0.81 [0.52-1.27],0.3606621345250946
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPHX2,Bifunctional epoxide hydrolase 2,22202,165,0.92 [0.73-1.17],0.5049216731222852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPN1,Epsin-1,19295,142,1.03 [0.72-1.48],0.8558870657507367
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPO,Erythropoietin,22569,167,0.94 [0.78-1.12],0.4762936340881131
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPPK1,Epiplakin,19177,139,0.82 [0.65-1.03],0.0859714352898074
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22775,167,1.02 [0.64-1.61],0.939142345908449
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERBB2,Receptor tyrosine-protein kinase erbB-2,22677,169,1.02 [0.58-1.79],0.951155994786064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERBB3,Receptor tyrosine-protein kinase erbB-3,22539,166,1.16 [0.56-2.40],0.6832827211826256
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERBB4,Receptor tyrosine-protein kinase erbB-4,22677,169,1.31 [0.74-2.31],0.3514509629113532
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERBIN,Erbin,22505,169,0.94 [0.83-1.08],0.3971643824004552
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERC2,ERC protein 2,19126,138,0.91 [0.72-1.15],0.445138316433075
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERCC1,DNA excision repair protein ERCC-1,18980,139,0.94 [0.56-1.58],0.8097178447198023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EREG,Proepiregulin,22411,168,1.05 [0.89-1.24],0.584217810840965
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERI1,3'-5' exoribonuclease 1,19295,142,0.96 [0.59-1.56],0.8754883961810358
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERMAP,Erythroid membrane-associated protein,19124,135,0.66 [0.45-0.96],0.027937897104398
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19568,141,0.88 [0.58-1.35],0.567202137055031
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERP29,Endoplasmic reticulum resident protein 29,19262,139,0.96 [0.84-1.11],0.6062112681941234
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERP44,Endoplasmic reticulum resident protein 44,22465,168,0.93 [0.55-1.59],0.8003430688129911
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19073,136,0.95 [0.66-1.36],0.7590020272758005
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ESAM,Endothelial cell-selective adhesion molecule,22879,170,0.79 [0.51-1.23],0.2989945727927304
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ESM1,Endothelial cell-specific molecule 1,22600,169,0.85 [0.57-1.27],0.422720281749612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ESPL1,Separin,18980,139,0.92 [0.68-1.25],0.6061368907928388
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ESR1,Estrogen receptor,19124,135,0.96 [0.72-1.28],0.786703162651876
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ESYT2,Extended synaptotagmin-2,19633,140,0.89 [0.73-1.09],0.2509682453510534
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EVI2B,Protein EVI2B,18980,139,0.90 [0.59-1.39],0.6395407832767657
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EVI5,Ecotropic viral integration site 5 protein homolog,19124,135,0.93 [0.77-1.12],0.4372314735072502
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EVPL,Envoplakin,19295,142,0.91 [0.55-1.49],0.6970660713864165
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EXOSC10,Exosome component 10,19073,136,0.80 [0.58-1.11],0.1788691445507792
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EXTL1,Exostosin-like 1,19073,136,1.09 [0.79-1.51],0.6039347319922682
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",EZR,Ezrin,22808,168,0.73 [0.41-1.32],0.2995779546734638
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F10,Coagulation factor X,19678,139,1.41 [0.84-2.38],0.1923015716641934
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F11,Coagulation factor XI,19415,135,1.32 [0.88-1.97],0.1814551940288792
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F11R,Junctional adhesion molecule A,22614,165,0.97 [0.76-1.24],0.810981907624296
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F12,Coagulation factor XII,19703,139,1.10 [0.75-1.62],0.6134601466791896
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F13B,Coagulation factor XIII B chain,19585,136,1.48 [0.77-2.83],0.2404587224433134
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F2,Prothrombin,19703,139,1.51 [0.51-4.47],0.4556176499438471
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F2R,Proteinase-activated receptor 1,22670,169,0.96 [0.76-1.22],0.7629381929687544
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F3,Tissue factor,22674,166,0.79 [0.48-1.30],0.3548364328096064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F7,Coagulation factor VII,22641,168,0.95 [0.60-1.49],0.8094429698014461
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",F9,Coagulation factor IX,22634,169,1.94 [0.92-4.10],0.08045768383309
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP1,"Fatty acid-binding protein, liver",22600,169,0.98 [0.85-1.14],0.8104630001037669
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP2,"Fatty acid-binding protein, intestinal",22609,170,1.04 [0.87-1.24],0.640993026919553
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP3,"Fatty acid-binding protein, heart",19673,140,1.01 [0.72-1.42],0.9643006360383184
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP4,"Fatty acid-binding protein, adipocyte",22879,170,0.80 [0.60-1.07],0.1267962519720975
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP5,Fatty acid-binding protein 5,22741,168,0.91 [0.74-1.10],0.327817824453988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP6,Gastrotropin,22169,165,1.18 [0.93-1.51],0.1678470418680824
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FABP9,Fatty acid-binding protein 9,22569,167,0.93 [0.73-1.19],0.5571528772972454
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FADD,FAS-associated death domain protein,22609,170,0.93 [0.78-1.11],0.4304364883125849
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM13A,Protein FAM13A,19573,142,0.87 [0.68-1.11],0.2684039826929361
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM171A2,Protein FAM171A2,19643,140,1.01 [0.91-1.11],0.8984351708649599
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM171B,Protein FAM171B,19568,141,1.11 [0.64-1.92],0.7188187162501409
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM172A,Cotranscriptional regulator FAM172A,19177,139,1.02 [0.78-1.33],0.885747679116895
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM20A,Pseudokinase FAM20A,19673,140,0.85 [0.48-1.51],0.5861644096716166
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM3B,Protein FAM3B,22505,169,0.70 [0.49-1.00],0.0481223591958165
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM3C,Protein FAM3C,22575,170,0.85 [0.53-1.35],0.489682544703248
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAM3D,Protein FAM3D,19573,142,0.97 [0.80-1.18],0.7489683401960026
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAP,Prolyl endopeptidase FAP,22879,170,1.13 [0.69-1.87],0.6246888501579216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FARSA,Phenylalanine--tRNA ligase alpha subunit,19126,138,0.87 [0.67-1.12],0.275595822730991
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FAS,Tumor necrosis factor receptor superfamily member 6,22810,167,1.08 [0.72-1.61],0.7151488342136862
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FASLG,Tumor necrosis factor ligand superfamily member 6,22856,169,0.69 [0.48-0.99],0.0435289110719248
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FBLN2,Fibulin-2,19669,142,0.98 [0.58-1.65],0.9408730608409062
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FBN2,Fibrillin-2,19126,138,0.83 [0.64-1.08],0.1687337811327514
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FBP1,"Fructose-1,6-bisphosphatase 1",22609,170,1.02 [0.85-1.23],0.818003535088343
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19673,140,0.91 [0.72-1.14],0.4067518811483904
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCAR,Immunoglobulin alpha Fc receptor,22569,167,1.00 [0.75-1.34],0.9865421296422516
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19643,140,1.06 [0.54-2.07],0.8578896522329018
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCER2,Low affinity immunoglobulin epsilon Fc receptor,22614,165,0.94 [0.69-1.26],0.6616466307567364
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22494,166,0.96 [0.77-1.20],0.7232149162381472
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22099,164,1.01 [0.80-1.28],0.9213449725561228
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22602,168,1.01 [0.77-1.32],0.9500873364254606
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCN1,Ficolin-1,19637,139,0.87 [0.67-1.13],0.3006235643818832
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCN2,Ficolin-2,22482,168,1.35 [0.95-1.92],0.0966018291811165
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRL1,Fc receptor-like protein 1,22609,170,0.99 [0.73-1.35],0.9472236583414696
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRL2,Fc receptor-like protein 2,22748,168,0.88 [0.66-1.18],0.3999968414821143
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRL3,Fc receptor-like protein 3,22181,166,0.93 [0.72-1.19],0.549468741665962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRL5,Fc receptor-like protein 5,22614,165,1.03 [0.80-1.32],0.8318339471849578
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRL6,Fc receptor-like protein 6,22569,167,1.02 [0.83-1.24],0.8728287915947076
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FCRLB,Fc receptor-like B,22099,164,0.96 [0.76-1.23],0.7666979906374609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FDX1,"Adrenodoxin, mitochondrial",19073,136,0.91 [0.69-1.20],0.5145597044698771
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FDX2,"Ferredoxin-2, mitochondrial",19073,136,0.91 [0.67-1.23],0.5232019549972777
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FEN1,Flap endonuclease 1,22099,164,0.95 [0.76-1.19],0.6412597608236058
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FES,Tyrosine-protein kinase Fes/Fps,22099,164,0.94 [0.70-1.27],0.6805397822276037
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FETUB,Fetuin-B,22634,169,0.75 [0.53-1.06],0.1080986554485641
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGA,Fibrinogen alpha chain,19234,134,1.32 [0.77-2.26],0.3065813784070609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19643,140,0.90 [0.74-1.11],0.3293138236345577
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF12,Fibroblast growth factor 12,19124,135,0.80 [0.51-1.25],0.3299443564841287
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF16,Fibroblast growth factor 16,19124,135,1.01 [0.72-1.41],0.9659873110087897
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF19,Fibroblast growth factor 19,22709,169,1.06 [0.89-1.27],0.5053110432741672
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF2,Fibroblast growth factor 2,22569,167,0.97 [0.79-1.19],0.775463994756076
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF20,Fibroblast growth factor 20,19124,135,0.74 [0.47-1.16],0.1952341604766212
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF21,Fibroblast growth factor 21,22770,167,1.00 [0.89-1.12],0.9982200477881832
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF23,Fibroblast growth factor 23,22776,166,0.69 [0.52-0.91],0.0096485849510264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF3,Fibroblast growth factor 3,19124,135,1.41 [0.95-2.09],0.0864590487201444
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF5,Fibroblast growth factor 5,22181,166,0.84 [0.55-1.30],0.4415188729753083
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF6,Fibroblast growth factor 6,19124,135,1.37 [1.07-1.76],0.0142314944586801
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF7,Fibroblast growth factor 7,18980,139,0.87 [0.69-1.10],0.2427154506167853
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGF9,Fibroblast growth factor 9,18942,139,0.95 [0.64-1.42],0.8165546734221933
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGFBP1,Fibroblast growth factor-binding protein 1,22677,169,0.93 [0.60-1.42],0.7221780391179116
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGFBP2,Fibroblast growth factor-binding protein 2,19669,142,1.30 [0.95-1.77],0.1017883189159657
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGFBP3,Fibroblast growth factor-binding protein 3,19633,140,0.74 [0.48-1.16],0.1910278526203514
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGFR2,Fibroblast growth factor receptor 2,22677,169,1.19 [0.63-2.26],0.5843248400040499
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGFR4,Fibroblast growth factor receptor 4,19262,139,0.92 [0.68-1.24],0.5742761553721567
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGL1,Fibrinogen-like protein 1,19678,139,0.88 [0.68-1.13],0.3173266279550145
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FGR,Tyrosine-protein kinase Fgr,22047,163,1.14 [0.93-1.41],0.2094120781845121
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FH,"Fumarate hydratase, mitochondrial",19065,134,0.93 [0.76-1.15],0.5128683711100074
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FHIP2A,FHF complex subunit HOOK interacting protein 2A,19073,136,1.10 [0.81-1.50],0.5488531554582075
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FHIT,Bis(5'-adenosyl)-triphosphatase,22047,163,0.95 [0.79-1.14],0.5753562450224639
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FIS1,Mitochondrial fission 1 protein,22606,166,0.95 [0.80-1.14],0.5812629494686103
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19643,140,0.93 [0.79-1.10],0.4175139016666482
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22675,168,0.98 [0.86-1.11],0.7147073067757302
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22459,168,0.95 [0.70-1.28],0.7171987041151586
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22459,168,1.02 [0.88-1.18],0.7995022907533231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,21999,163,1.05 [0.79-1.40],0.7297037390694304
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FKBPL,FK506-binding protein-like,19573,142,1.07 [0.82-1.41],0.610349728507166
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLI1,Friend leukemia integration 1 transcription factor,22099,164,0.96 [0.84-1.09],0.5398751658383552
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22459,168,0.83 [0.51-1.35],0.4526430982333599
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLT1,Vascular endothelial growth factor receptor 1,22465,169,0.63 [0.32-1.24],0.1848624105342997
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLT3,Receptor-type tyrosine-protein kinase FLT3,22099,164,0.86 [0.54-1.39],0.5418692136237178
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLT3LG,Fms-related tyrosine kinase 3 ligand,22856,169,1.11 [0.73-1.69],0.6198622631161945
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FLT4,Vascular endothelial growth factor receptor 3,22677,169,1.21 [0.80-1.82],0.3670921881524377
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FMNL1,Formin-like protein 1,22047,163,1.05 [0.86-1.29],0.6294414465355083
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FMR1,Synaptic functional regulator FMR1,22099,164,0.91 [0.61-1.36],0.6514665337246344
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FN1,Fibronectin,19703,139,2.52 [1.42-4.48],0.0015871143395749
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FNDC1,Fibronectin type III domain-containing protein 1,19633,140,0.93 [0.66-1.32],0.6894013404850068
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19568,141,1.09 [0.70-1.69],0.7109318974252328
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOLH1,Glutamate carboxypeptidase 2,19124,135,0.93 [0.79-1.11],0.436150461938818
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOLR1,Folate receptor alpha,22570,169,0.92 [0.56-1.52],0.7424593670151242
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOLR2,Folate receptor beta,22808,168,1.03 [0.65-1.64],0.8974127792783051
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOLR3,Folate receptor gamma,22604,169,0.97 [0.90-1.05],0.4032050151791252
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOS,Proto-oncogene c-Fos,18942,139,0.84 [0.53-1.32],0.4435983108972076
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOSB,Protein fosB,22047,163,1.06 [0.76-1.48],0.7304353904151726
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOXJ3,Forkhead box protein J3,19124,135,0.88 [0.60-1.30],0.5200195837165841
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOXO1,Forkhead box protein O1,22569,167,1.00 [0.85-1.17],0.9702401324343476
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FOXO3,Forkhead box protein O3,22099,164,0.94 [0.81-1.09],0.4379738223575173
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FRMD4B,FERM domain-containing protein 4B,19073,136,0.84 [0.66-1.08],0.1791956087129941
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FRMD7,FERM domain-containing protein 7,19126,138,0.88 [0.53-1.43],0.5972902089471459
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FRZB,Secreted frizzled-related protein 3,22384,168,0.92 [0.56-1.53],0.759868740474665
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FSHB,Follitropin subunit beta,19177,139,0.90 [0.72-1.14],0.4019965126194232
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FST,Follistatin,22670,169,1.01 [0.78-1.32],0.9185966202845642
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FSTL1,Follistatin-related protein 1,19177,139,0.76 [0.37-1.57],0.4569042964854782
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FSTL3,Follistatin-related protein 3,22567,169,0.98 [0.62-1.54],0.9143226925952606
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FTCD,Formimidoyltransferase-cyclodeaminase,19605,140,0.99 [0.81-1.20],0.8904632265134751
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUCA1,Tissue alpha-L-fucosidase,22752,170,1.02 [0.86-1.21],0.7892724917284772
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUOM,Fucose mutarotase,19262,139,1.08 [0.83-1.39],0.5660406958708635
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FURIN,Furin,22677,169,0.89 [0.60-1.34],0.5863055920187223
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUS,RNA-binding protein FUS,22067,163,1.03 [0.72-1.46],0.8778845526180143
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19252,142,0.93 [0.71-1.21],0.5862451797614537
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22808,168,1.08 [0.80-1.46],0.6032465370373925
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FUT8,"Alpha-(1,6)-fucosyltransferase",22459,168,1.04 [0.82-1.31],0.7595855760098575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FXN,"Frataxin, mitochondrial",22809,167,0.99 [0.82-1.19],0.9163373093100092
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FXYD5,FXYD domain-containing ion transport regulator 5,22181,166,1.04 [0.84-1.28],0.7240466552452178
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FYB1,FYN-binding protein 1,22579,164,1.01 [0.87-1.18],0.889384485142495
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FZD10,Frizzled-10,19126,138,0.90 [0.66-1.22],0.4865215433669168
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",FZD8,Frizzled-8,19065,134,0.79 [0.51-1.21],0.280031958643275
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GABARAP,Gamma-aminobutyric acid receptor-associated protein,19568,141,0.66 [0.46-0.96],0.0300946593151374
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19295,142,1.17 [0.95-1.43],0.1426761093761575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19065,134,0.78 [0.58-1.06],0.1174663833501659
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAD1,Glutamate decarboxylase 1,18980,139,1.13 [0.61-2.09],0.7058241027726994
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAD2,Glutamate decarboxylase 2,19124,135,1.18 [0.88-1.58],0.2784985063206124
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19295,142,1.03 [0.76-1.40],0.8316648166806284
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19177,139,1.04 [0.76-1.41],0.8139942759420197
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAGE2A,G antigen 2A,18980,139,1.00 [0.78-1.29],0.9929916810938038
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAL,Galanin peptides,22709,169,1.25 [1.01-1.54],0.0427107313812662
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22505,169,0.81 [0.49-1.32],0.3920227188975786
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22809,167,0.89 [0.52-1.52],0.6719419483954285
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22181,166,0.84 [0.60-1.17],0.2994441804243011
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19673,140,0.85 [0.47-1.55],0.6035474324164789
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GALNT7,N-acetylgalactosaminyltransferase 7,22505,169,0.76 [0.40-1.44],0.3924387560287402
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAMT,Guanidinoacetate N-methyltransferase,19073,136,0.94 [0.60-1.46],0.7763022703514746
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18841,138,1.14 [0.70-1.88],0.5967514249480728
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GART,Trifunctional purine biosynthetic protein adenosine-3,19643,140,0.71 [0.36-1.38],0.3078457438368525
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAS2,Growth arrest-specific protein 2,19295,142,0.93 [0.67-1.29],0.6656971447785152
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAS6,Growth arrest-specific protein 6,22731,167,1.12 [0.66-1.91],0.6808050725965884
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GASK1A,Golgi-associated kinase 1A,19073,136,1.17 [0.80-1.71],0.4201841440564927
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GAST,Gastrin,19633,140,0.98 [0.86-1.11],0.7156766377476675
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,18980,139,1.05 [0.57-1.93],0.879068060429843
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19177,139,1.06 [0.86-1.30],0.5753143017361393
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GBA,Lysosomal acid glucosylceramidase,19126,138,1.02 [0.75-1.37],0.907417144948854
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GBP1,Guanylate-binding protein 1,19596,140,1.23 [0.97-1.56],0.0857423814743714
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GBP2,Guanylate-binding protein 2,22181,166,0.99 [0.78-1.25],0.915881777447543
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GBP4,Guanylate-binding protein 4,22047,163,1.00 [0.75-1.33],0.9946015239354264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GBP6,Guanylate-binding protein 6,19073,136,0.81 [0.53-1.22],0.3088831291249577
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GC,Vitamin D-binding protein,19703,139,1.32 [0.72-2.42],0.3744814861375661
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GCC1,GRIP and coiled-coil domain-containing protein 1,19633,140,0.94 [0.81-1.09],0.4204319788136172
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GCG,Pro-glucagon,22099,164,0.96 [0.86-1.07],0.4705878828763024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18794,138,0.92 [0.65-1.29],0.6122138178703989
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GCLM,Glutamate--cysteine ligase regulatory subunit,19073,136,1.03 [0.73-1.45],0.8769454049060419
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22505,169,1.14 [0.77-1.68],0.522977090713264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GDF15,Growth/differentiation factor 15,22879,170,1.01 [0.72-1.41],0.9664926823066744
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GDF2,Growth/differentiation factor 2,22609,170,1.08 [0.74-1.58],0.6864702017368531
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GDNF,Glial cell line-derived neurotrophic factor,22047,163,0.72 [0.49-1.06],0.0963408315982774
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GET3,ATPase GET3,19673,140,0.83 [0.61-1.14],0.2531968678946482
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFAP,Glial fibrillary acidic protein,22063,164,0.98 [0.73-1.33],0.9170535577672824
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFER,FAD-linked sulfhydryl oxidase ALR,22099,164,0.98 [0.79-1.22],0.8472904578902241
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22099,164,0.97 [0.86-1.09],0.5778465761428992
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFRA1,GDNF family receptor alpha-1,22770,167,0.69 [0.41-1.15],0.1538886936174431
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFRA2,GDNF family receptor alpha-2,22505,169,0.69 [0.37-1.29],0.2474358864160782
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFRA3,GDNF family receptor alpha-3,22392,166,1.01 [0.62-1.64],0.9630355725411336
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GFRAL,GDNF family receptor alpha-like,19040,135,1.03 [0.79-1.34],0.8452793405444812
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGA1,ADP-ribosylation factor-binding protein GGA1,22047,163,1.15 [0.97-1.37],0.1120308240517953
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGACT,Gamma-glutamylaminecyclotransferase,19673,140,0.93 [0.74-1.17],0.5266676073056171
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGCT,Gamma-glutamylcyclotransferase,19630,140,1.04 [0.75-1.45],0.8137203748569136
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGH,Gamma-glutamyl hydrolase,22206,162,1.10 [0.74-1.65],0.6333289883400406
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGT1,Glutathione hydrolase 1 proenzyme,22580,165,0.90 [0.67-1.21],0.4884562490734325
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GGT5,Glutathione hydrolase 5 proenzyme,22459,168,0.70 [0.39-1.28],0.2498674235798668
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GH1,Somatotropin,22575,170,1.03 [0.95-1.11],0.4860338874587119
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GH2,Growth hormone variant,22099,164,1.00 [0.93-1.09],0.9268585742220404
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GHR,Growth hormone receptor,19262,139,0.96 [0.54-1.68],0.8803349119446785
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GHRHR,Growth hormone-releasing hormone receptor,22047,163,0.97 [0.76-1.25],0.8324590339875542
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GHRL,Appetite-regulating hormone,22609,170,1.16 [0.97-1.38],0.100589628571282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GID8,Glucose-induced degradation protein 8 homolog,19643,140,0.98 [0.60-1.59],0.9260461610021616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIGYF2,GRB10-interacting GYF protein 2,19643,140,0.86 [0.69-1.07],0.1692961113545813
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIMAP7,GTPase IMAP family member 7,19262,139,1.14 [0.71-1.82],0.591931078803287
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIMAP8,GTPase IMAP family member 8,18980,139,0.79 [0.56-1.12],0.1884940956646814
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIP,Gastric inhibitory polypeptide,19177,139,0.80 [0.57-1.11],0.185684462578432
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIPC2,PDZ domain-containing protein GIPC2,19633,140,0.69 [0.39-1.23],0.2043429442239196
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIPC3,PDZ domain-containing protein GIPC3,19573,142,0.99 [0.84-1.17],0.9020619336474338
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIPR,Gastric inhibitory polypeptide receptor,19124,135,0.77 [0.51-1.16],0.2137949103884559
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GIT1,ARF GTPase-activating protein GIT1,19124,135,0.96 [0.81-1.15],0.6773547207993116
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GJA8,Gap junction alpha-8 protein,18980,139,0.89 [0.67-1.18],0.419465075499371
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GKN1,Gastrokine-1,21622,161,1.14 [0.68-1.89],0.6171382558319718
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLA,Alpha-galactosidase A,19219,139,1.26 [0.82-1.95],0.2897844361315475
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLB1,Beta-galactosidase,22459,168,1.11 [0.80-1.55],0.5326364275039559
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLI2,Zinc finger protein GLI2,19124,135,0.79 [0.46-1.37],0.4052328846317192
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLO1,Lactoylglutathione lyase,22202,165,1.03 [0.82-1.30],0.810047711642991
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLOD4,Glyoxalase domain-containing protein 4,22567,166,0.95 [0.65-1.38],0.7698909735268676
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLP1R,Glucagon-like peptide 1 receptor,19065,134,0.88 [0.55-1.39],0.5751871573094997
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLRX,Glutaredoxin-1,22459,170,1.07 [0.85-1.35],0.5616019281208551
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19262,139,0.99 [0.83-1.19],0.936212954632664
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22047,163,1.03 [0.78-1.36],0.8466852371877779
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GLYR1,Putative oxidoreductase GLYR1,19568,141,0.92 [0.69-1.22],0.552070529897592
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GM2A,Ganglioside GM2 activator,19196,142,0.94 [0.60-1.46],0.7727990570121904
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GMFG,Glia maturation factor gamma,19673,140,0.93 [0.75-1.17],0.5547914752798988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GMPR,GMP reductase 1,22856,169,0.95 [0.73-1.23],0.6763979638553188
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GMPR2,GMP reductase 2,19262,139,1.02 [0.80-1.30],0.8696213223851057
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNAS,Neuroendocrine secretory protein 55,19643,140,0.97 [0.81-1.17],0.7505420564316159
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22099,164,0.98 [0.79-1.21],0.854351459056222
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19126,138,1.06 [0.80-1.42],0.6769444134177844
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNLY,Granulysin,22614,165,1.24 [0.95-1.62],0.1180301138185076
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNPDA1,Glucosamine-6-phosphate isomerase 1,19177,139,0.73 [0.42-1.29],0.281409209015127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GNPDA2,Glucosamine-6-phosphate isomerase 2,19262,139,0.94 [0.60-1.47],0.7839752200004969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GOLGA3,Golgin subfamily A member 3,19643,140,0.90 [0.73-1.12],0.343783491950886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GOLM2,Protein GOLM2,22808,168,0.73 [0.39-1.35],0.3167787292204841
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22569,167,0.98 [0.85-1.12],0.7495528762674052
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GORASP2,Golgi reassembly-stacking protein 2,19573,142,1.02 [0.73-1.44],0.899341218168604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GOT1,"Aspartate aminotransferase, cytoplasmic",19669,142,1.03 [0.69-1.52],0.8901077834888707
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GP1BA,Platelet glycoprotein Ib alpha chain,22481,166,1.09 [0.71-1.67],0.6926873352898415
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GP1BB,Platelet glycoprotein Ib beta chain,19073,136,1.05 [0.82-1.35],0.6820978124839316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,21926,162,1.04 [0.88-1.22],0.6624560509103634
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GP5,Platelet glycoprotein V,19262,139,0.76 [0.49-1.17],0.2133119068002701
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GP6,Platelet glycoprotein VI,22579,164,0.99 [0.85-1.16],0.9420164206967984
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPA33,Cell surface A33 antigen,22505,169,0.96 [0.87-1.07],0.4766025256279259
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPC1,Glypican-1,22809,167,0.72 [0.45-1.15],0.1750300215664445
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPC5,Glypican-5,22459,168,0.79 [0.62-1.01],0.0590722614485156
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPD1,Glycerol-3-phosphate dehydrogenase,19568,141,0.84 [0.61-1.17],0.3089871328693154
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPHA2,Glycoprotein hormone alpha-2,19573,142,0.98 [0.70-1.37],0.895874170816943
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPI,Glucose-6-phosphate isomerase,19678,139,0.96 [0.68-1.35],0.8133777532303763
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19573,142,1.01 [0.80-1.26],0.9604628157621048
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPKOW,G-patch domain and KOW motifs-containing protein,22047,163,1.02 [0.62-1.65],0.9496699943128852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPNMB,Transmembrane glycoprotein NMB,21991,162,1.11 [0.68-1.83],0.6796810960947887
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPR101,Probable G-protein coupled receptor 101,19065,134,1.07 [0.83-1.37],0.6102783981007168
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPR158,Probable G-protein coupled receptor 158,19643,140,0.86 [0.53-1.39],0.5357284250245506
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPR15L,Protein GPR15L,19573,142,0.87 [0.67-1.12],0.2792884029728574
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPR37,Prosaposin receptor GPR37,22202,165,0.86 [0.70-1.06],0.1488926359248613
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GPRC5C,G-protein coupled receptor family C group 5 member C,19568,141,0.77 [0.55-1.07],0.1184935126690344
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRAP2,GRB2-related adapter protein 2,22609,170,0.95 [0.86-1.06],0.3840315488721217
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19673,140,0.92 [0.72-1.18],0.5003573326934189
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRIK2,"Glutamate receptor ionotropic, kainate 2",19643,140,0.78 [0.51-1.20],0.2559358986782522
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19065,134,0.77 [0.54-1.11],0.1586914189896481
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRK5,G protein-coupled receptor kinase 5,22202,165,0.86 [0.64-1.16],0.3250824392907042
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRN,Progranulin,22517,165,1.48 [0.85-2.60],0.1692472700809826
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRP,Gastrin-releasing peptide,19177,139,0.97 [0.72-1.32],0.8555844401358877
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRPEL1,"GrpE protein homolog 1, mitochondrial",22505,169,1.07 [0.86-1.34],0.5333134610874173
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GRSF1,G-rich sequence factor 1,18874,138,0.89 [0.72-1.11],0.2963594931655261
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSAP,Gamma-secretase-activating protein,22099,164,1.23 [1.10-1.37],0.0002068664385158
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSN,Gelsolin,19609,139,1.18 [0.49-2.83],0.7079585838693294
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSR,"Glutathione reductase, mitochondrial",19559,139,0.94 [0.45-1.98],0.8708527167595008
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSTA1,Glutathione S-transferase A1,22574,170,1.03 [0.87-1.20],0.7611016088742852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSTA3,Glutathione S-transferase A3,22099,164,1.07 [0.90-1.28],0.4470821659269239
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSTM4,Glutathione S-transferase Mu 4,19073,136,0.98 [0.77-1.23],0.8449720655114284
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSTP1,Glutathione S-transferase P,21911,162,1.02 [0.83-1.24],0.866891850540629
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GSTT2B,Glutathione S-transferase theta-2B,19633,140,1.03 [0.97-1.11],0.3307178373892644
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19295,142,1.15 [0.96-1.37],0.1310788489213942
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GTPBP2,GTP-binding protein 2,19126,138,0.94 [0.77-1.16],0.5936364742724616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GUCA2A,Guanylin,22504,163,0.95 [0.62-1.45],0.8055797444863529
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GUCY2C,Heat-stable enterotoxin receptor,19295,142,0.84 [0.67-1.05],0.1224957112915794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GUK1,Guanylate kinase,19073,136,1.00 [0.67-1.51],0.993358114737042
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GUSB,Beta-glucuronidase,22716,167,1.05 [0.83-1.31],0.6991427010209863
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GYS1,"Glycogen [starch] synthase, muscle",22202,165,0.92 [0.79-1.07],0.2964811989708619
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GZMA,Granzyme A,22856,169,0.75 [0.51-1.12],0.1568454550129116
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GZMB,Granzyme B,22569,167,0.83 [0.66-1.05],0.1172760773267036
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",GZMH,Granzyme H,22202,165,0.90 [0.74-1.10],0.3044696923351055
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",H2AP,Huntingtin-interacting protein M,18980,139,0.85 [0.58-1.24],0.4080413551293557
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19073,136,0.96 [0.74-1.24],0.7340772764254964
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22737,166,0.96 [0.80-1.15],0.6407099788658461
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HAO1,Hydroxyacid oxidase 1,22809,167,1.08 [0.98-1.19],0.139069409433189
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HARS1,"Histidine--tRNA ligase, cytoplasmic",22614,165,1.00 [0.84-1.20],0.98711638563392
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HAVCR1,Hepatitis A virus cellular receptor 1,22776,166,1.05 [0.83-1.32],0.6923285985451074
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HAVCR2,Hepatitis A virus cellular receptor 2,22614,165,0.97 [0.64-1.46],0.8771133269989951
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HBEGF,Proheparin-binding EGF-like growth factor,22737,166,0.90 [0.75-1.09],0.2717838097825979
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HBQ1,Hemoglobin subunit theta-1,22809,167,1.06 [0.85-1.32],0.6097835237561349
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HBZ,Hemoglobin subunit zeta,19673,140,1.05 [0.90-1.21],0.5582430491437396
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HCG22,Protein PBMUCL2,19073,136,0.97 [0.71-1.32],0.8390458877608522
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HCLS1,Hematopoietic lineage cell-specific protein,22856,169,0.91 [0.72-1.16],0.4488141457342337
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HDAC8,Histone deacetylase 8,19124,135,0.98 [0.74-1.28],0.8629775207855166
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HDAC9,Histone deacetylase 9,19065,134,0.77 [0.56-1.07],0.1174040388415949
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HDDC2,5'-deoxynucleotidase HDDC2,19573,142,0.92 [0.64-1.32],0.6382552466573586
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HDGF,Hepatoma-derived growth factor,22780,167,0.96 [0.83-1.11],0.5961312567817145
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HDGFL2,Hepatoma-derived growth factor-related protein 2,19633,140,1.07 [0.83-1.36],0.6141694995398792
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HEBP1,Heme-binding protein 1,22202,165,1.13 [0.91-1.40],0.2791365427060659
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HEG1,Protein HEG homolog 1,19262,139,1.17 [0.62-2.18],0.6315135339641089
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HEPACAM2,HEPACAM family member 2,19633,140,0.69 [0.46-1.02],0.0612835554493312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HEPH,Hephaestin,19673,140,0.95 [0.50-1.80],0.8694524733712616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HEXIM1,Protein HEXIM1,22569,167,0.96 [0.81-1.13],0.6226287515719893
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HGF,Hepatocyte growth factor,22856,169,0.77 [0.51-1.16],0.2188549428687384
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HGFAC,Hepatocyte growth factor activator,19485,137,0.90 [0.53-1.53],0.6966458385759133
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22099,164,0.94 [0.78-1.12],0.4756223670170719
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HHEX,Hematopoietically-expressed homeobox protein HHEX,19633,140,0.90 [0.73-1.12],0.3466470548764312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HIF1A,Hypoxia-inducible factor 1-alpha,19124,135,1.06 [0.85-1.33],0.5859615388447984
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HIP1,Huntingtin-interacting protein 1,19073,136,0.78 [0.45-1.33],0.3605695816972335
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HIP1R,Huntingtin-interacting protein 1-related protein,19599,140,0.90 [0.60-1.34],0.5905892983308653
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HJV,Hemojuvelin,19643,140,0.94 [0.65-1.36],0.7362045991355466
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HK2,Hexokinase-2,22202,165,1.36 [0.86-2.15],0.1907359479674739
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19643,140,0.61 [0.37-0.99],0.0456995056411075
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22504,167,1.28 [0.89-1.86],0.1844696798432005
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22569,167,0.90 [0.55-1.48],0.689667797088585
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMBS,Porphobilinogen deaminase,22809,167,1.15 [0.85-1.54],0.3671017017589966
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMCN2,Hemicentin-2,19226,139,1.33 [0.99-1.78],0.0577568248077207
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19177,139,1.01 [0.73-1.40],0.9634992405967276
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19073,136,0.72 [0.48-1.10],0.126229572318822
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMMR,Hyaluronan mediated motility receptor,18952,139,0.81 [0.55-1.18],0.2738402445118105
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMOX1,Heme oxygenase 1,22359,167,1.05 [0.78-1.42],0.7294433291126703
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HMOX2,Heme oxygenase 2,22047,163,1.17 [0.89-1.55],0.2583302976233049
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HNF1A,Hepatocyte nuclear factor 1-alpha,19126,138,0.96 [0.76-1.22],0.7574871375370877
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HNMT,Histamine N-methyltransferase,22341,168,0.89 [0.66-1.20],0.4445707054189459
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22137,165,0.95 [0.79-1.14],0.5692955932661851
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19643,140,0.93 [0.66-1.31],0.6871592536183164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HPCAL1,Hippocalcin-like protein 1,22856,169,0.97 [0.81-1.17],0.779743581001699
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HPGDS,Hematopoietic prostaglandin D synthase,22099,164,0.96 [0.66-1.40],0.8333498012351451
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HPSE,Heparanase,19392,142,0.94 [0.79-1.11],0.4494725497616247
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HRAS,GTPase Hras,19259,141,1.00 [0.85-1.18],0.97102293691608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19177,139,0.69 [0.41-1.15],0.1530446581480764
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HRG,Histidine-rich glycoprotein,19585,136,0.99 [0.59-1.66],0.9744884007635384
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HS1BP3,HCLS1-binding protein 3,19177,139,0.97 [0.80-1.16],0.7160402641376598
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22505,169,1.12 [0.78-1.59],0.5424906967240921
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22809,167,0.71 [0.48-1.07],0.0992341463329016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19124,135,1.06 [0.61-1.84],0.8330350121304216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSBP1,Heat shock factor-binding protein 1,19177,139,0.91 [0.77-1.08],0.2817681860917054
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22569,167,1.14 [0.80-1.61],0.4750961397236304
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19633,140,1.09 [0.85-1.41],0.4976872703312297
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSD17B3,Testosterone 17-beta-dehydrogenase 3,19073,136,0.90 [0.63-1.29],0.5700497109950999
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19177,139,1.09 [0.78-1.53],0.6195842432395503
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSP90B1,Endoplasmin,21946,163,0.98 [0.80-1.20],0.8396546740457171
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSPA1A,Heat shock 70 kDa protein 1A,22675,169,0.99 [0.82-1.19],0.8765756541514967
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSPA2,Heat shock-related 70 kDa protein 2,19568,141,1.13 [0.72-1.78],0.604111548083675
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSPB1,Heat shock protein beta-1,22241,165,0.83 [0.69-1.01],0.0609244914150598
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSPB6,Heat shock protein beta-6,22809,167,0.88 [0.60-1.30],0.5159202795939802
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22413,166,1.21 [0.69-2.10],0.5068178221303049
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HTR1A,5-hydroxytryptamine receptor 1A,19065,134,0.77 [0.59-1.01],0.0583526254358064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HTR1B,5-hydroxytryptamine receptor 1B,19065,134,0.75 [0.48-1.17],0.201154735969311
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HTRA2,"Serine protease HTRA2, mitochondrial",22677,169,1.00 [0.80-1.24],0.9890775270392744
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HYAL1,Hyaluronidase-1,22444,169,1.36 [0.76-2.44],0.2975182494543365
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",HYOU1,Hypoxia up-regulated protein 1,22879,170,0.94 [0.50-1.76],0.8397202085108274
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICA1,Islet cell autoantigen 1,22181,166,0.98 [0.82-1.17],0.8308998855651475
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICAM1,Intercellular adhesion molecule 1,22492,165,1.11 [0.68-1.81],0.6860437947416522
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICAM2,Intercellular adhesion molecule 2,22879,170,0.85 [0.55-1.31],0.4565842884212723
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICAM3,Intercellular adhesion molecule 3,22879,170,0.95 [0.55-1.64],0.8629405395768204
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICAM4,Intercellular adhesion molecule 4,22569,167,0.91 [0.70-1.17],0.4630202401496155
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICAM5,Intercellular adhesion molecule 5,22609,170,0.80 [0.59-1.09],0.1581122339131673
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ICOSLG,ICOS ligand,22505,169,1.24 [0.61-2.51],0.5570637731110012
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ID4,DNA-binding protein inhibitor ID-4,19295,142,0.99 [0.70-1.41],0.9506288766591576
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IDI2,Isopentenyl-diphosphate delta-isomerase 2,22047,163,1.17 [0.89-1.55],0.2691971845396766
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IDO1,"Indoleamine 2,3-dioxygenase 1",19177,139,0.87 [0.67-1.13],0.2891612857008466
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IDS,Iduronate 2-sulfatase,22856,169,0.55 [0.12-2.50],0.4369785440337494
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IDUA,Alpha-L-iduronidase,22809,167,0.93 [0.69-1.24],0.6038541551595606
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19092,137,0.97 [0.63-1.50],0.9064938307127935
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19295,142,0.83 [0.60-1.14],0.2534612007452441
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19295,142,1.21 [0.81-1.81],0.3601323788426815
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNAR1,Interferon alpha/beta receptor 1,19573,142,0.99 [0.54-1.82],0.977812177878462
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNG,Interferon gamma,22181,166,0.91 [0.81-1.02],0.0915547051024479
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNGR1,Interferon gamma receptor 1,22709,169,0.89 [0.45-1.77],0.7503755739547585
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNGR2,Interferon gamma receptor 2,22459,168,1.03 [0.79-1.33],0.8321561667037182
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNL1,Interferon lambda-1,22047,163,1.05 [0.77-1.43],0.7708902356914351
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNL2,Interferon lambda-2,19065,134,0.93 [0.70-1.22],0.5868895055503717
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNLR1,Interferon lambda receptor 1,22569,167,0.89 [0.60-1.31],0.5526495192823211
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFNW1,Interferon omega-1,19073,136,0.82 [0.50-1.36],0.4426884818774192
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IFT20,Intraflagellar transport protein 20 homolog,19126,138,0.77 [0.52-1.15],0.2058149751814972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGBP1,Immunoglobulin-binding protein 1,19643,140,0.94 [0.72-1.22],0.631075260704586
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19065,134,0.90 [0.62-1.30],0.5652873605769924
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19669,142,1.10 [0.59-2.08],0.7570230617048969
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGF1R,Insulin-like growth factor 1 receptor,22505,169,0.41 [0.21-0.81],0.0104413501648221
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19073,136,0.67 [0.43-1.03],0.0692377763946066
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGF2R,Cation-independent mannose-6-phosphate receptor,22614,165,0.86 [0.47-1.56],0.610734444521982
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP1,Insulin-like growth factor-binding protein 1,22839,168,1.06 [0.94-1.19],0.350488974533461
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP2,Insulin-like growth factor-binding protein 2,22840,170,0.90 [0.73-1.11],0.3218619204949618
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP3,Insulin-like growth factor-binding protein 3,22671,169,1.42 [0.85-2.39],0.1834750100586644
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP4,Insulin-like growth factor-binding protein 4,22318,164,1.07 [0.76-1.52],0.6869956064525802
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP6,Insulin-like growth factor-binding protein 6,22488,166,1.27 [0.78-2.06],0.3415365125786898
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBP7,Insulin-like growth factor-binding protein 7,22879,170,1.36 [0.87-2.11],0.1735272884299998
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFBPL1,Insulin-like growth factor-binding protein-like 1,22609,170,0.86 [0.57-1.29],0.459987155149529
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGFL4,Insulin growth factor-like family member 4,19124,135,1.10 [0.91-1.32],0.3255547675280734
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGHMBP2,DNA-binding protein SMUBP-2,19073,136,0.74 [0.53-1.03],0.0730353735353382
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGLC2,Immunoglobulin lambda constant 2,19663,138,0.89 [0.43-1.85],0.7540423955621505
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGLON5,IgLON family member 5,18980,139,0.91 [0.74-1.11],0.3532689627051989
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGSF21,Immunoglobulin superfamily member 21,19177,139,0.78 [0.49-1.23],0.278479694836803
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGSF3,Immunoglobulin superfamily member 3,22505,169,0.79 [0.51-1.21],0.2757752086965838
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGSF8,Immunoglobulin superfamily member 8,22609,170,1.24 [0.79-1.94],0.3479640515297768
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IGSF9,Protein turtle homolog A,19673,140,1.02 [0.84-1.25],0.8087977677131305
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IKBKG,NF-kappa-B essential modulator,22569,167,0.96 [0.83-1.12],0.6241384396647043
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IKZF2,Zinc finger protein Helios,22099,164,1.02 [0.88-1.17],0.8332765704015261
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL10,Interleukin-10,22181,166,1.01 [0.86-1.20],0.8661028539224099
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL10RA,Interleukin-10 receptor subunit alpha,22181,166,0.91 [0.71-1.17],0.4617526745815371
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL10RB,Interleukin-10 receptor subunit beta,22709,169,0.97 [0.60-1.57],0.8918062550094132
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL11,Interleukin-11,22181,166,0.97 [0.77-1.20],0.753093292956438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL12A_IL12B,Interleukin-12,22505,169,0.82 [0.68-0.98],0.030937438544988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL12B,Interleukin-12 subunit beta,22856,169,0.78 [0.61-1.01],0.0582144694854729
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL12RB1,Interleukin-12 receptor subunit beta-1,22181,166,0.95 [0.66-1.38],0.7851004513329531
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL12RB2,Interleukin-12 receptor subunit beta-2,19124,135,0.76 [0.50-1.15],0.195262263283015
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL13,Interleukin-13,22181,166,0.98 [0.73-1.30],0.874390098656382
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL13RA1,Interleukin-13 receptor subunit alpha-1,22324,168,1.17 [0.61-2.28],0.6347083294793562
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL13RA2,Interleukin-13 receptor subunit alpha-2,19065,134,0.75 [0.42-1.33],0.3181993926852431
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL15,Interleukin-15,22569,167,1.12 [0.74-1.70],0.5947753015399959
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL15RA,Interleukin-15 receptor subunit alpha,22181,166,1.05 [0.71-1.57],0.7919650285174035
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL16,Pro-interleukin-16,22856,169,1.00 [0.72-1.38],0.9900475746325718
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17A,Interleukin-17A,22157,166,0.86 [0.61-1.22],0.399126412537977
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17C,Interleukin-17C,22181,166,0.98 [0.80-1.19],0.8122772827494201
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17D,Interleukin-17D,22181,166,0.74 [0.46-1.18],0.2076343663214165
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17F,Interleukin-17F,22181,166,1.06 [0.90-1.25],0.4763094472243789
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17RA,Interleukin-17 receptor A,22614,165,1.11 [0.81-1.51],0.5176910535048656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL17RB,Interleukin-17 receptor B,22276,164,1.04 [0.81-1.35],0.7443803241552088
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL18,Interleukin-18,22525,169,0.87 [0.65-1.16],0.3440573728340524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL18BP,Interleukin-18-binding protein,22671,169,1.23 [0.79-1.91],0.3682358121683703
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL18R1,Interleukin-18 receptor 1,22856,169,1.09 [0.73-1.64],0.6708554015382135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL18RAP,Interleukin-18 receptor accessory protein,22313,167,0.93 [0.86-1.01],0.0959036203425097
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL19,Interleukin-19,22042,166,0.98 [0.80-1.21],0.8688188811161665
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1A,Interleukin-1 alpha,22181,166,1.10 [0.88-1.38],0.3852220171554714
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1B,Interleukin-1 beta,22081,166,0.76 [0.58-0.99],0.0421996275845544
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1R1,Interleukin-1 receptor type 1,22580,165,1.22 [0.66-2.26],0.5337396918901559
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1R2,Interleukin-1 receptor type 2,22570,168,0.96 [0.48-1.94],0.9125776202739068
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1RAP,Interleukin-1 receptor accessory protein,22614,165,1.25 [0.92-1.71],0.1591462804658903
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1RL1,Interleukin-1 receptor-like 1,22810,167,1.22 [0.90-1.66],0.1925935560937075
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1RL2,Interleukin-1 receptor-like 2,22181,166,0.93 [0.66-1.30],0.6682050617668149
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL1RN,Interleukin-1 receptor antagonist protein,22565,166,0.85 [0.65-1.10],0.2204716475089333
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL2,Interleukin-2,22181,166,0.66 [0.43-1.02],0.0592815858972629
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL20,Interleukin-20,22181,166,0.94 [0.71-1.25],0.6886528956447886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL20RA,Interleukin-20 receptor subunit alpha,22181,166,1.19 [0.92-1.53],0.1845146097698047
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL20RB,Interleukin-20 receptor subunit beta,19124,135,1.21 [0.84-1.75],0.3126243927424347
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL21R,Interleukin-21 receptor,19124,135,1.02 [0.76-1.36],0.9112663281853182
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL22,Interleukin-22,19568,141,1.07 [0.85-1.36],0.5676373456725143
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL22RA1,Interleukin-22 receptor subunit alpha-1,22181,166,1.04 [0.77-1.41],0.8023018655229003
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL24,Interleukin-24,22181,166,1.07 [0.82-1.40],0.6303922224502496
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL25,Interleukin-25,18910,138,0.97 [0.61-1.55],0.8961422204403822
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL2RA,Interleukin-2 receptor subunit alpha,22437,162,1.54 [1.10-2.16],0.0114755055478612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL2RB,Interleukin-2 receptor subunit beta,22181,166,1.05 [0.75-1.48],0.7754583725828205
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL2RG,Cytokine receptor common subunit gamma,19568,141,0.99 [0.65-1.50],0.9535907419980608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL3,Interleukin-3,18980,139,0.93 [0.72-1.20],0.5825196038609433
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL31,Interleukin-31,19124,135,0.67 [0.47-0.97],0.0349680503968807
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL31RA,Interleukin-31 receptor subunit alpha,19050,135,0.94 [0.62-1.42],0.763365878992622
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL32,Interleukin-32,22569,167,1.04 [0.75-1.43],0.809580103088763
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL33,Interleukin-33,22181,166,0.99 [0.69-1.41],0.94852495155378
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL34,Interleukin-34,22017,163,0.92 [0.62-1.34],0.6507488217031204
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL36A,Interleukin-36 alpha,19124,135,0.83 [0.60-1.15],0.2585363470559309
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL36G,Interleukin-36 gamma,19043,135,1.16 [0.94-1.43],0.1619843734346892
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL3RA,Interleukin-3 receptor subunit alpha,22181,166,0.89 [0.58-1.38],0.6088876760606632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL4,Interleukin-4,22181,166,1.01 [0.87-1.18],0.8558300746484444
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL4R,Interleukin-4 receptor subunit alpha,22569,167,0.92 [0.62-1.37],0.6777179713155825
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL5,Interleukin-5,22181,166,0.99 [0.90-1.09],0.8498316862729091
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL5RA,Interleukin-5 receptor subunit alpha,22569,167,0.84 [0.65-1.09],0.1877336476850631
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL6,Interleukin-6,22505,169,0.86 [0.70-1.06],0.1684838690731809
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL6R,Interleukin-6 receptor subunit alpha,22448,165,1.22 [0.81-1.83],0.346156601381516
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL6ST,Interleukin-6 receptor subunit beta,22609,170,0.73 [0.33-1.60],0.435533312379191
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL7,Interleukin-7,22569,167,0.93 [0.75-1.15],0.4944334093525668
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL7R,Interleukin-7 receptor subunit alpha,22614,165,0.88 [0.68-1.14],0.3467530234754937
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IL9,Interleukin-9,19295,142,1.02 [0.77-1.34],0.9146815425758243
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22021,162,0.96 [0.75-1.23],0.7354173637987831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IMMT,MICOS complex subunit MIC60,19568,141,0.61 [0.40-0.93],0.0219318955643562
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IMPA1,Inositol monophosphatase 1,22459,168,0.98 [0.78-1.22],0.8404104217614932
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IMPACT,Protein IMPACT,19633,140,0.95 [0.72-1.27],0.7390313166302684
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IMPG1,Interphotoreceptor matrix proteoglycan 1,19065,134,0.61 [0.33-1.15],0.1267865288849851
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ING1,Inhibitor of growth protein 1,21999,163,1.19 [0.91-1.57],0.2123714531537344
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INHBB,Inhibin beta B chain,19262,139,1.13 [0.83-1.55],0.4343514105532199
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INHBC,Inhibin beta C chain,22614,165,0.97 [0.70-1.33],0.8352761944865142
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INPP1,Inositol polyphosphate 1-phosphatase,22505,169,1.02 [0.80-1.32],0.8494468104542828
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19177,139,0.83 [0.61-1.11],0.2052342537239722
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19643,140,0.97 [0.67-1.41],0.8720085761928966
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22505,169,0.94 [0.82-1.09],0.4260026866288073
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INSL3,Insulin-like 3,19633,140,1.03 [0.78-1.36],0.8134248329032923
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INSL4,Early placenta insulin-like peptide,19568,141,0.91 [0.65-1.27],0.5943123981086988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INSL5,Insulin-like peptide INSL5,19573,142,1.12 [0.95-1.32],0.1602583633911596
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",INSR,Insulin receptor,19124,135,0.89 [0.33-2.40],0.8121707973690026
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IPCEF1,Interactor protein for cytohesin exchange factors 1,22424,168,0.97 [0.83-1.13],0.6891391811029226
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IQGAP2,Ras GTPase-activating-like protein IQGAP2,22505,169,0.99 [0.77-1.27],0.9427568987594608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22202,165,1.00 [0.85-1.17],0.9782449214805548
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IRAK1,Interleukin-1 receptor-associated kinase 1,22181,166,1.01 [0.83-1.23],0.9260314404132018
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IRAK4,Interleukin-1 receptor-associated kinase 4,22569,167,0.99 [0.87-1.13],0.9335071226643148
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21739,161,0.75 [0.51-1.10],0.1401196830768712
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ISM1,Isthmin-1,22569,167,0.92 [0.65-1.31],0.6480916979243806
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ISM2,Isthmin-2,19669,142,0.92 [0.63-1.34],0.6535708557472146
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IST1,IST1 homolog,19433,140,0.95 [0.81-1.12],0.5616249475436335
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGA11,Integrin alpha-11,22569,167,0.92 [0.62-1.37],0.6770980064067713
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGA2,Integrin alpha-2,19262,139,1.00 [0.61-1.63],0.9955089309815024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGA5,Integrin alpha-5,22614,165,1.31 [0.76-2.28],0.3339451618376604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGA6,Integrin alpha-6,22569,167,0.85 [0.65-1.11],0.2342133716147163
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGAL,Integrin alpha-L,19124,135,1.07 [0.73-1.57],0.7324698198426499
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGAM,Integrin alpha-M,22614,165,1.16 [0.75-1.79],0.4979582261704699
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGAV,Integrin alpha-V,22809,167,0.97 [0.42-2.23],0.9360836308590932
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGAX,Integrin alpha-X,19295,142,0.90 [0.66-1.23],0.5023328451484949
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB1,Integrin beta-1,22562,166,1.16 [0.62-2.18],0.6364895283626729
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB1BP1,Integrin beta-1-binding protein 1,22099,164,0.82 [0.58-1.14],0.2352072371569514
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB1BP2,Integrin beta-1-binding protein 2,22202,165,0.94 [0.83-1.06],0.2885629048841484
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB2,Integrin beta-2,22460,167,1.01 [0.62-1.63],0.9796181385097624
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB5,Integrin beta-5,22677,169,0.93 [0.64-1.35],0.7068238871114709
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB6,Integrin beta-6,22181,166,0.87 [0.54-1.38],0.5462562605452495
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGB7,Integrin beta-7,22809,167,1.11 [0.83-1.49],0.4880827007338983
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITGBL1,Integrin beta-like protein 1,19669,142,0.95 [0.59-1.53],0.8442848138937638
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19703,139,1.03 [0.44-2.39],0.9508351783061256
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22671,169,1.33 [0.92-1.92],0.1251657632218447
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19703,139,1.08 [0.60-1.94],0.7870798909869587
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19568,141,1.03 [0.73-1.45],0.8753953501115592
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITM2A,Integral membrane protein 2A,22569,167,1.10 [0.87-1.38],0.4338811870745427
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITPA,Inosine triphosphate pyrophosphatase,19073,136,0.93 [0.73-1.19],0.5646293780114691
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19177,139,0.91 [0.71-1.16],0.447351497441231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19065,134,0.81 [0.54-1.20],0.2890379788998024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22047,163,0.92 [0.69-1.23],0.5840407377526571
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",IZUMO1,Izumo sperm-egg fusion protein 1,18980,139,0.96 [0.67-1.36],0.815591093661076
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JAM2,Junctional adhesion molecule B,22808,168,0.89 [0.52-1.54],0.6776563327803786
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JAM3,Junctional adhesion molecule C,19262,139,0.95 [0.68-1.31],0.7399464067602998
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JCHAIN,Immunoglobulin J chain,22181,166,0.97 [0.77-1.21],0.7653532637452383
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,18980,139,0.88 [0.64-1.20],0.4207901796602382
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JPT2,Jupiter microtubule associated homolog 2,19573,142,0.99 [0.82-1.19],0.894105059550762
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",JUN,Transcription factor AP-1,22181,166,1.01 [0.78-1.31],0.94781810226416
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22505,169,1.14 [0.84-1.56],0.403463223463375
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KAZN,Kazrin,19573,142,0.94 [0.81-1.10],0.4380855528022142
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KCNC4,Potassium voltage-gated channel subfamily C member 4,19065,134,0.69 [0.47-1.00],0.0516024948406391
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KCNH2,Potassium voltage-gated channel subfamily H member 2,19126,138,0.96 [0.77-1.19],0.6951623675033523
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KCNIP4,Kv channel-interacting protein 4,22047,163,1.10 [0.86-1.41],0.4446249548305495
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KCTD5,BTB/POZ domain-containing protein KCTD5,19270,137,0.99 [0.67-1.44],0.9384482624038174
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KDM3A,Lysine-specific demethylase 3A,19124,135,0.92 [0.75-1.12],0.3852909589152438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KDR,Vascular endothelial growth factor receptor 2,22677,169,1.01 [0.59-1.72],0.9749190105812114
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KEL,Kell blood group glycoprotein,22047,163,0.67 [0.46-1.00],0.0474408541960133
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KHDC3L,KH domain-containing protein 3,18980,139,0.83 [0.62-1.11],0.2061896852502325
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KHK,Ketohexokinase,19177,139,1.03 [0.80-1.32],0.8410926910519954
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIAA0319,Dyslexia-associated protein KIAA0319,19633,140,0.67 [0.38-1.16],0.1537466759996404
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIAA1549,UPF0606 protein KIAA1549,19295,142,1.09 [0.87-1.35],0.4632322221450025
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIAA1549L,UPF0606 protein KIAA1549L,19295,142,0.65 [0.36-1.18],0.1554296739922335
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIAA2013,Uncharacterized protein KIAA2013,19568,141,1.03 [0.79-1.35],0.8251526107748628
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIF1C,Kinesin-like protein KIF1C,19073,136,0.80 [0.47-1.34],0.3887964947678043
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIF20B,Kinesin-like protein KIF20B,19065,134,1.04 [0.85-1.28],0.6977492335428113
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIF22,Kinesin-like protein KIF22,19073,136,0.91 [0.80-1.04],0.1863733964037887
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIFBP,KIF-binding protein,22505,169,0.98 [0.84-1.16],0.8470260259843643
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19568,141,0.94 [0.78-1.13],0.5097737621368441
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22099,164,1.01 [0.84-1.21],0.9345417036864064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19573,142,1.02 [0.93-1.12],0.6168282084300936
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22099,164,0.92 [0.82-1.03],0.1325545431914422
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,18980,139,1.03 [0.86-1.24],0.7273324458385466
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIRREL1,Kin of IRRE-like protein 1,19065,134,0.64 [0.42-0.96],0.0316091086042557
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIRREL2,Kin of IRRE-like protein 2,22047,163,0.65 [0.46-0.93],0.0188691087141768
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KIT,Mast/stem cell growth factor receptor Kit,22634,169,1.77 [1.13-2.80],0.013576817626304
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KITLG,Kit ligand,22609,170,1.08 [0.74-1.57],0.7036935199481962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLB,Beta-klotho,22047,163,0.87 [0.72-1.05],0.1446915622194035
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLF4,Krueppel-like factor 4,19065,134,0.73 [0.47-1.14],0.1687321834163322
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLHL41,Kelch-like protein 41,19643,140,0.88 [0.62-1.26],0.4863738902578088
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK1,Kallikrein-1,22371,167,0.99 [0.88-1.10],0.8001117114268481
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK10,Kallikrein-10,22605,169,0.82 [0.58-1.16],0.2684023817666388
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK11,Kallikrein-11,22454,169,0.74 [0.46-1.20],0.228023375116856
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK12,Kallikrein-12,22099,164,0.90 [0.82-0.99],0.0301255195208758
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK13,Kallikrein-13,22109,167,0.86 [0.63-1.18],0.3396567003685429
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK14,Kallikrein-14,22809,167,1.02 [0.76-1.37],0.9096110717411288
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK15,Kallikrein-15,19543,141,0.83 [0.61-1.14],0.251245479184979
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK3,Prostate-specific antigen,19669,142,1.13 [0.86-1.47],0.3870029077776673
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK4,Kallikrein-4,22809,167,1.22 [0.99-1.51],0.0628306010349111
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK6,Kallikrein-6,22650,169,1.06 [0.67-1.66],0.8118945207286039
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK7,Kallikrein-7,18743,139,1.06 [0.69-1.61],0.8017748602268877
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLK8,Kallikrein-8,21849,164,0.83 [0.56-1.24],0.3611506790240112
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLKB1,Plasma kallikrein,19301,133,1.53 [0.80-2.92],0.201254063539312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLRB1,Killer cell lectin-like receptor subfamily B member 1,22856,169,1.04 [0.72-1.50],0.8298875255280083
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19065,134,0.91 [0.67-1.22],0.5226634323965027
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLRD1,Natural killer cells antigen CD94,22856,169,0.84 [0.62-1.13],0.2538296161613252
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLRF1,Killer cell lectin-like receptor subfamily F member 1,19124,135,0.87 [0.58-1.31],0.498441531181901
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KLRK1,NKG2-D type II integral membrane protein,19633,140,0.77 [0.55-1.08],0.1306777695080944
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT14,"Keratin, type I cytoskeletal 14",21323,153,0.72 [0.41-1.26],0.2467383494917811
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT17,"Keratin, type I cytoskeletal 17",19073,136,1.05 [0.69-1.60],0.8089242688449614
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT18,"Keratin, type I cytoskeletal 18",22505,169,1.02 [0.86-1.21],0.8346038348116633
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT19,"Keratin, type I cytoskeletal 19",22536,167,0.93 [0.75-1.14],0.475001921412132
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT5,"Keratin, type II cytoskeletal 5",22047,163,0.97 [0.73-1.30],0.852751171101441
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT6C,"Keratin, type II cytoskeletal 6C",19073,136,1.09 [0.74-1.61],0.647766569531937
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KRT8,"Keratin, type II cytoskeletal 8",19065,134,0.73 [0.52-1.04],0.080666484695864
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KYAT1,Kynurenine--oxoglutarate transaminase 1,22570,168,1.00 [0.79-1.27],0.9884258843117536
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",KYNU,Kynureninase,22856,169,1.01 [0.75-1.36],0.964790031468024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",L1CAM,Neural cell adhesion molecule L1,22677,169,1.05 [0.65-1.70],0.8403850988577312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19673,140,1.01 [0.84-1.20],0.935004322165115
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LACRT,Extracellular glycoprotein lacritin,19531,140,1.10 [0.83-1.46],0.5215682502585933
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LACTB2,Endoribonuclease LACTB2,22609,170,0.95 [0.77-1.17],0.6207271803370573
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAG3,Lymphocyte activation gene 3 protein,22505,169,1.07 [0.76-1.49],0.7081920610808878
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22600,169,1.01 [0.70-1.45],0.951278855690628
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22459,168,1.08 [0.94-1.23],0.2870223423782829
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMA1,Laminin subunit alpha-1,19073,136,0.87 [0.62-1.23],0.4373241645810067
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMA4,Laminin subunit alpha-4,22709,169,0.83 [0.54-1.26],0.3716017064036857
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMB1,Laminin subunit beta-1,19177,139,0.91 [0.53-1.58],0.742115904081448
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMP1,Lysosome-associated membrane glycoprotein 1,19120,142,1.21 [0.78-1.89],0.3955497301849989
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMP2,Lysosome-associated membrane glycoprotein 2,21923,166,0.54 [0.26-1.13],0.1009939311236798
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMP3,Lysosome-associated membrane glycoprotein 3,22816,168,1.17 [0.89-1.53],0.2504448225280098
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAMTOR5,Ragulator complex protein LAMTOR5,19568,141,1.17 [0.82-1.67],0.3983558307295379
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAP3,Cytosol aminopeptidase,22181,166,0.99 [0.75-1.32],0.95874897473408
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LARP1,La-related protein 1,19568,141,1.10 [0.88-1.39],0.4007239096264018
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAT,Linker for activation of T-cells family member 1,22856,169,0.92 [0.77-1.09],0.3198803909908882
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAT2,Linker for activation of T-cells family member 2,22505,169,0.97 [0.86-1.08],0.5447410951076294
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LATS1,Serine/threonine-protein kinase LATS1,19124,135,0.98 [0.80-1.19],0.8410061441334453
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LAYN,Layilin,22411,168,0.93 [0.61-1.41],0.7170163407299706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LBP,Lipopolysaccharide-binding protein,22671,169,1.12 [0.89-1.41],0.337196164405135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LBR,Delta(14)-sterol reductase LBR,22808,168,1.10 [0.92-1.33],0.2948738400760844
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LCAT,Phosphatidylcholine-sterol acyltransferase,19678,139,1.09 [0.52-2.29],0.816644598336467
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LCN15,Lipocalin-15,19643,140,0.97 [0.75-1.26],0.8325832951972015
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LCN2,Neutrophil gelatinase-associated lipocalin,21903,160,1.05 [0.72-1.52],0.8185066899945059
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LCP1,Plastin-2,19669,142,1.00 [0.71-1.40],0.98690374569538
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LDLR,Low-density lipoprotein receptor,22669,166,0.78 [0.60-1.01],0.0620580193246073
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LDLRAP1,Low density lipoprotein receptor adapter protein 1,19643,140,0.90 [0.76-1.06],0.2186359813511265
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LECT2,Leukocyte cell-derived chemotaxin-2,19673,140,0.80 [0.62-1.03],0.0834310535830119
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LEFTY2,Left-right determination factor 2,22770,167,0.93 [0.71-1.21],0.5753649007847892
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LEG1,Protein LEG1 homolog,18603,135,1.01 [0.79-1.28],0.9621600167966712
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LELP1,Late cornified envelope-like proline-rich protein 1,19065,134,0.95 [0.75-1.21],0.6941234142138217
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LEO1,RNA polymerase-associated protein LEO1,19643,140,0.79 [0.43-1.44],0.443850236892903
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LEP,Leptin,22609,170,0.91 [0.73-1.12],0.3525319336811111
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LEPR,Leptin receptor,22609,170,0.85 [0.54-1.34],0.4821394990479533
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LETM1,Mitochondrial proton/calcium exchanger protein,19643,140,0.80 [0.58-1.11],0.1900816097493026
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS1,Galectin-1,22609,170,1.11 [0.74-1.67],0.6055454982992456
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS3,Galectin-3,22661,166,0.96 [0.60-1.53],0.8641687570592743
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS3BP,Galectin-3-binding protein,19703,139,0.78 [0.45-1.37],0.3912830085171663
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS4,Galectin-4,22600,169,0.93 [0.71-1.20],0.5643336858555219
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS7_LGALS7B,Galectin-7,22572,165,0.87 [0.61-1.24],0.434107126780626
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS8,Galectin-8,22808,168,0.97 [0.77-1.21],0.7774531770374437
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGALS9,Galectin-9,22601,166,0.79 [0.51-1.22],0.2915622535576164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LGMN,Legumain,22709,169,0.81 [0.55-1.19],0.2782830457907955
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LHB,Lutropin subunit beta,22099,164,0.84 [0.70-1.01],0.0665981335127736
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22634,169,1.11 [0.89-1.39],0.3575701557176205
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LIF,Leukemia inhibitory factor,22047,163,0.93 [0.70-1.23],0.6158386420765458
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LIFR,Leukemia inhibitory factor receptor,22569,167,0.86 [0.49-1.52],0.6124296192098967
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22614,165,1.16 [0.79-1.71],0.4511483503073271
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19669,142,1.03 [0.91-1.17],0.611680616231244
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19073,136,1.01 [0.74-1.39],0.9303567976771046
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22575,170,0.87 [0.57-1.34],0.540258732429847
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19673,140,1.00 [0.80-1.24],0.9919393659878304
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22879,170,0.99 [0.61-1.63],0.9788481347100652
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22771,167,1.27 [0.85-1.90],0.2457724982305484
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22181,166,0.95 [0.68-1.31],0.7374528091038364
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,22879,170,0.92 [0.76-1.11],0.3719069021377215
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LIPF,Gastric triacylglycerol lipase,19177,139,1.15 [0.88-1.50],0.2980669636128793
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LMNB1,Lamin-B1,19530,142,1.26 [1.01-1.57],0.0427053935576752
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LMNB2,Lamin-B2,19633,140,0.99 [0.55-1.79],0.9688024157799798
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LMOD1,Leiomodin-1,19643,140,0.77 [0.47-1.27],0.3051310567802224
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LMOD2,Leiomodin-2,19065,134,0.77 [0.57-1.03],0.0799356104172372
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LONP1,"Lon protease homolog, mitochondrial",19177,139,0.98 [0.81-1.19],0.8412688142418098
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LPA,Apolipoprotein(a),19209,133,0.99 [0.90-1.09],0.8126783234556071
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LPCAT2,Lysophosphatidylcholine acyltransferase 2,22505,169,1.21 [0.93-1.56],0.1582251873642612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LPL,Lipoprotein lipase,22609,170,1.18 [0.88-1.60],0.2696601168364126
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LPO,Lactoperoxidase,21908,166,1.04 [0.83-1.31],0.7312763019943427
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LPP,Lipoma-preferred partner,19073,136,0.99 [0.77-1.27],0.9415840083169764
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19073,136,0.94 [0.74-1.21],0.6416126375282474
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19126,138,0.69 [0.45-1.04],0.0780727515450026
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRG1,Leucine-rich alpha-2-glycoprotein,19703,139,1.08 [0.58-2.01],0.8096048359517463
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22737,166,0.90 [0.60-1.34],0.6066640181587477
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19049,134,0.91 [0.50-1.65],0.7484039449757025
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRP1,Prolow-density lipoprotein receptor-related protein 1,22505,169,1.13 [0.68-1.88],0.6426653932300597
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRP11,Low-density lipoprotein receptor-related protein 11,22609,170,0.84 [0.57-1.25],0.3945504170605843
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRP2,Low-density lipoprotein receptor-related protein 2,19126,138,0.71 [0.43-1.15],0.1654015885483973
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRP2BP,LRP2-binding protein,19126,138,0.97 [0.79-1.18],0.7299109614183441
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22808,168,0.99 [0.78-1.26],0.945962029020622
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRC25,Leucine-rich repeat-containing protein 25,22505,169,0.78 [0.54-1.13],0.1899402105431515
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRC37A2,Leucine-rich repeat-containing protein 37A2,19573,142,0.94 [0.64-1.37],0.7418733686767157
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRC38,Leucine-rich repeat-containing protein 38,19126,138,0.92 [0.65-1.30],0.6310672615849302
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRC59,Leucine-rich repeat-containing protein 59,19673,140,0.88 [0.62-1.26],0.4914580203760389
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19568,141,0.82 [0.58-1.17],0.2688313258110277
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRRN1,Leucine-rich repeat neuronal protein 1,22181,166,1.18 [0.82-1.70],0.363897505134202
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19126,138,0.55 [0.34-0.89],0.0141148195523607
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19643,140,0.89 [0.48-1.65],0.7157308565686711
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LSM1,U6 snRNA-associated Sm-like protein LSm1,22099,164,0.89 [0.68-1.16],0.3973842121419714
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LSM8,U6 snRNA-associated Sm-like protein LSm8,19295,142,0.94 [0.78-1.14],0.5237749257461831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LSP1,Lymphocyte-specific protein 1,22569,167,1.08 [0.77-1.50],0.6686051965166357
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTA,Lymphotoxin-alpha,22569,167,0.81 [0.58-1.15],0.236505127657185
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTA4H,Leukotriene A-4 hydrolase,22809,167,1.04 [0.82-1.31],0.765360376567001
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTB,Lymphotoxin-beta,19568,141,0.84 [0.51-1.37],0.4895485176219345
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTBP2,Latent-transforming growth factor beta-binding protein 2,22879,170,0.93 [0.60-1.44],0.7415600385098674
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTBP3,Latent-transforming growth factor beta-binding protein 3,22099,164,0.99 [0.77-1.29],0.9669913937487962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTBR,Tumor necrosis factor receptor superfamily member 3,22497,166,1.18 [0.71-1.95],0.5298702650676681
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LTO1,Protein LTO1 homolog,22181,166,1.14 [0.84-1.54],0.4128633407909233
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LUZP2,Leucine zipper protein 2,19568,141,0.87 [0.59-1.27],0.4559254574696834
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LXN,Latexin,22356,168,1.04 [0.85-1.27],0.6938167254300293
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LY6D,Lymphocyte antigen 6D,22498,166,0.94 [0.64-1.39],0.771471198687427
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LY75,Lymphocyte antigen 75,22569,167,0.91 [0.64-1.28],0.5772943191202514
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LY9,T-lymphocyte surface antigen Ly-9,22390,168,0.81 [0.50-1.33],0.4114707518477845
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LY96,Lymphocyte antigen 96,22459,168,0.74 [0.49-1.12],0.1535847990409396
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYAR,Cell growth-regulating nucleolar protein,22099,164,0.94 [0.72-1.24],0.6757409634519631
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYN,Tyrosine-protein kinase Lyn,22505,169,0.96 [0.82-1.13],0.6430002292736754
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYPD1,Ly6/PLAUR domain-containing protein 1,22047,163,0.89 [0.70-1.14],0.355531265955875
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYPD3,Ly6/PLAUR domain-containing protein 3,22490,169,1.26 [0.86-1.86],0.2414561196565077
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYPD8,Ly6/PLAUR domain-containing protein 8,22099,164,0.81 [0.60-1.08],0.1455870355699683
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYPLA2,Acyl-protein thioesterase 2,19065,134,1.01 [0.87-1.18],0.8891664639043932
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19126,138,0.86 [0.72-1.03],0.1095024238476914
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19703,139,0.94 [0.41-2.14],0.8854086878549465
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LYZL2,Lysozyme-like protein 2,18980,139,1.22 [0.81-1.83],0.3361782428817469
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",LZTFL1,Leucine zipper transcription factor-like protein 1,19262,139,1.00 [0.80-1.26],0.974866242769274
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",M6PR,Cation-dependent mannose-6-phosphate receptor,19177,139,0.98 [0.66-1.45],0.9019094439677426
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22375,167,1.02 [0.77-1.34],0.9022328462657276
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAEA,E3 ubiquitin-protein transferase MAEA,22099,164,0.76 [0.52-1.11],0.1513505396186786
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAG,Myelin-associated glycoprotein,19126,138,0.86 [0.61-1.21],0.3892278097889491
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAGEA3,Melanoma-associated antigen 3,19295,142,0.97 [0.81-1.16],0.7239244325954459
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAGED1,Melanoma-associated antigen D1,22099,164,1.02 [0.76-1.36],0.896196657106061
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAMDC2,MAM domain-containing protein 2,19673,140,0.89 [0.55-1.45],0.64602041330743
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAMDC4,Apical endosomal glycoprotein,19568,141,1.16 [0.87-1.55],0.3104896909945394
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19177,139,0.92 [0.48-1.74],0.7935871480409857
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAN2B2,Epididymis-specific alpha-mannosidase,19673,140,1.16 [0.88-1.52],0.295213430031664
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",18980,139,1.04 [0.75-1.43],0.8266463214467494
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MANF,Mesencephalic astrocyte-derived neurotrophic factor,22709,169,0.95 [0.85-1.06],0.3186086748870181
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MANSC1,MANSC domain-containing protein 1,22677,169,1.06 [0.64-1.74],0.8211790976157715
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MANSC4,MANSC domain-containing protein 4,19073,136,0.91 [0.70-1.18],0.4600294222604699
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19065,134,0.87 [0.51-1.47],0.5973043014994153
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19073,136,1.01 [0.79-1.29],0.9123458365792508
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP2,Microtubule-associated protein 2,19633,140,0.70 [0.47-1.04],0.0764380747181749
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19573,142,0.98 [0.76-1.26],0.8590816596843127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22569,167,1.00 [0.88-1.15],0.9642603079131092
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22099,164,0.92 [0.80-1.07],0.2884276277104767
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22411,168,0.98 [0.86-1.10],0.6947582833837116
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAPK13,Mitogen-activated protein kinase 13,18980,139,0.99 [0.69-1.44],0.9699304272275634
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAPK9,Mitogen-activated protein kinase 9,22569,167,0.95 [0.70-1.31],0.773277642388568
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAPKAPK2,MAP kinase-activated protein kinase 2,19295,142,0.97 [0.77-1.21],0.7624707547380073
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAPRE3,Microtubule-associated protein RP/EB family member 3,18980,139,0.97 [0.86-1.09],0.576804159622371
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAPT,Microtubule-associated protein tau,22047,163,1.19 [0.91-1.56],0.2006940547552965
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MARCO,Macrophage receptor MARCO,22609,170,0.71 [0.43-1.18],0.1885803251917803
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MARS1,"Methionine--tRNA ligase, cytoplasmic",19219,139,0.98 [0.81-1.19],0.8631780457908873
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MASP1,Mannan-binding lectin serine protease 1,22411,168,1.19 [0.67-2.12],0.5579371637391586
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MATN2,Matrilin-2,22642,169,1.21 [0.77-1.91],0.4076033295636436
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MATN3,Matrilin-3,22424,168,1.11 [0.72-1.71],0.646330040512177
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAVS,Mitochondrial antiviral-signaling protein,22099,164,0.97 [0.83-1.12],0.6592033365220465
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MAX,Protein max,22047,163,0.99 [0.86-1.13],0.8266899407972335
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MB,Myoglobin,22879,170,1.11 [0.85-1.45],0.4245182333560019
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MBL2,Mannose-binding protein C,19415,135,1.10 [0.94-1.28],0.2458743607769191
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MCAM,Cell surface glycoprotein MUC18,22671,169,1.13 [0.76-1.69],0.5382088860915908
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19643,140,0.93 [0.63-1.37],0.7004526009604086
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MCEMP1,Mast cell-expressed membrane protein 1,19124,135,0.92 [0.76-1.10],0.3512943002665001
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MCFD2,Multiple coagulation factor deficiency protein 2,22511,169,1.04 [0.76-1.42],0.8152926098885886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MCTS1,Malignant T-cell-amplified sequence 1,19573,142,1.13 [0.63-2.03],0.6853983516380726
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22459,168,0.88 [0.72-1.06],0.174953333690291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MDH1,"Malate dehydrogenase, cytoplasmic",19557,139,0.98 [0.66-1.45],0.9140546261577064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MDK,Midkine,22618,169,0.92 [0.70-1.20],0.5273913085763411
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MDM1,Nuclear protein MDM1,19126,138,0.46 [0.27-0.80],0.0061522551289391
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19177,139,1.01 [0.84-1.21],0.913026146727676
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MED18,Mediator of RNA polymerase II transcription subunit 18,22099,164,0.97 [0.81-1.17],0.7780378757857449
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MED21,Mediator of RNA polymerase II transcription subunit 21,19073,136,0.88 [0.61-1.27],0.4890596741295936
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEGF10,Multiple epidermal growth factor-like domains protein 10,22600,169,0.74 [0.52-1.05],0.0910857885812266
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEGF11,Multiple epidermal growth factor-like domains protein 11,19073,136,0.57 [0.31-1.04],0.0653433323211694
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEGF9,Multiple epidermal growth factor-like domains protein 9,22810,167,1.00 [0.52-1.92],0.9980652341092006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MELTF,Melanotransferrin,19673,140,0.54 [0.31-0.93],0.027682425799786
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MENT,Protein MENT,19262,139,1.10 [0.52-2.33],0.8038717686078127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEP1A,Meprin A subunit alpha,19573,142,0.92 [0.73-1.17],0.5067372939635822
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEP1B,Meprin A subunit beta,22609,170,0.98 [0.88-1.10],0.7545323033568034
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MEPE,Matrix extracellular phosphoglycoprotein,22600,169,0.72 [0.44-1.16],0.1790990504084489
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MERTK,Tyrosine-protein kinase Mer,22856,169,0.88 [0.52-1.48],0.6346134203966995
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MESD,LRP chaperone MESD,22614,165,1.00 [0.90-1.12],0.9586541325681824
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MET,Hepatocyte growth factor receptor,22665,169,0.87 [0.44-1.70],0.6767576160293204
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",METAP1,Methionine aminopeptidase 1,22047,163,1.05 [0.66-1.65],0.8404305553614795
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22569,167,1.04 [0.88-1.22],0.6715594100279902
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",METAP2,Methionine aminopeptidase 2,22770,167,0.99 [0.79-1.25],0.9489138676183432
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MFAP3,Microfibril-associated glycoprotein 3,22202,165,1.18 [0.93-1.50],0.1738192546083977
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MFAP3L,Microfibrillar-associated protein 3-like,19126,138,0.84 [0.63-1.13],0.2476882668463577
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MFAP4,Microfibril-associated glycoprotein 4,19262,139,1.15 [0.68-1.93],0.6035275226646483
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MFAP5,Microfibrillar-associated protein 5,22879,170,0.99 [0.71-1.38],0.9703545145805524
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MFGE8,Lactadherin,22614,165,0.79 [0.57-1.11],0.1705202663382319
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MGLL,Monoglyceride lipase,22670,169,0.98 [0.84-1.14],0.7939615525968093
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MGMT,Methylated-DNA--protein-cysteine methyltransferase,22569,167,1.02 [0.91-1.14],0.7479960507799572
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MIA,Melanoma-derived growth regulatory protein,22677,169,1.07 [0.74-1.55],0.7221629878455704
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MICALL2,MICAL-like protein 2,19126,138,0.74 [0.56-0.97],0.0288677896324199
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22569,167,1.04 [0.94-1.15],0.4099445118770632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MIF,Macrophage migration inhibitory factor,22584,165,1.00 [0.82-1.22],0.9853210089723704
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MILR1,Allergin-1,22181,166,0.89 [0.67-1.18],0.410527125787989
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19568,141,0.89 [0.77-1.03],0.126141990330511
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MINK1,Misshapen-like kinase 1,19633,140,0.91 [0.77-1.08],0.2895209967981173
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MITD1,MIT domain-containing protein 1,22459,168,0.98 [0.85-1.13],0.7891364157464809
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MKI67,Proliferation marker protein Ki-67,19124,135,0.94 [0.61-1.45],0.7867640263084346
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MLLT1,Protein ENL,18980,139,1.02 [0.81-1.28],0.8924451371040345
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MLN,Promotilin,22569,167,0.98 [0.84-1.14],0.7527922849947586
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MME,Neprilysin,22505,169,1.04 [0.88-1.23],0.6417758692975843
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP1,Interstitial collagenase,21737,159,0.90 [0.77-1.04],0.1598795433989075
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP10,Stromelysin-2,22569,169,1.04 [0.83-1.31],0.7060987752852756
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP12,Macrophage metalloelastase,22629,166,1.02 [0.77-1.34],0.90554397989317
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP13,Collagenase 3,22047,163,1.05 [0.68-1.61],0.8281469735934686
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP15,Matrix metalloproteinase-15,19673,140,1.23 [0.97-1.56],0.0872106817667242
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP3,Stromelysin-1,22614,165,1.15 [0.87-1.53],0.3303631953056402
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP7,Matrilysin,22161,165,1.08 [0.81-1.45],0.6012552039801186
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP8,Neutrophil collagenase,22768,168,0.98 [0.82-1.18],0.8606872484829526
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMP9,Matrix metalloproteinase-9,22573,165,1.06 [0.84-1.32],0.6375493586147742
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19073,136,1.08 [0.78-1.50],0.62612555191055
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MN1,Transcriptional activator MN1,19126,138,0.76 [0.55-1.06],0.1018080677426884
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MNAT1,CDK-activating kinase assembly factor MAT1,19295,142,1.20 [0.86-1.66],0.2884150811348052
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MNDA,Myeloid cell nuclear differentiation antigen,22574,170,1.02 [0.90-1.17],0.7354942871182197
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MOCS2,Molybdopterin synthase catalytic subunit,19262,139,0.83 [0.65-1.07],0.1426506895587823
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MOG,Myelin-oligodendrocyte glycoprotein,22809,167,0.86 [0.56-1.33],0.5032800737955307
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MORC3,MORC family CW-type zinc finger protein 3,19633,140,1.25 [0.76-2.05],0.3873152721861532
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MORF4L1,Mortality factor 4-like protein 1,19295,142,0.66 [0.41-1.06],0.0854195644790366
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MORF4L2,Mortality factor 4-like protein 2,18980,139,1.01 [0.66-1.56],0.953942508494906
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MORN4,MORN repeat-containing protein 4,18980,139,0.82 [0.64-1.05],0.1225378269912818
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MPHOSPH8,M-phase phosphoprotein 8,22202,165,0.97 [0.81-1.17],0.7556541414203904
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MPI,Mannose-6-phosphate isomerase,22505,169,1.02 [0.87-1.19],0.8278773106605912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22670,169,0.90 [0.76-1.07],0.2312422595344341
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MPO,Myeloperoxidase,22614,165,1.04 [0.78-1.39],0.7874579588152164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MPRIP,Myosin phosphatase Rho-interacting protein,19525,141,0.93 [0.64-1.34],0.6821603757024122
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRC1,Macrophage mannose receptor 1,19678,139,0.97 [0.55-1.73],0.9267199030598048
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRI1,Methylthioribose-1-phosphate isomerase,19126,138,0.95 [0.75-1.20],0.6440841360217114
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPL24,"39S ribosomal protein L24, mitochondrial",19073,136,0.93 [0.60-1.44],0.7476638618530356
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPL28,"39S ribosomal protein L28, mitochondrial",19643,140,0.93 [0.58-1.49],0.7616710206398294
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPL46,"39S ribosomal protein L46, mitochondrial",22047,163,1.29 [0.80-2.06],0.2936131211801307
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPL52,"39S ribosomal protein L52, mitochondrial",18952,139,1.16 [0.62-2.18],0.6363192944442239
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19643,140,0.70 [0.52-0.93],0.0129788004796234
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MRPS16,"28S ribosomal protein S16, mitochondrial",19124,135,1.45 [0.94-2.23],0.0923834364263476
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSLN,Mesothelin,22474,169,0.96 [0.74-1.25],0.7688176291311116
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSLNL,Mesothelin-like protein,19126,138,0.61 [0.38-0.98],0.0417980170309747
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSMB,Beta-microseminoprotein,22520,168,1.06 [0.87-1.29],0.5643825136193501
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSR1,Macrophage scavenger receptor types I and II,22808,168,1.04 [0.76-1.41],0.8212041480949546
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSRA,Mitochondrial peptide methionine sulfoxide reductase,22677,169,0.96 [0.80-1.15],0.6583596929042054
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MST1,Hepatocyte growth factor-like protein,19363,134,0.86 [0.70-1.06],0.1640151140772424
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MSTN,Growth/differentiation factor 8,22202,165,1.07 [0.82-1.41],0.6040296648470229
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTDH,Protein LYRIC,19124,135,0.99 [0.82-1.19],0.9090031670759996
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19633,140,0.80 [0.41-1.56],0.5076061757979962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19295,142,0.94 [0.81-1.09],0.4259938756025623
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTIF3,"Translation initiation factor IF-3, mitochondrial",19573,142,0.99 [0.82-1.19],0.8991612214479502
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTPN,Myotrophin,22202,165,1.04 [0.69-1.56],0.860072425976885
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTR,Methionine synthase,19073,136,0.87 [0.66-1.16],0.3532362829573223
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTSS1,Protein MTSS 1,19573,142,0.87 [0.75-1.01],0.0693039982781313
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTSS2,Protein MTSS 2,19568,141,0.99 [0.84-1.16],0.8708307142589515
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MTUS1,Microtubule-associated tumor suppressor 1,19295,142,0.84 [0.62-1.14],0.2530166268561927
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MUC13,Mucin-13,22047,163,0.80 [0.60-1.06],0.1225684004754365
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MUC16,Mucin-16,22505,169,1.02 [0.94-1.09],0.6749171991621998
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MUC2,Mucin-2,19669,142,1.00 [0.84-1.20],0.9644171729209186
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MUCL3,Mucin-like protein 3,18980,139,1.00 [0.70-1.43],0.9950800348204382
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MVK,Mevalonate kinase,22181,166,0.98 [0.82-1.17],0.8069839667927157
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MXRA8,Matrix remodeling-associated protein 8,19262,139,0.86 [0.50-1.46],0.5703834881727219
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYBPC1,"Myosin-binding protein C, slow-type",19673,140,1.09 [0.86-1.40],0.4768554196392995
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYBPC2,"Myosin-binding protein C, fast-type",19177,139,1.06 [0.88-1.27],0.5642805731656115
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19643,140,0.89 [0.70-1.15],0.3761738467418671
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYDGF,Myeloid-derived growth factor,19673,140,0.99 [0.84-1.16],0.8630990786444915
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYH4,Myosin-4,19073,136,0.76 [0.50-1.16],0.2112273955903282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYH7B,Myosin-7B,18980,139,1.09 [0.77-1.54],0.6390286330899635
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYH9,Myosin-9,19669,142,0.95 [0.83-1.10],0.526451374649589
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19073,136,1.11 [0.77-1.61],0.5680116393527395
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYL3,Myosin light chain 3,19177,139,1.12 [0.89-1.42],0.3316586806583555
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYL4,Myosin light chain 4,19177,139,0.98 [0.72-1.33],0.9018988377212044
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYL6B,Myosin light chain 6B,19126,138,0.92 [0.76-1.12],0.4196035424797988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19126,138,0.96 [0.65-1.41],0.8238763828934194
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYO6,Unconventional myosin-VI,19643,140,0.64 [0.38-1.07],0.0855707626739525
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYO9B,Unconventional myosin-IXb,22181,166,0.98 [0.79-1.20],0.8139426396417279
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYOC,Myocilin,22614,165,0.82 [0.61-1.10],0.1868315796386936
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYOM1,Myomesin-1,19065,134,0.99 [0.70-1.41],0.963164341117519
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYOM2,Myomesin-2,19073,136,1.00 [0.70-1.43],0.9950055051063796
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MYOM3,Myomesin-3,19262,139,1.16 [0.97-1.38],0.1037726998046712
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MZB1,Marginal zone B- and B1-cell-specific protein,22681,169,1.03 [0.79-1.35],0.8088614209386402
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",MZT1,Mitotic-spindle organizing protein 1,22099,164,0.97 [0.74-1.27],0.8231886477546736
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAA10,N-alpha-acetyltransferase 10,19073,136,0.90 [0.65-1.24],0.5037451424480568
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAA80,N-alpha-acetyltransferase 80,19126,138,0.92 [0.80-1.06],0.2352975978032886
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAAA,N-acylethanolamine-hydrolyzing acid amidase,22353,166,0.98 [0.77-1.24],0.8565782620404241
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NACC1,Nucleus accumbens-associated protein 1,19568,141,0.96 [0.71-1.29],0.7818163147439463
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NADK,NAD kinase,22609,170,1.10 [0.88-1.38],0.4063135162296847
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAGA,Alpha-N-acetylgalactosaminidase,19085,135,0.95 [0.71-1.27],0.7430506814067883
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAGK,N-acetyl-D-glucosamine kinase,19140,139,1.08 [0.81-1.43],0.6133030762952651
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19262,139,1.15 [0.53-2.47],0.7284733083067525
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAMPT,Nicotinamide phosphoribosyltransferase,22099,164,0.83 [0.62-1.12],0.2216722662807483
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAP1L4,Nucleosome assembly protein 1-like 4,19545,142,1.08 [0.74-1.60],0.6854040021513805
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NAPRT,Nicotinate phosphoribosyltransferase,19633,140,0.79 [0.47-1.33],0.3753907329977406
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NARS1,"Asparagine--tRNA ligase, cytoplasmic",19643,140,0.96 [0.68-1.34],0.7894597265475778
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NBL1,Neuroblastoma suppressor of tumorigenicity 1,22677,169,1.00 [0.59-1.69],0.9855861661531656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NBN,Nibrin,22181,166,0.95 [0.72-1.25],0.7001616451058543
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCAM1,Neural cell adhesion molecule 1,22671,169,1.27 [0.78-2.06],0.3416845463138448
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCAM2,Neural cell adhesion molecule 2,22614,165,1.08 [0.65-1.79],0.7735922586665053
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCAN,Neurocan core protein,22808,168,0.87 [0.60-1.25],0.443736823247758
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCF2,Neutrophil cytosol factor 2,22541,167,1.01 [0.86-1.18],0.932773215204661
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCK2,Cytoplasmic protein NCK2,22709,169,0.95 [0.84-1.08],0.4646393160800922
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCLN,Nicalin,22181,166,0.94 [0.72-1.23],0.6595096804064056
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCR1,Natural cytotoxicity triggering receptor 1,22536,167,0.97 [0.66-1.42],0.8595713574570656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19573,142,0.86 [0.52-1.41],0.5408095800952054
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NCS1,Neuronal calcium sensor 1,22809,167,0.66 [0.41-1.07],0.0914592524260096
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NDRG1,Protein NDRG1,22047,163,0.96 [0.78-1.18],0.7053991713404615
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19568,141,1.00 [0.77-1.28],0.9705521888569908
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19090,135,1.02 [0.64-1.63],0.9330538687843658
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19573,142,0.97 [0.81-1.16],0.759395864538074
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22099,164,0.91 [0.75-1.10],0.3161243452816049
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEB,Nebulin,19073,136,0.65 [0.38-1.11],0.1140205789722003
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NECAP2,Adaptin ear-binding coat-associated protein 2,19073,136,0.96 [0.75-1.23],0.7637386299851634
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NECTIN1,Nectin-1,19124,135,0.89 [0.52-1.52],0.6726206322969949
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NECTIN2,Nectin-2,22575,170,0.91 [0.56-1.48],0.6951977054218754
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NECTIN4,Nectin-4,22677,169,1.18 [0.74-1.87],0.4825291112098735
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19124,135,0.88 [0.64-1.23],0.4667303670141399
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEDD9,Enhancer of filamentation 1,19124,135,0.86 [0.51-1.45],0.5757048969962444
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEFL,Neurofilament light polypeptide,21968,163,1.11 [0.79-1.56],0.5336862763062391
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEK7,Serine/threonine-protein kinase Nek7,19295,142,1.09 [0.91-1.32],0.3539418702860664
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NELL1,Protein kinase C-binding protein NELL1,22677,169,0.99 [0.71-1.37],0.9464245676945648
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NELL2,Protein kinase C-binding protein NELL2,22709,169,0.49 [0.30-0.81],0.0051486415579023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NENF,Neudesin,19568,141,1.00 [0.86-1.15],0.9580169797837238
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEO1,Neogenin,19643,140,0.89 [0.42-1.89],0.7665530187721071
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NEXN,Nexilin,19678,139,1.13 [0.90-1.42],0.3032603598818799
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFASC,Neurofascin,22856,169,1.13 [0.68-1.86],0.6426787386062252
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFAT5,Nuclear factor of activated T-cells 5,19124,135,0.90 [0.73-1.10],0.284305581182962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22569,167,0.94 [0.82-1.09],0.4414312004222147
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22181,166,0.94 [0.73-1.19],0.5886112658946325
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFE2,Transcription factor NF-E2 45 kDa subunit,19177,139,0.95 [0.76-1.19],0.6690531107875186
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFIC,Nuclear factor 1 C-type,19643,140,0.94 [0.63-1.40],0.7628969152588302
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFKB1,Nuclear factor NF-kappa-B p105 subunit,19073,136,0.95 [0.76-1.19],0.6687160538891093
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFKB2,Nuclear factor NF-kappa-B p100 subunit,19295,142,0.77 [0.53-1.12],0.1699270892116902
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFKBIE,NF-kappa-B inhibitor epsilon,22099,164,0.78 [0.58-1.05],0.0973622699458159
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19573,142,1.00 [0.86-1.17],0.9575004276486392
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFX1,Transcriptional repressor NF-X1,19073,136,1.09 [0.85-1.38],0.5052203847879351
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NFYA,Nuclear transcription factor Y subunit alpha,19073,136,1.35 [0.97-1.87],0.0755631832934066
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NGF,Beta-nerve growth factor,22459,168,0.73 [0.24-2.25],0.5825979537762527
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NGFR,Tumor necrosis factor receptor superfamily member 16,19673,140,0.75 [0.41-1.36],0.3383136990787114
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NGRN,Neugrin,19633,140,0.90 [0.43-1.90],0.7897753858003322
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NHLRC3,NHL repeat-containing protein 3,18783,138,0.96 [0.57-1.60],0.8653175947488763
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NID1,Nidogen-1,22594,169,1.14 [0.81-1.60],0.4589431788986127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NID2,Nidogen-2,22614,165,1.12 [0.94-1.34],0.2027331957713619
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NINJ1,Ninjurin-1,22099,164,0.93 [0.72-1.20],0.5831692913880706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NIT1,Deaminated glutathione amidase,19177,139,1.00 [0.72-1.40],0.9856903464222072
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NIT2,Omega-amidase NIT2,19603,139,0.99 [0.80-1.22],0.915452333974042
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NLGN1,Neuroligin-1,19126,138,0.93 [0.72-1.20],0.5817501313488724
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NLGN2,Neuroligin-2,19065,134,1.03 [0.74-1.43],0.8612632055299885
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NME1,Nucleoside diphosphate kinase A,19124,135,1.36 [0.66-2.81],0.4074703216226507
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NME3,Nucleoside diphosphate kinase 3,22642,169,0.48 [0.26-0.88],0.0179463455019772
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NMI,N-myc-interactor,19497,141,1.01 [0.80-1.26],0.962032870693832
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22459,168,1.04 [0.87-1.24],0.6566800997937841
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NMRK2,Nicotinamide riboside kinase 2,18980,139,0.82 [0.52-1.28],0.3732689972072444
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19643,140,0.92 [0.72-1.19],0.5408867840367777
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOMO1,Nodal modulator 1,22614,165,1.34 [0.76-2.36],0.3116769838712376
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOP56,Nucleolar protein 56,19073,136,1.04 [0.91-1.20],0.5532618793844286
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOS1,"Nitric oxide synthase, brain",22047,163,1.15 [0.87-1.52],0.3254244706854711
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOS2,"Nitric oxide synthase, inducible",19073,136,0.98 [0.64-1.49],0.9146543277024608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOS3,"Nitric oxide synthase, endothelial",22047,163,0.90 [0.69-1.19],0.4761153976202239
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOTCH1,Neurogenic locus notch homolog protein 1,22879,170,0.57 [0.24-1.38],0.2126834673308837
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOTCH2,Neurogenic locus notch homolog protein 2,19669,142,1.77 [0.88-3.58],0.1088678388032832
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NOTCH3,Neurogenic locus notch homolog protein 3,22879,170,0.90 [0.61-1.33],0.5999073060849608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPC2,NPC intracellular cholesterol transporter 2,19335,142,0.79 [0.46-1.36],0.390743792980191
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPDC1,Neural proliferation differentiation and control protein 1,22609,170,1.14 [0.73-1.80],0.5630347682693697
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPHS1,Nephrin,19124,135,0.78 [0.47-1.30],0.3432976774253615
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPHS2,Podocin,19124,135,0.84 [0.70-1.01],0.0661960383461837
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPL,N-acetylneuraminate lyase,19673,140,0.96 [0.66-1.38],0.8081605008690035
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPPB,Natriuretic peptides B,22202,165,1.05 [0.94-1.17],0.427329345557462
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPPC,C-type natriuretic peptide,22569,167,1.10 [0.80-1.52],0.5534694489438269
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPR1,Atrial natriuretic peptide receptor 1,19073,136,0.75 [0.47-1.20],0.2375643031623412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPTN,Neuroplastin,22099,164,0.97 [0.81-1.15],0.6971289250428369
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPTX1,Neuronal pentraxin-1,22614,165,1.07 [0.75-1.52],0.7015468193326788
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPTX2,Neuronal pentraxin-2,19669,142,1.22 [0.75-2.00],0.4178700035772481
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPTXR,Neuronal pentraxin receptor,22609,170,1.22 [0.83-1.78],0.3075252232867414
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NPY,Pro-neuropeptide Y,22809,167,1.02 [0.83-1.25],0.8721992968468364
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRCAM,Neuronal cell adhesion molecule,22609,170,0.78 [0.48-1.28],0.3330630394676135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRGN,Neurogranin,19678,139,0.95 [0.80-1.14],0.5938094922254066
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRN1,Neuritin,19643,140,0.81 [0.48-1.36],0.4308022201540383
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRP1,Neuropilin-1,22714,169,1.92 [1.20-3.08],0.0062060336155789
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRP2,Neuropilin-2,22614,165,1.07 [0.67-1.71],0.7826981071411196
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRTN,Neurturin,22181,166,1.25 [0.99-1.58],0.0630524467152478
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NRXN3,Neurexin-3,19126,138,0.98 [0.62-1.55],0.9256379934113366
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NSFL1C,NSFL1 cofactor p47,22808,168,0.95 [0.77-1.16],0.6118532140272777
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19673,140,0.98 [0.79-1.22],0.8412947710555114
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NT5C1A,Cytosolic 5'-nucleotidase 1A,19633,140,0.86 [0.50-1.47],0.5766228187280775
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NT5C3A,Cytosolic 5'-nucleotidase 3A,22540,167,1.00 [0.85-1.16],0.9649038634925068
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NT5E,5'-nucleotidase,22677,169,0.97 [0.76-1.23],0.7798385751609374
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NTF3,Neurotrophin-3,22569,167,0.83 [0.56-1.23],0.3560372116829717
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NTF4,Neurotrophin-4,22099,164,0.99 [0.70-1.41],0.9640057471926496
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NTRK2,BDNF/NT-3 growth factors receptor,22609,170,0.61 [0.36-1.03],0.0626307994912083
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NTRK3,NT-3 growth factor receptor,22808,168,0.82 [0.44-1.52],0.5258567517020343
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NTproBNP,N-terminal prohormone of brain natriuretic peptide,22609,170,1.04 [0.90-1.19],0.6244879831899295
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUB1,NEDD8 ultimate buster 1,22569,167,1.01 [0.86-1.18],0.93513144037219
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19568,141,0.90 [0.75-1.07],0.2251510614305903
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUCB2,Nucleobindin-2,22768,167,0.89 [0.61-1.29],0.5388882544678275
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDC,Nuclear migration protein nudC,22856,169,1.00 [0.81-1.24],0.9717231882517086
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19177,139,1.20 [0.69-2.08],0.51875369339057
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19073,136,0.77 [0.53-1.12],0.1679888307337976
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDT16,U8 snoRNA-decapping enzyme,19537,141,0.96 [0.79-1.15],0.6265175459927683
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22505,169,1.05 [0.83-1.33],0.6690953619245257
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUDT5,ADP-sugar pyrophosphatase,22614,165,1.08 [0.83-1.40],0.5743448009821781
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUMB,Protein numb homolog,19124,135,0.95 [0.78-1.16],0.6046460524773823
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NUP50,Nuclear pore complex protein Nup50,19073,136,0.99 [0.60-1.62],0.9629390970499656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NXPE4,NXPE family member 4,19073,136,1.20 [0.82-1.78],0.3492801069619093
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NXPH1,Neurexophilin-1,22047,163,0.96 [0.66-1.40],0.8189412478678351
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",NXPH3,Neurexophilin-3,19124,135,0.78 [0.45-1.35],0.3756266613916439
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OBP2B,Odorant-binding protein 2b,22388,168,1.04 [0.85-1.28],0.6855066039224562
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OCLN,Occludin,19643,140,0.81 [0.55-1.19],0.2776263745385146
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ODAM,Odontogenic ameloblast-associated protein,22017,163,0.99 [0.77-1.29],0.9586027786067196
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OFD1,Oral-facial-digital syndrome 1 protein,19295,142,0.84 [0.63-1.11],0.2181265869415354
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OGA,Protein O-GlcNAcase,19573,142,0.98 [0.78-1.24],0.885786864580742
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OGFR,Opioid growth factor receptor,22505,169,0.95 [0.62-1.44],0.7969302190887175
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OGN,Mimecan,22614,165,1.02 [0.72-1.44],0.9269479636738652
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19295,142,0.77 [0.57-1.04],0.0929818630288876
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OLFM4,Olfactomedin-4,18536,135,1.00 [0.88-1.15],0.9642379265024636
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OLR1,Oxidized low-density lipoprotein receptor 1,22390,166,1.13 [0.90-1.40],0.2888687977257492
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OMD,Osteomodulin,22709,169,0.86 [0.64-1.16],0.3169994099735575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OMG,Oligodendrocyte-myelin glycoprotein,22505,169,0.95 [0.76-1.18],0.6304950940070894
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OMP,Olfactory marker protein,19065,134,1.00 [0.72-1.38],0.981946177445122
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OPHN1,Oligophrenin-1,19633,140,0.95 [0.81-1.10],0.4727664800822228
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OPLAH,5-oxoprolinase,19177,139,0.94 [0.74-1.20],0.6117472420453465
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OPTC,Opticin,22505,169,0.83 [0.60-1.14],0.256515562492877
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ORM1,Alpha-1-acid glycoprotein 1,19635,138,1.01 [0.45-2.30],0.9759509540298438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OSBPL2,Oxysterol-binding protein-related protein 2,19633,140,1.22 [0.88-1.69],0.2253189764759486
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OSCAR,Osteoclast-associated immunoglobulin-like receptor,22642,169,1.26 [0.84-1.90],0.2705338081857195
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OSM,Oncostatin-M,22465,164,0.99 [0.82-1.20],0.9395501909272196
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OSMR,Oncostatin-M-specific receptor subunit beta,22714,169,1.24 [0.65-2.38],0.5121868367463192
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OSTN,Osteocrin,19126,138,0.51 [0.31-0.86],0.0119720406308609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OTOA,Otoancorin,19065,134,0.72 [0.49-1.06],0.0919758867010469
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OTUD6B,Deubiquitinase OTUD6B,19573,142,0.90 [0.68-1.18],0.4462235070305654
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OTUD7B,OTU domain-containing protein 7B,19643,140,0.86 [0.66-1.11],0.2439594270103012
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19177,139,1.03 [0.81-1.31],0.8079409598829786
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",OXT,Oxytocin-neurophysin 1,22808,168,0.99 [0.89-1.09],0.7725619758157077
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",P4HB,Protein disulfide-isomerase,22493,169,1.06 [0.74-1.50],0.765396405542706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PACS2,Phosphofurin acidic cluster sorting protein 2,19073,136,0.86 [0.65-1.13],0.2742515129681508
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PADI2,Protein-arginine deiminase type-2,22181,166,0.97 [0.75-1.24],0.7899666349480814
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PADI4,Protein-arginine deiminase type-4,22017,163,1.11 [0.94-1.31],0.2368789754748217
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAEP,Glycodelin,22459,168,1.00 [0.90-1.11],0.96594837909468
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19643,140,0.92 [0.78-1.07],0.2678928433127135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19295,142,0.94 [0.67-1.31],0.7125735986802446
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22202,165,0.96 [0.75-1.23],0.7513856116677486
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAGR1,PAXIP1-associated glutamate-rich protein 1,19177,139,1.02 [0.71-1.46],0.9235996876060728
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,18942,139,1.21 [0.92-1.61],0.1768447541480572
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAK4,Serine/threonine-protein kinase PAK 4,22047,163,1.02 [0.81-1.28],0.8668957469105388
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PALLD,Palladin,19124,135,0.76 [0.47-1.22],0.2524931177746685
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PALM,Paralemmin-1,19470,141,1.19 [0.69-2.07],0.5258535206828261
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PALM2,Paralemmin-2,19633,140,0.75 [0.47-1.19],0.2198570888061377
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PALM3,Paralemmin-3,19073,136,0.85 [0.65-1.12],0.2463417806999856
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAM,Peptidyl-glycine alpha-amidating monooxygenase,22750,170,0.92 [0.57-1.49],0.7399159133962913
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAMR1,Inactive serine protease PAMR1,22614,165,1.45 [0.88-2.39],0.1420155605254519
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAPPA,Pappalysin-1,22181,166,0.93 [0.69-1.25],0.6186370073445718
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PARD3,Partitioning defective 3 homolog,19295,142,0.90 [0.71-1.14],0.370636251385766
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PARK7,Parkinson disease protein 7,22614,165,1.05 [0.82-1.36],0.6868675093085606
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PARP1,Poly [ADP-ribose] polymerase 1,22569,167,0.86 [0.65-1.14],0.2903176123432631
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PAXX,Protein PAXX,19262,139,0.91 [0.63-1.30],0.5913918606316519
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PBK,Lymphokine-activated killer T-cell-originated protein kinase,18980,139,1.01 [0.59-1.72],0.969476598789246
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PBLD,Phenazine biosynthesis-like domain-containing protein,22047,163,1.13 [0.86-1.48],0.3708620748014903
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19573,142,0.98 [0.57-1.67],0.935245500682867
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCARE,Photoreceptor cilium actin regulator,19065,134,0.91 [0.74-1.13],0.3973144790170475
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19223,139,0.95 [0.66-1.36],0.768368662773783
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCBP2,Poly(rC)-binding protein 2,19643,140,0.85 [0.68-1.07],0.1764807012380777
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDH1,Protocadherin-1,22786,168,0.96 [0.51-1.82],0.9086747767353848
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDH12,Protocadherin-12,19643,140,0.68 [0.36-1.29],0.2374623273251719
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDH17,Protocadherin-17,22609,170,1.01 [0.68-1.50],0.9489509326152892
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDH7,Protocadherin-7,19573,142,0.85 [0.52-1.40],0.5244237343162369
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDH9,Protocadherin-9,19573,142,0.89 [0.55-1.42],0.6182166913922826
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCDHB15,Protocadherin beta-15,19568,141,0.96 [0.64-1.44],0.8361306002046653
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCNA,Proliferating cell nuclear antigen,18980,139,0.85 [0.63-1.15],0.2834817676192123
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCSK7,Proprotein convertase subtilisin/kexin type 7,19568,141,1.02 [0.72-1.44],0.9244419100257162
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCSK9,Proprotein convertase subtilisin/kexin type 9,22879,170,0.95 [0.67-1.34],0.7685301514594185
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PCYT2,Ethanolamine-phosphate cytidylyltransferase,19573,142,0.94 [0.76-1.15],0.5302384804895621
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDAP1,28 kDa heat- and acid-stable phosphoprotein,19673,140,0.97 [0.82-1.14],0.7101664164096443
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDCD1,Programmed cell death protein 1,22777,167,0.80 [0.57-1.11],0.1813852813438801
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDCD1LG2,Programmed cell death 1 ligand 2,22505,169,1.02 [0.66-1.58],0.9328888919172776
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDCD5,Programmed cell death protein 5,22808,168,1.03 [0.82-1.30],0.786823029408162
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDCD6,Programmed cell death protein 6,22609,170,1.10 [0.89-1.37],0.3720780508784438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDCL2,Phosducin-like protein 2,18980,139,0.98 [0.73-1.32],0.8970156459256471
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",18980,139,0.95 [0.70-1.28],0.7206160285886463
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19073,136,1.00 [0.77-1.30],0.9962951876374352
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19262,139,0.94 [0.81-1.10],0.4595343678844871
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDGFA,Platelet-derived growth factor subunit A,22879,170,0.94 [0.78-1.13],0.4925179400612501
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDGFB,Platelet-derived growth factor subunit B,22709,169,0.94 [0.80-1.09],0.4017074685224492
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDGFC,Platelet-derived growth factor C,22099,164,1.05 [0.66-1.67],0.8455188659296429
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDGFRA,Platelet-derived growth factor receptor alpha,22609,170,1.03 [0.64-1.65],0.91780902996101
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDGFRB,Platelet-derived growth factor receptor beta,22879,170,0.99 [0.67-1.45],0.9498965086683512
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDIA2,Protein disulfide-isomerase A2,18980,139,0.88 [0.58-1.35],0.5589387154244005
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDIA3,Protein disulfide-isomerase A3,19262,139,1.01 [0.53-1.91],0.9862262453637992
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDIA4,Protein disulfide-isomerase A4,19669,142,1.01 [0.78-1.32],0.9367899497875998
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDIA5,Protein disulfide-isomerase A5,18980,139,0.78 [0.58-1.06],0.1085000349627533
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDLIM5,PDZ and LIM domain protein 5,19643,140,0.94 [0.82-1.07],0.3305696701377688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDLIM7,PDZ and LIM domain protein 7,22709,169,0.97 [0.87-1.08],0.6204145639847503
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22099,164,0.92 [0.69-1.22],0.5696370573712006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDRG1,p53 and DNA damage-regulated protein 1,19126,138,0.78 [0.54-1.11],0.160634842643609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,18980,139,0.68 [0.45-1.03],0.0697809363021293
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDZD2,PDZ domain-containing protein 2,19073,136,0.88 [0.66-1.17],0.377402687541715
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19124,135,0.86 [0.57-1.29],0.454663780865693
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PEAR1,Platelet endothelial aggregation receptor 1,22879,170,0.70 [0.39-1.26],0.2352005831683591
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PEBP1,Phosphatidylethanolamine-binding protein 1,22614,165,1.02 [0.81-1.29],0.8592396117050298
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PECAM1,Platelet endothelial cell adhesion molecule,22614,165,0.96 [0.61-1.52],0.8722772882369242
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PECR,Peroxisomal trans-2-enoyl-CoA reductase,19177,139,0.80 [0.43-1.47],0.4669598629238816
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PENK,Proenkephalin-A,19262,139,0.86 [0.50-1.49],0.5940598962859365
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PEPD,Xaa-Pro dipeptidase,19678,139,1.24 [0.66-2.32],0.5001399528553818
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PER3,Period circadian protein homolog 3,19124,135,0.93 [0.80-1.07],0.320585042683385
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PF4,Platelet factor 4,19561,136,0.91 [0.77-1.07],0.256257202859084
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PFDN2,Prefoldin subunit 2,22047,163,1.26 [1.01-1.58],0.0391470225229098
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PFDN4,Prefoldin subunit 4,18980,139,0.77 [0.55-1.09],0.1424523422856941
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PFDN6,Prefoldin subunit 6,19126,138,0.86 [0.65-1.14],0.2936747387419398
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22465,168,1.00 [0.84-1.19],0.9911005726126298
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGA4,Pepsin A-4,19678,139,1.35 [1.07-1.72],0.0131320017616687
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19673,140,0.96 [0.71-1.29],0.7961140171900856
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGF,Placenta growth factor,22856,169,0.90 [0.51-1.58],0.7134086431213369
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGLYRP1,Peptidoglycan recognition protein 1,22771,167,1.06 [0.77-1.46],0.7261101203169962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19444,135,1.35 [0.79-2.31],0.2670336788965541
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGLYRP4,Peptidoglycan recognition protein 4,19073,136,1.03 [0.80-1.33],0.8045628624906505
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGM2,Phosphoglucomutase-2,19126,138,0.78 [0.55-1.09],0.1483749378767409
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PGR,Progesterone receptor,19124,135,1.03 [0.89-1.20],0.6790658616934162
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PHACTR2,Phosphatase and actin regulator 2,19643,140,0.92 [0.80-1.06],0.2286650107395487
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PHLDB1,Pleckstrin homology-like domain family B member 1,19573,142,1.08 [0.80-1.45],0.6161177672904813
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PHLDB2,Pleckstrin homology-like domain family B member 2,18980,139,1.00 [0.84-1.19],0.9784390994529956
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22459,168,1.15 [0.72-1.84],0.5708321585701852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19262,139,1.10 [0.74-1.63],0.636979222087301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PI16,Peptidase inhibitor 16,19678,139,1.33 [0.69-2.57],0.39347843206569
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PI3,Elafin,22309,163,1.05 [0.81-1.36],0.7392221553933456
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19643,140,0.89 [0.72-1.10],0.2923920040139973
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PIGR,Polymeric immunoglobulin receptor,22326,164,1.03 [0.69-1.55],0.8665807634072907
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22569,167,1.14 [0.92-1.42],0.2342693348941722
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22614,165,0.89 [0.52-1.54],0.6836507450027182
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19124,135,1.00 [0.74-1.33],0.976590225281954
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PILRA,Paired immunoglobulin-like type 2 receptor alpha,22614,165,0.83 [0.60-1.16],0.2744944802892063
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PILRB,Paired immunoglobulin-like type 2 receptor beta,22609,170,0.80 [0.64-1.00],0.0515369544536169
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19262,139,1.00 [0.79-1.28],0.982574539538176
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PITHD1,PITH domain-containing protein 1,18942,139,0.97 [0.79-1.19],0.7653889569907707
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PKD1,Polycystin-1,19673,140,0.68 [0.37-1.25],0.2133555720105565
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PKD2,Polycystin-2,19073,136,0.93 [0.70-1.24],0.6258942017671003
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PKLR,Pyruvate kinase PKLR,22636,169,1.04 [0.86-1.27],0.6635471085351353
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PKN3,Serine/threonine-protein kinase N3,19295,142,0.91 [0.73-1.13],0.3770599459133339
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G10,Group 10 secretory phospholipase A2,22459,168,0.99 [0.79-1.24],0.919789493824842
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G15,Phospholipase A2 group XV,22677,169,1.03 [0.61-1.75],0.9107056467856678
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G1B,Phospholipase A2,22841,169,1.00 [0.72-1.38],0.997303005999176
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G2A,"Phospholipase A2, membrane associated",22535,168,1.01 [0.80-1.27],0.940790310695978
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G4A,Cytosolic phospholipase A2,22709,169,1.00 [0.85-1.17],0.9812764136333922
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLA2G7,Platelet-activating factor acetylhydrolase,22614,165,1.07 [0.69-1.67],0.7477384935352542
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLAT,Tissue-type plasminogen activator,22810,167,0.99 [0.75-1.31],0.959352381638831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLAU,Urokinase-type plasminogen activator,22614,165,1.01 [0.64-1.61],0.9592117924749644
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLAUR,Urokinase plasminogen activator surface receptor,22457,166,0.97 [0.57-1.66],0.924442071019821
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLB1,"Phospholipase B1, membrane-associated",19633,140,0.89 [0.69-1.16],0.4007625504541087
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19124,135,1.17 [0.86-1.60],0.3231267903987142
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19633,140,0.90 [0.77-1.07],0.232000373821748
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLEKHO1,Pleckstrin homology domain-containing family O member 1,19633,140,0.91 [0.72-1.15],0.4306765994138847
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLG,Plasminogen,19184,132,1.36 [0.68-2.73],0.3911999628936056
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLIN1,Perilipin-1,22047,163,1.25 [0.87-1.80],0.2218902308649138
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLIN3,Perilipin-3,22609,170,0.98 [0.72-1.35],0.9115716604846116
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLPBP,Pyridoxal phosphate homeostasis protein,22609,170,0.96 [0.79-1.17],0.6938709789574313
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLSCR3,Phospholipid scramblase 3,19604,140,0.86 [0.65-1.13],0.2787672585255875
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLTP,Phospholipid transfer protein,22792,170,1.13 [0.76-1.68],0.5599718194993412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLXDC1,Plexin domain-containing protein 1,22099,164,0.94 [0.62-1.43],0.7741987401692904
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLXDC2,Plexin domain-containing protein 2,19633,140,1.05 [0.58-1.88],0.8760285258659798
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLXNA4,Plexin-A4,22569,167,0.97 [0.83-1.15],0.7565926838662924
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLXNB2,Plexin-B2,22777,167,0.76 [0.42-1.38],0.3644459377788204
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PLXNB3,Plexin-B3,22543,169,0.95 [0.71-1.27],0.7444027320736961
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22504,170,0.99 [0.92-1.06],0.7139457176724966
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PMCH,Pro-MCH,19073,136,0.95 [0.78-1.17],0.6474496946550161
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PMM2,Phosphomannomutase 2,19073,136,0.90 [0.69-1.19],0.4802672495738374
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PMS1,PMS1 protein homolog 1,19126,138,0.61 [0.42-0.88],0.0085111103936581
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PMVK,Phosphomevalonate kinase,22007,162,0.96 [0.85-1.08],0.4571143264213764
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNLIP,Pancreatic triacylglycerol lipase,19678,139,0.83 [0.63-1.09],0.1847229435810334
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNLIPRP1,Inactive pancreatic lipase-related protein 1,19633,140,0.85 [0.69-1.05],0.1349310416828975
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNLIPRP2,Pancreatic lipase-related protein 2,22600,169,1.00 [0.95-1.04],0.886269058673303
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNMA1,Paraneoplastic antigen Ma1,19177,139,0.95 [0.70-1.28],0.7198801655776583
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNMA2,Paraneoplastic antigen Ma2,19065,134,0.78 [0.52-1.17],0.2312871067409119
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22181,166,1.01 [0.91-1.13],0.8095271629009895
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PODXL,Podocalyxin,22505,169,0.54 [0.22-1.31],0.1711680284650987
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PODXL2,Podocalyxin-like protein 2,22677,169,0.84 [0.51-1.39],0.5086628246273559
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",POF1B,Protein POF1B,19124,135,0.84 [0.57-1.24],0.3788447274715477
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",POLR2A,DNA-directed RNA polymerase II subunit RPB1,19124,135,0.82 [0.46-1.47],0.5097506851682476
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22505,169,1.06 [0.72-1.57],0.7614663291477486
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",POMC,Pro-opiomelanocortin,19177,139,1.07 [0.84-1.36],0.5928819510255809
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PON1,Serum paraoxonase/arylesterase 1,19678,139,0.83 [0.46-1.50],0.538796245208216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PON2,Serum paraoxonase/arylesterase 2,22202,165,0.94 [0.63-1.40],0.7610798707241874
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PON3,Serum paraoxonase/lactonase 3,22709,169,0.95 [0.60-1.49],0.8112445054371026
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",POSTN,Periostin,19669,142,1.55 [1.04-2.31],0.0328056190336282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPBP,Platelet basic protein,19557,134,0.91 [0.75-1.10],0.3297296689245509
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPCDC,Phosphopantothenoylcysteine decarboxylase,22808,168,1.04 [0.78-1.38],0.7982416902156784
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPIB,Peptidyl-prolyl cis-trans isomerase B,22616,167,0.94 [0.81-1.08],0.3737967275129478
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPIE,Peptidyl-prolyl cis-trans isomerase E,19295,142,1.17 [0.95-1.44],0.1343030371143813
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19669,142,1.09 [0.85-1.39],0.504292320296766
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPL,Periplakin,19124,135,0.93 [0.56-1.54],0.7680379013011494
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPM1A,Protein phosphatase 1A,22099,164,0.83 [0.52-1.32],0.4250315262910581
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPM1B,Protein phosphatase 1B,19124,135,1.05 [0.83-1.34],0.6844639784379589
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPM1F,Protein phosphatase 1F,19673,140,0.96 [0.71-1.31],0.8050576260409165
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPME1,Protein phosphatase methylesterase 1,22505,169,0.90 [0.73-1.13],0.3670088634756817
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19568,141,0.92 [0.75-1.12],0.3940948892679733
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22677,169,0.98 [0.85-1.13],0.8275265265816552
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19295,142,0.91 [0.71-1.15],0.4195925906354346
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19643,140,0.86 [0.69-1.06],0.1590728150233363
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19643,140,0.66 [0.41-1.07],0.0922777237278098
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R2,Protein phosphatase inhibitor 2,22609,170,0.95 [0.80-1.13],0.5795935572102504
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP1R9B,Neurabin-2,22856,169,0.96 [0.83-1.11],0.5907110993603295
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19573,142,0.99 [0.86-1.14],0.9042478892027404
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPP3R1,Calcineurin subunit B type 1,22459,168,1.12 [0.81-1.55],0.5084368570986506
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPT1,Palmitoyl-protein thioesterase 1,19126,138,0.91 [0.72-1.16],0.4487754778715516
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PPY,Pancreatic prohormone,22595,169,0.89 [0.78-1.02],0.0983718647862868
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PQBP1,Polyglutamine-binding protein 1,22099,164,0.97 [0.75-1.25],0.8171548784092415
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRAME,Melanoma antigen preferentially expressed in tumors,18980,139,0.67 [0.35-1.28],0.2244145298124842
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRAP1,Proline-rich acidic protein 1,19669,142,0.80 [0.55-1.17],0.2487289624491069
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRC1,Protein regulator of cytokinesis 1,19568,141,1.33 [1.09-1.62],0.0046683319103517
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRCP,Lysosomal Pro-X carboxypeptidase,22747,169,0.81 [0.52-1.26],0.3496859147167647
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRDX1,Peroxiredoxin-1,21994,165,0.98 [0.84-1.15],0.8231872216483783
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRDX2,Peroxiredoxin-2,19335,135,1.09 [0.85-1.40],0.4923091137023169
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22181,166,0.99 [0.82-1.20],0.9068250617795794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRDX5,"Peroxiredoxin-5, mitochondrial",22856,169,0.94 [0.77-1.13],0.4991340256508836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRDX6,Peroxiredoxin-6,22809,167,1.00 [0.80-1.26],0.9741130992953794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PREB,Prolactin regulatory element-binding protein,22181,166,1.03 [0.66-1.62],0.8818550747676911
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRELP,Prolargin,22600,169,0.65 [0.39-1.08],0.0993873158782767
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRG2,Bone marrow proteoglycan,19669,142,0.84 [0.62-1.15],0.2725725464224287
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRG3,Proteoglycan 3,19669,142,0.86 [0.62-1.17],0.3316886115688623
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22181,166,0.95 [0.74-1.23],0.7066901371536614
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19126,138,0.49 [0.27-0.89],0.0198128779097024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22609,170,0.96 [0.82-1.13],0.6508493084918101
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19598,139,0.90 [0.74-1.09],0.2838264442891129
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKCQ,Protein kinase C theta type,22181,166,1.01 [0.74-1.37],0.9637794775513204
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKD2,Serine/threonine-protein kinase D2,19073,136,0.76 [0.50-1.15],0.1950677485437163
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKG1,cGMP-dependent protein kinase 1,19262,139,0.98 [0.86-1.12],0.7688338434200868
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22099,164,1.19 [0.97-1.45],0.0929511513837183
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRL,Prolactin,22808,168,0.98 [0.81-1.17],0.7961064825102203
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRND,Prion-like protein doppel,19633,140,0.99 [0.73-1.34],0.9430780070436776
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PROC,Vitamin K-dependent protein C,22634,169,1.25 [0.72-2.15],0.4311008198548989
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PROCR,Endothelial protein C receptor,19073,136,0.64 [0.36-1.12],0.1147027754150793
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PROK1,Prokineticin-1,22569,167,1.03 [0.85-1.25],0.7760070779429507
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PROS1,Vitamin K-dependent protein S,19703,139,1.69 [0.94-3.05],0.0823631578786353
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRR4,Proline-rich protein 4,19124,138,0.93 [0.73-1.18],0.5461730042840687
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRR5,Proline-rich protein 5,19124,135,1.01 [0.72-1.43],0.957007003871862
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRRT3,Proline-rich transmembrane protein 3,19177,139,0.91 [0.59-1.42],0.687200840115269
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRSS2,Trypsin-2,22671,169,0.95 [0.72-1.25],0.7282539844984504
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRSS22,Brain-specific serine protease 4,19124,135,0.82 [0.49-1.37],0.4492610794143169
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRSS27,Serine protease 27,22541,167,1.02 [0.73-1.42],0.9217551948585792
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRSS53,Serine protease 53,19633,140,0.62 [0.40-0.97],0.0349548076908068
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRSS8,Prostasin,22524,166,0.98 [0.70-1.39],0.93014865200993
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22047,163,0.98 [0.87-1.11],0.7831127669890849
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRTG,Protogenin,22809,167,0.99 [0.57-1.70],0.9598509855264332
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRTN3,Myeloblastin,22021,164,0.89 [0.66-1.21],0.4571356867485284
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PRUNE2,Protein prune homolog 2,19295,142,0.99 [0.57-1.72],0.9739238107186624
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSAP,Prosaposin,19479,142,0.86 [0.48-1.53],0.5988101045166072
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSAPL1,Proactivator polypeptide-like 1,19573,142,1.21 [0.88-1.66],0.239210618586424
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSCA,Prostate stem cell antigen,19573,142,0.99 [0.94-1.06],0.8689446405732152
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSG1,Pregnancy-specific beta-1-glycoprotein 1,22459,168,1.03 [0.91-1.16],0.6352947764247246
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSIP1,PC4 and SFRS1-interacting protein,22569,167,0.98 [0.79-1.22],0.8804642037103433
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMA1,Proteasome subunit alpha type-1,22099,164,0.84 [0.61-1.15],0.2823707263031269
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMC3,26S proteasome regulatory subunit 6A,18980,139,0.95 [0.56-1.62],0.8517988595059468
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMD1,26S proteasome non-ATPase regulatory subunit 1,19643,140,1.08 [0.79-1.48],0.6370846153367583
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMD5,26S proteasome non-ATPase regulatory subunit 5,19126,138,0.77 [0.54-1.09],0.1389417927236624
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMD9,26S proteasome non-ATPase regulatory subunit 9,22505,169,0.97 [0.76-1.23],0.7886376643578195
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSME1,Proteasome activator complex subunit 1,22429,168,1.04 [0.73-1.49],0.8106487185280781
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSME2,Proteasome activator complex subunit 2,22347,168,1.14 [0.79-1.63],0.4925942275107771
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMG3,Proteasome assembly chaperone 3,22569,167,1.07 [0.82-1.38],0.6246030773386362
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSMG4,Proteasome assembly chaperone 4,19124,135,0.96 [0.72-1.28],0.7634369089233907
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSPN,Persephin,22569,167,1.10 [0.97-1.26],0.1499909031926175
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSRC1,Proline/serine-rich coiled-coil protein 1,22099,164,0.98 [0.77-1.24],0.8592011936182229
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18574,133,0.93 [0.80-1.08],0.3552078789018712
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22047,163,0.93 [0.59-1.47],0.7518477512082523
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTGDS,Prostaglandin-H2 D-isomerase,22411,165,1.18 [0.73-1.90],0.5008355660482962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTGES2,Prostaglandin E synthase 2,18975,135,1.09 [0.81-1.47],0.5730603233789587
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTGR1,Prostaglandin reductase 1,19673,140,1.12 [0.92-1.37],0.2486515113773598
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTH,Parathyroid hormone,19126,138,0.77 [0.62-0.95],0.0172462047976898
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22569,167,1.10 [0.79-1.52],0.5808539657049424
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTK7,Inactive tyrosine-protein kinase 7,22047,163,1.03 [0.71-1.49],0.8707852956071613
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTN,Pleiotrophin,22202,165,0.82 [0.62-1.08],0.1597933041679443
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTP4A3,Protein tyrosine phosphatase type IVA 3,19124,135,0.90 [0.65-1.25],0.5228214783122269
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22459,168,1.04 [0.88-1.24],0.6480148998792522
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22670,169,0.97 [0.84-1.13],0.7370013273094517
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19086,135,1.07 [0.70-1.62],0.7550524552006546
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRB,Receptor-type tyrosine-protein phosphatase beta,19673,140,1.41 [0.82-2.44],0.2181633231156006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRC,Receptor-type tyrosine-protein phosphatase C,19669,142,0.69 [0.33-1.41],0.3064112532397877
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRF,Receptor-type tyrosine-protein phosphatase F,22879,170,1.31 [0.82-2.09],0.2648842998347619
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRH,Receptor-type tyrosine-protein phosphatase H,19573,142,0.87 [0.62-1.22],0.4251561668427542
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19573,142,1.45 [0.79-2.67],0.226939652860108
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRM,Receptor-type tyrosine-protein phosphatase mu,22532,167,0.86 [0.49-1.51],0.5954698318727433
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22380,168,0.88 [0.57-1.37],0.5828181157543824
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRR,Receptor-type tyrosine-protein phosphatase R,19633,140,0.93 [0.59-1.48],0.7600039538299219
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRS,Receptor-type tyrosine-protein phosphatase S,22879,170,1.28 [0.73-2.24],0.3881772585216891
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19673,140,0.69 [0.42-1.13],0.1378949993173198
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19262,139,0.91 [0.70-1.19],0.5054349817378164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTS,6-pyruvoyl tetrahydrobiopterin synthase,21956,162,1.03 [0.80-1.32],0.8376943354096937
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTTG1,Securin,19295,142,0.98 [0.66-1.45],0.9122532092614298
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PTX3,Pentraxin-related protein PTX3,22569,167,0.99 [0.75-1.31],0.9537735228679448
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PVALB,Parvalbumin alpha,22697,166,0.91 [0.81-1.02],0.1205093734795069
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PVR,Poliovirus receptor,22808,168,0.95 [0.65-1.37],0.7771537996647633
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PXDNL,Peroxidasin-like protein,19568,141,1.09 [0.85-1.40],0.4933062787451059
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PXN,Paxillin,22047,163,0.86 [0.65-1.13],0.2797235057890128
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PYDC1,Pyrin domain-containing protein 1,19177,139,1.24 [0.89-1.73],0.2030984339891582
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PYY,Peptide YY,19073,136,0.85 [0.70-1.02],0.0771433866620875
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",PZP,Pregnancy zone protein,19703,139,0.85 [0.66-1.09],0.1954690818581252
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",QDPR,Dihydropteridine reductase,22509,169,1.13 [0.83-1.54],0.4263969055926829
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",QPCT,Glutaminyl-peptide cyclotransferase,22649,166,0.84 [0.51-1.40],0.5026817598074942
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",QSOX1,Sulfhydryl oxidase 1,19299,136,0.75 [0.44-1.26],0.2745213227897861
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB10,Ras-related protein Rab-10,19673,140,0.94 [0.70-1.28],0.7080601348789572
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB11FIP3,Rab11 family-interacting protein 3,19673,140,0.95 [0.82-1.10],0.4970067953831071
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB27B,Ras-related protein Rab-27B,19673,140,0.88 [0.72-1.06],0.1693122657231749
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB2B,Ras-related protein Rab-2B,19568,141,0.86 [0.66-1.13],0.2760977218064346
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB33A,Ras-related protein Rab-33A,19073,136,1.02 [0.79-1.30],0.9008490145048688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB37,Ras-related protein Rab-37,22181,166,0.98 [0.83-1.16],0.8283042774192021
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB39B,Ras-related protein Rab-39B,19073,136,0.97 [0.80-1.18],0.746760912165098
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19065,134,0.97 [0.72-1.30],0.8162609982441628
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB44,Ras-related protein Rab-44,19568,141,1.01 [0.71-1.45],0.9457610030846678
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB6A,Ras-related protein Rab-6A,22569,167,1.02 [0.77-1.35],0.8722499098743758
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAB6B,Ras-related protein Rab-6B,22047,163,0.90 [0.67-1.21],0.4755079415992468
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RABEP1,Rab GTPase-binding effector protein 1,19262,139,0.90 [0.73-1.11],0.3234297931647401
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RABEPK,Rab9 effector protein with kelch motifs,22099,164,1.04 [0.83-1.30],0.7651388017196593
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RABGAP1L,Rab GTPase-activating protein 1-like,22181,166,1.04 [0.83-1.31],0.7039247058896971
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAC3,Ras-related C3 botulinum toxin substrate 3,19126,138,0.70 [0.51-0.97],0.0329401308684767
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAD23B,UV excision repair protein RAD23 homolog B,22099,164,0.97 [0.72-1.30],0.8413680379435726
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAD51,DNA repair protein RAD51 homolog 1,19295,142,0.91 [0.67-1.25],0.5743031598375326
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RALB,Ras-related protein Ral-B,19124,135,1.60 [0.99-2.60],0.056105055411329
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RALY,RNA-binding protein Raly,19568,141,0.99 [0.72-1.37],0.9616994732578747
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RANBP1,Ran-specific GTPase-activating protein,19177,139,0.89 [0.65-1.21],0.4438716576658479
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RANBP2,E3 SUMO-protein ligase RanBP2,19065,134,0.89 [0.53-1.47],0.6445228548994135
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RANGAP1,Ran GTPase-activating protein 1,22099,164,0.79 [0.58-1.09],0.1534044327157571
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAP1A,Ras-related protein Rap-1A,19124,135,0.87 [0.67-1.14],0.324516683832395
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RAPGEF2,Rap guanine nucleotide exchange factor 2,19295,142,0.89 [0.65-1.22],0.472512035842706
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RARRES1,Retinoic acid receptor responder protein 1,22099,164,0.86 [0.55-1.33],0.4939052275006796
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RARRES2,Retinoic acid receptor responder protein 2,22714,169,0.89 [0.66-1.20],0.4496275818847972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RASA1,Ras GTPase-activating protein 1,22047,163,0.93 [0.61-1.42],0.735707663355555
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,18980,139,1.01 [0.70-1.46],0.9626855307956144
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RASSF2,Ras association domain-containing protein 2,22099,164,0.99 [0.78-1.27],0.9554305110755944
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBFOX3,RNA binding protein fox-1 homolog 3,19643,140,0.71 [0.44-1.15],0.1606237414112917
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBKS,Ribokinase,22067,164,1.12 [0.86-1.46],0.4067326504328544
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBM17,Splicing factor 45,19643,140,0.85 [0.68-1.05],0.1367528690388413
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBM19,Probable RNA-binding protein 19,19073,136,1.17 [0.87-1.57],0.3115149477770057
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBM25,RNA-binding protein 25,18980,139,1.15 [0.83-1.60],0.4101823847891412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBP1,Retinol-binding protein 1,19126,138,0.78 [0.58-1.06],0.1115485255882252
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBP2,Retinol-binding protein 2,22505,169,1.04 [0.87-1.24],0.676197527452178
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBP5,Retinol-binding protein 5,22505,169,0.92 [0.72-1.18],0.5187220600936474
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBP7,Retinoid-binding protein 7,19573,142,0.93 [0.71-1.22],0.5832692933768902
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBPMS,RNA-binding protein with multiple splicing,19124,135,1.08 [0.86-1.35],0.496356145543245
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RBPMS2,RNA-binding protein with multiple splicing 2,19177,139,0.93 [0.79-1.09],0.3916109754591612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RCC1,Regulator of chromosome condensation,19568,141,0.97 [0.71-1.33],0.8491879758953063
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RCOR1,REST corepressor 1,22202,165,0.96 [0.70-1.32],0.7900362370333527
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19177,139,0.81 [0.36-1.83],0.6117625486445168
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REEP4,Receptor expression-enhancing protein 4,19643,140,0.83 [0.63-1.09],0.1830979788710301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REG1A,Lithostathine-1-alpha,22450,167,1.01 [0.76-1.34],0.9381303970794584
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REG1B,Lithostathine-1-beta,22879,170,0.94 [0.73-1.20],0.6234960637879616
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REG3A,Regenerating islet-derived protein 3-alpha,22879,170,0.80 [0.63-1.01],0.0613545177772418
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REG3G,Regenerating islet-derived protein 3-gamma,19568,141,0.68 [0.45-1.04],0.0785350871932244
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REG4,Regenerating islet-derived protein 4,22642,169,0.88 [0.66-1.18],0.3911314843745247
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RELB,Transcription factor RelB,19124,135,0.89 [0.63-1.25],0.5084507144632937
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RELT,Tumor necrosis factor receptor superfamily member 19L,22614,165,0.98 [0.58-1.66],0.9288407200243428
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REN,Renin,22609,170,0.99 [0.81-1.20],0.8875959891085897
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REPS1,RalBP1-associated Eps domain-containing protein 1,19124,135,0.80 [0.51-1.26],0.3406682896694132
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REST,RE1-silencing transcription factor,18980,139,0.70 [0.42-1.16],0.1649607295739186
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22505,169,0.90 [0.65-1.25],0.5273059672849848
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RETN,Resistin,22541,166,0.86 [0.62-1.21],0.3992846207053379
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",REXO2,"Oligoribonuclease, mitochondrial",19073,136,0.78 [0.52-1.15],0.2103297737624575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RFC4,Replication factor C subunit 4,19568,141,0.94 [0.43-2.04],0.8724945660670275
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGCC,Regulator of cell cycle RGCC,19643,140,0.89 [0.72-1.10],0.2730116366919147
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19295,142,0.99 [0.78-1.27],0.9639190940427892
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGMA,Repulsive guidance molecule A,22808,168,0.60 [0.39-0.94],0.025051021961374
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGMB,RGM domain family member B,22808,168,0.93 [0.54-1.60],0.7960507760436335
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGS10,Regulator of G-protein signaling 10,19643,140,0.94 [0.72-1.23],0.6540374282510207
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RGS8,Regulator of G-protein signaling 8,22181,166,0.98 [0.79-1.21],0.8279590957830555
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RHOC,Rho-related GTP-binding protein RhoC,22301,166,0.97 [0.87-1.09],0.6425356090337611
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RICTOR,Rapamycin-insensitive companion of mTOR,19124,135,0.94 [0.66-1.34],0.7269578603054303
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19262,139,0.94 [0.67-1.31],0.7030337370913669
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RILP,Rab-interacting lysosomal protein,22737,166,1.00 [0.80-1.26],0.9668692726124404
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RILPL2,RILP-like protein 2,19673,140,0.97 [0.82-1.14],0.7017686152589357
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19073,136,1.06 [0.85-1.32],0.6055150876380502
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RLN1,Prorelaxin H1,19643,140,0.89 [0.71-1.12],0.3107603013731617
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RLN2,Prorelaxin H2,19225,138,0.97 [0.87-1.10],0.670173990644821
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASE1,Ribonuclease pancreatic,19678,139,1.46 [0.81-2.65],0.2112091678592949
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASE10,Inactive ribonuclease-like protein 10,19177,139,0.93 [0.66-1.31],0.6711947864005644
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASE3,Eosinophil cationic protein,22506,167,1.06 [0.94-1.19],0.3668180278276417
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASE4,Ribonuclease 4,19013,137,0.91 [0.49-1.68],0.7626892844229405
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASE6,Ribonuclease K6,19523,139,0.76 [0.41-1.40],0.3750373953839064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASEH2A,Ribonuclease H2 subunit A,19643,140,0.80 [0.56-1.15],0.2313466135387664
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNASET2,Ribonuclease T2,22779,169,0.91 [0.54-1.54],0.7245778846933636
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF149,E3 ubiquitin-protein ligase RNF149,19177,139,1.21 [0.71-2.06],0.4790787943563428
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF168,E3 ubiquitin-protein ligase RNF168,19124,135,0.83 [0.54-1.28],0.3973868242569974
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF31,E3 ubiquitin-protein ligase RNF31,19124,135,0.95 [0.60-1.50],0.815913424600425
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF4,E3 ubiquitin-protein ligase RNF4,19295,142,0.98 [0.77-1.25],0.8755020827965112
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF41,E3 ubiquitin-protein ligase NRDP1,22099,164,0.96 [0.78-1.18],0.6786481910424556
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF43,E3 ubiquitin-protein ligase RNF43,19295,142,0.99 [0.75-1.31],0.948372578797508
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RNF5,E3 ubiquitin-protein ligase RNF5,19177,139,0.88 [0.71-1.10],0.2720664364104567
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ROBO1,Roundabout homolog 1,22642,169,0.66 [0.37-1.18],0.1589628732076394
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ROBO2,Roundabout homolog 2,22808,168,1.06 [0.59-1.90],0.8549680850201695
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ROBO4,Roundabout homolog 4,19177,139,0.70 [0.28-1.75],0.4399046930202372
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22609,170,1.22 [0.79-1.88],0.3725916050079235
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RP2,Protein XRP2,22505,169,0.93 [0.67-1.29],0.6568716208546216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RPA2,Replication protein A 32 kDa subunit,19124,135,1.38 [0.89-2.15],0.1544911860256739
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RPE,Ribulose-phosphate 3-epimerase,19295,142,0.94 [0.74-1.18],0.5906982479025632
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RPGR,X-linked retinitis pigmentosa GTPase regulator,19126,138,0.59 [0.37-0.94],0.0252260345894009
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RPL14,60S ribosomal protein L14,19177,139,1.12 [0.77-1.62],0.5604367981994761
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RPS10,40S ribosomal protein S10,19073,136,0.75 [0.48-1.18],0.2099037121064316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RRAS,Ras-related protein R-Ras,19126,138,0.98 [0.86-1.11],0.7452082553825699
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RRM2,Ribonucleoside-diphosphate reductase subunit M2,22099,164,0.97 [0.74-1.28],0.8311376265238238
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22099,164,1.00 [0.82-1.23],0.9732292597072688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RRP15,RRP15-like protein,19065,134,0.98 [0.82-1.18],0.8664469990709753
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RSPO1,R-spondin-1,22459,168,0.85 [0.57-1.25],0.4077020058347564
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RSPO3,R-spondin-3,22809,167,0.62 [0.37-1.02],0.0596226860683325
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RTBDN,Retbindin,22505,169,0.57 [0.35-0.92],0.0215269923402943
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RTKN2,Rhotekin-2,19073,136,0.65 [0.43-0.97],0.0372734905225798
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19643,140,0.93 [0.78-1.11],0.4384753879127591
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RTN4R,Reticulon-4 receptor,22809,167,0.96 [0.64-1.44],0.8404711434473024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RUVBL1,RuvB-like 1,22099,164,1.06 [0.94-1.20],0.3285391526970361
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RWDD1,RWD domain-containing protein 1,22808,168,0.96 [0.78-1.18],0.6855578027122096
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",RYR1,Ryanodine receptor 1,19073,136,0.62 [0.35-1.11],0.1084268011766123
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A11,Protein S100-A11,22427,168,0.97 [0.73-1.30],0.8579186645608982
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A12,Protein S100-A12,22302,168,0.94 [0.79-1.13],0.505928339737678
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A13,Protein S100-A13,19124,135,1.25 [0.80-1.96],0.3162022167110974
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A14,Protein S100-A14,19643,140,0.94 [0.69-1.27],0.6731162496492821
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A16,Protein S100-A16,22017,163,0.93 [0.74-1.17],0.5416093914734412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A3,Protein S100-A3,19568,141,0.82 [0.54-1.25],0.3611555516922589
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100A4,Protein S100-A4,22677,169,0.98 [0.77-1.24],0.8427564313937554
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100G,Protein S100-G,19643,140,0.83 [0.57-1.22],0.3444806184942972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",S100P,Protein S100-P,22202,165,0.98 [0.76-1.27],0.8841024830915851
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAA4,Serum amyloid A-4 protein,19703,139,0.71 [0.33-1.54],0.3858890593508873
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAFB2,Scaffold attachment factor B2,19643,140,0.58 [0.30-1.10],0.0969425756361833
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAG,S-arrestin,19065,134,0.97 [0.70-1.33],0.8371908674731422
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAMD9L,Sterile alpha motif domain-containing protein 9-like,22569,167,1.04 [0.86-1.25],0.685844258107305
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAP18,Histone deacetylase complex subunit SAP18,19295,142,1.02 [0.82-1.26],0.869767490604813
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SARG,Specifically androgen-regulated gene protein,19598,140,0.95 [0.82-1.11],0.5293366053604458
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SART1,U4/U6.U5 tri-snRNP-associated protein 1,19073,136,0.88 [0.54-1.44],0.6050320582951381
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAT1,Diamine acetyltransferase 1,19073,136,1.05 [0.77-1.43],0.7375097816341789
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SAT2,Thialysine N-epsilon-acetyltransferase,19295,142,1.10 [0.89-1.36],0.3829592014930234
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SATB1,DNA-binding protein SATB1,19643,140,0.97 [0.58-1.64],0.916934835976223
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SBSN,Suprabasin,19631,142,1.09 [0.68-1.74],0.7278423036128714
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCAMP3,Secretory carrier-associated membrane protein 3,22505,169,0.94 [0.80-1.10],0.4171578432974721
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCARA5,Scavenger receptor class A member 5,22808,168,0.80 [0.50-1.29],0.3682349040061916
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCARB1,Scavenger receptor class B member 1,22047,163,1.22 [1.01-1.46],0.0348645397867737
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCARB2,Lysosome membrane protein 2,22036,164,0.85 [0.52-1.39],0.5253948071914596
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCARF1,Scavenger receptor class F member 1,22879,170,0.89 [0.64-1.23],0.4751041963331818
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCARF2,Scavenger receptor class F member 2,22808,168,0.87 [0.55-1.36],0.5394252629160791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCG2,Secretogranin-2,22696,166,0.73 [0.47-1.14],0.1653039332076344
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCG3,Secretogranin-3,22642,169,0.94 [0.62-1.41],0.7510448526490698
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCGB1A1,Uteroglobin,22636,169,0.95 [0.75-1.21],0.6749223997564426
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCGB2A2,Mammaglobin-A,19073,136,0.72 [0.40-1.31],0.2808215945514589
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCGB3A1,Secretoglobin family 3A member 1,19262,139,2.25 [1.17-4.33],0.0152310155706624
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCGB3A2,Secretoglobin family 3A member 2,22670,169,1.04 [0.89-1.21],0.6539808415685231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCGN,Secretagogin,22181,166,0.93 [0.68-1.28],0.6518679788664415
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCIN,Adseverin,19065,134,0.81 [0.63-1.04],0.1032274553150733
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCLY,Selenocysteine lyase,22737,166,1.05 [0.79-1.40],0.7304646612431107
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCN2A,Sodium channel protein type 2 subunit alpha,19065,134,0.85 [0.58-1.24],0.3973865959033398
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCN2B,Sodium channel subunit beta-2,19126,138,0.59 [0.31-1.10],0.0974966476366622
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCN3A,Sodium channel protein type 3 subunit alpha,19126,138,1.18 [0.82-1.72],0.3733266850037927
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCN3B,Sodium channel subunit beta-3,19065,134,1.02 [0.72-1.44],0.9157435468193807
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCN4B,Sodium channel subunit beta-4,19177,139,1.00 [0.68-1.49],0.984901781363006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCP2,Non-specific lipid-transfer protein,22099,164,0.94 [0.78-1.14],0.5469481529471729
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCPEP1,Retinoid-inducible serine carboxypeptidase,19102,139,1.14 [0.83-1.58],0.4178110858619415
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCRG1,Scrapie-responsive protein 1,19673,140,0.87 [0.47-1.60],0.6563335669994552
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCRIB,Protein scribble homolog,19177,139,0.92 [0.77-1.11],0.3813410549194032
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCRN1,Secernin-1,22569,167,0.95 [0.75-1.22],0.7025933248846437
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SCT,Secretin,19126,138,1.00 [0.70-1.44],0.9951978021071364
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SDC1,Syndecan-1,22609,170,1.06 [0.75-1.49],0.756795884158352
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SDC4,Syndecan-4,22609,170,0.97 [0.72-1.31],0.8281049967884497
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SDCCAG8,Serologically defined colon cancer antigen 8,19568,141,0.93 [0.81-1.08],0.3517499705807033
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SDHB,Succinate dehydrogenase,19573,142,1.12 [0.90-1.38],0.3151216737354181
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SDK2,Protein sidekick-2,19262,139,1.00 [0.65-1.54],0.9939815294935004
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEC31A,Protein transport protein Sec31A,19177,139,1.01 [0.81-1.25],0.9576948964776918
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEL1L,Protein sel-1 homolog 1,19177,139,0.67 [0.36-1.24],0.2006908155564696
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SELE,E-selectin,22879,170,0.87 [0.67-1.14],0.3158245710649031
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SELENOP,Selenoprotein P,19703,139,0.91 [0.44-1.89],0.8074276239446109
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SELL,L-selectin,19703,139,0.62 [0.31-1.23],0.1726572138499049
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SELP,P-selectin,22671,169,1.01 [0.80-1.27],0.9444683254103938
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SELPLG,P-selectin glycoprotein ligand 1,22569,167,0.90 [0.56-1.45],0.6631972502655146
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA3F,Semaphorin-3F,22609,170,0.87 [0.51-1.49],0.6204429599916754
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA3G,Semaphorin-3G,19262,139,1.01 [0.70-1.48],0.9407610476796466
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA4C,Semaphorin-4C,22505,169,0.92 [0.56-1.53],0.7535438157215437
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA4D,Semaphorin-4D,22808,168,0.68 [0.43-1.06],0.0900891102158723
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA6C,Semaphorin-6C,19124,135,0.71 [0.36-1.40],0.3286347407553633
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEMA7A,Semaphorin-7A,22810,167,0.70 [0.41-1.21],0.2047660071475463
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEPTIN3,Neuronal-specific septin-3,19643,140,0.89 [0.71-1.12],0.3116143207576443
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEPTIN7,Septin-7,19295,142,0.97 [0.71-1.32],0.8462723562174279
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEPTIN8,Septin-8,19592,140,0.75 [0.44-1.28],0.2929830765018335
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEPTIN9,Septin-9,22505,169,1.28 [0.83-2.00],0.2643588301902576
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA1,Alpha-1-antitrypsin,19313,135,1.60 [0.20-12.55],0.6527093996715022
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA11,Serpin A11,22879,170,1.08 [0.78-1.52],0.6353469668699934
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA12,Serpin A12,21963,166,1.07 [0.96-1.19],0.2320174667707172
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA3,Alpha-1-antichymotrypsin,19622,138,1.41 [0.47-4.20],0.5401091208921154
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA4,Kallistatin,19326,135,1.03 [0.51-2.06],0.9378504355133466
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA5,Plasma serine protease inhibitor,19399,136,1.24 [0.79-1.97],0.3536259227730085
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA6,Corticosteroid-binding globulin,19703,139,1.55 [0.67-3.62],0.3082588208662746
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA7,Thyroxine-binding globulin,19703,139,2.58 [1.12-5.98],0.0264550341130915
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINA9,Serpin A9,22374,168,1.02 [0.85-1.23],0.824488380816023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINB1,Leukocyte elastase inhibitor,22543,165,1.06 [0.92-1.24],0.4170268804258311
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINB5,Serpin B5,22202,165,0.88 [0.67-1.15],0.3459284619949185
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINB6,Serpin B6,22737,168,1.00 [0.80-1.25],0.9995796868072324
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINB8,Serpin B8,22856,169,1.19 [0.98-1.46],0.0825060431069831
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINB9,Serpin B9,22459,168,1.13 [0.76-1.69],0.5351412860503001
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINC1,Antithrombin-III,19659,137,2.27 [0.76-6.80],0.1437456399717372
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPIND1,Heparin cofactor 2,19659,137,1.62 [0.90-2.93],0.1101426297581767
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINE1,Plasminogen activator inhibitor 1,22879,170,0.95 [0.78-1.16],0.6265262406219186
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINE2,Glia-derived nexin,19673,140,0.88 [0.69-1.14],0.3415200701496214
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINF1,Pigment epithelium-derived factor,19398,134,1.79 [0.98-3.27],0.0600134813790769
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINF2,Alpha-2-antiplasmin,19322,134,1.41 [0.43-4.68],0.5699430095355236
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPING1,Plasma protease C1 inhibitor,19659,137,1.82 [0.76-4.34],0.1755224253215421
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINH1,Serpin H1,19295,142,0.96 [0.85-1.09],0.5118885984302433
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINI1,Neuroserpin,19219,139,1.39 [0.86-2.23],0.1798697042338444
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SERPINI2,Serpin I2,19573,142,0.93 [0.70-1.24],0.631424636014129
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22047,163,0.94 [0.75-1.17],0.5826178061094287
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SETMAR,Histone-lysine N-methyltransferase SETMAR,22396,167,1.10 [0.70-1.74],0.6739474494092035
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEZ6,Seizure protein 6 homolog,19126,138,0.45 [0.26-0.80],0.0067514820397023
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEZ6L,Seizure 6-like protein,22677,169,0.97 [0.58-1.60],0.900656051359763
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SEZ6L2,Seizure 6-like protein 2,22505,169,0.86 [0.48-1.54],0.6168827634714549
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SF3B4,Splicing factor 3B subunit 4,22505,169,0.93 [0.77-1.12],0.4358337024880276
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SFRP1,Secreted frizzled-related protein 1,22393,168,0.86 [0.62-1.20],0.3789136623794263
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SFRP4,Secreted frizzled-related protein 4,19262,139,1.03 [0.70-1.52],0.8626473859713104
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SFTPA1,Pulmonary surfactant-associated protein A1,22099,164,0.94 [0.73-1.21],0.6210006031988583
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SFTPA2,Pulmonary surfactant-associated protein A2,22099,164,1.13 [0.86-1.49],0.3735065489980506
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SFTPD,Pulmonary surfactant-associated protein D,22609,170,1.35 [1.10-1.66],0.0036093395938704
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SGSH,N-sulphoglucosamine sulphohydrolase,19320,137,1.04 [0.77-1.39],0.8116052806858951
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH2B3,SH2B adapter protein 3,22099,164,0.98 [0.85-1.13],0.7423110387332437
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH2D1A,SH2 domain-containing protein 1A,22569,167,0.90 [0.69-1.17],0.422243533311225
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19065,134,1.10 [0.87-1.41],0.4281081871006161
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH3BP1,SH3 domain-binding protein 1,19573,142,1.11 [0.82-1.51],0.4917315892744188
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH3GL3,Endophilin-A3,19190,142,0.87 [0.72-1.04],0.1299231773240533
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SH3GLB2,Endophilin-B2,19633,140,0.89 [0.70-1.13],0.3205216290352521
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHBG,Sex hormone-binding globulin,19678,139,0.76 [0.57-1.01],0.0609818032160264
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHC1,SHC-transforming protein 1,18980,139,0.94 [0.81-1.09],0.4066664973622594
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHD,SH2 domain-containing adapter protein D,19034,136,1.04 [0.87-1.24],0.682206785260326
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHH,Sonic hedgehog protein,19124,135,1.25 [0.90-1.73],0.1841067995171281
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHISA5,Protein shisa-5,19669,142,0.96 [0.50-1.86],0.9150828056875868
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHMT1,"Serine hydroxymethyltransferase, cytosolic",22670,169,0.97 [0.83-1.14],0.7345617697274487
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SHPK,Sedoheptulokinase,19295,142,1.01 [0.69-1.47],0.9690913216140412
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIAE,Sialate O-acetylesterase,22640,167,1.04 [0.78-1.39],0.775048967710791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC1,Sialoadhesin,22709,169,1.03 [0.75-1.41],0.8636418244141859
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC10,Sialic acid-binding Ig-like lectin 10,22569,167,1.07 [0.70-1.63],0.7613641271053464
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC15,Sialic acid-binding Ig-like lectin 15,22047,163,0.91 [0.75-1.10],0.3082360391164925
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC5,Sialic acid-binding Ig-like lectin 5,22614,165,0.98 [0.87-1.09],0.6803496944767532
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC6,Sialic acid-binding Ig-like lectin 6,22809,167,0.83 [0.55-1.26],0.3893119678428582
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC7,Sialic acid-binding Ig-like lectin 7,22609,170,1.45 [0.90-2.35],0.1262427607829293
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC8,Sialic acid-binding Ig-like lectin 8,19177,139,0.76 [0.53-1.10],0.1490513209086696
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIGLEC9,Sialic acid-binding Ig-like lectin 9,22776,166,1.21 [0.76-1.92],0.429553798280795
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIL1,Nucleotide exchange factor SIL1,19177,139,1.12 [0.71-1.77],0.6132395886122415
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22659,167,1.09 [0.85-1.39],0.4983152785354702
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIRPB1,Signal-regulatory protein beta-1,22566,169,0.97 [0.72-1.32],0.8638050077908107
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIRT1,NAD-dependent protein deacetylase sirtuin-1,19124,135,0.98 [0.80-1.18],0.8049804401089206
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIRT2,NAD-dependent protein deacetylase sirtuin-2,22505,169,0.96 [0.82-1.11],0.5693418771196275
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22047,163,0.97 [0.76-1.25],0.8188437098975843
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SIT1,Signaling threshold-regulating transmembrane adapter 1,22181,166,1.12 [0.88-1.43],0.3683621643278819
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SKAP1,Src kinase-associated phosphoprotein 1,22411,168,1.04 [0.87-1.26],0.6419721303278425
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SKAP2,Src kinase-associated phosphoprotein 2,22709,169,0.95 [0.83-1.08],0.4106235439478259
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SKIV2L,Helicase SKI2W,19073,136,0.95 [0.63-1.43],0.8021712820727958
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLA2,Src-like-adapter 2,19643,140,0.94 [0.80-1.10],0.4425903564091888
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLAMF1,Signaling lymphocytic activation molecule,22181,166,0.81 [0.65-1.01],0.0565925981060349
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLAMF6,SLAM family member 6,22099,164,0.96 [0.66-1.40],0.8451349121409517
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLAMF7,SLAM family member 7,22569,167,1.09 [0.86-1.38],0.4775007285595486
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLAMF8,SLAM family member 8,22099,164,0.90 [0.70-1.17],0.4485166929872914
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC12A2,Solute carrier family 12 member 2,19073,136,1.09 [0.64-1.87],0.7530229168158067
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC13A1,Solute carrier family 13 member 1,19568,141,0.69 [0.47-1.00],0.0512479723708592
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC16A1,Monocarboxylate transporter 1,22047,163,0.87 [0.67-1.12],0.2802771772043358
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC1A4,Neutral amino acid transporter A,19126,138,0.91 [0.65-1.26],0.5513010160626813
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC27A4,Long-chain fatty acid transport protein 4,22047,163,1.10 [0.91-1.34],0.3172262446434846
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC28A1,Sodium/nucleoside cotransporter 1,18980,139,0.92 [0.69-1.23],0.5895237182430553
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC34A3,Sodium-dependent phosphate transport protein 2C,18980,139,0.96 [0.68-1.35],0.8074665360711917
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC39A14,Zinc transporter ZIP14,22047,163,1.15 [0.78-1.72],0.4768009611674466
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC39A5,Zinc transporter ZIP5,22569,167,1.14 [0.91-1.43],0.2481820016005156
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC44A4,Choline transporter-like protein 4,19126,138,0.92 [0.72-1.19],0.5303816296630024
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC4A1,Band 3 anion transport protein,19669,142,0.96 [0.69-1.35],0.8342788058798392
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC51B,Organic solute transporter subunit beta,19073,136,0.98 [0.79-1.21],0.8419941331710912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19262,139,0.94 [0.78-1.15],0.566356578364493
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19573,142,0.99 [0.72-1.35],0.936591477586074
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",18980,139,0.95 [0.71-1.28],0.7367146709832046
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLIT2,Slit homolog 2 protein,22047,163,1.05 [0.80-1.36],0.7399410149693277
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLITRK1,SLIT and NTRK-like protein 1,19124,135,0.81 [0.48-1.36],0.4181768045190381
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLITRK2,SLIT and NTRK-like protein 2,22809,167,0.77 [0.54-1.11],0.1579135228986077
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLITRK6,SLIT and NTRK-like protein 6,22202,165,1.10 [0.74-1.63],0.6482038623075852
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLK,STE20-like serine/threonine-protein kinase,19295,142,0.99 [0.81-1.21],0.92094742463238
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLMAP,Sarcolemmal membrane-associated protein,19573,142,0.89 [0.73-1.08],0.2395496687138938
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SLURP1,Secreted Ly-6/uPAR-related protein 1,19515,141,1.02 [0.68-1.55],0.9075871307193216
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMAD1,Mothers against decapentaplegic homolog 1,22099,164,0.95 [0.80-1.13],0.5473177618555379
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMAD2,Mothers against decapentaplegic homolog 2,19568,141,0.89 [0.70-1.13],0.3447315846621112
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMAD3,Mothers against decapentaplegic homolog 3,19568,141,0.90 [0.65-1.24],0.5034617179037688
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMAD5,Mothers against decapentaplegic homolog 5,22505,169,1.01 [0.52-1.96],0.9746300864318934
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMARCA2,Probable global transcription activator SNF2L2,22047,163,0.93 [0.76-1.13],0.458460537376781
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMC3,Structural maintenance of chromosomes protein 3,18980,139,0.89 [0.65-1.22],0.4751849114685444
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMNDC1,Survival of motor neuron-related-splicing factor 30,19573,142,1.00 [0.77-1.30],0.9785098835879248
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMOC1,SPARC-related modular calcium-binding protein 1,22809,167,0.90 [0.60-1.36],0.6260888069303386
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMOC2,SPARC-related modular calcium-binding protein 2,22709,169,0.67 [0.46-0.97],0.0353632618134247
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMPD1,Sphingomyelin phosphodiesterase,22695,168,0.98 [0.74-1.31],0.8965242680541841
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMPD3,Sphingomyelin phosphodiesterase 3,19124,135,0.81 [0.58-1.15],0.2397848119254453
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22675,169,1.02 [0.83-1.26],0.8492294422644231
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19568,141,0.78 [0.59-1.02],0.0662119503510066
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMS,Spermine synthase,19065,134,0.97 [0.75-1.26],0.8234277769147282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SMTN,Smoothelin,19601,140,0.86 [0.72-1.02],0.0905938322680941
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNAP23,Synaptosomal-associated protein 23,22609,170,0.93 [0.80-1.09],0.3624215106240965
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNAP25,Synaptosomal-associated protein 25,19065,134,0.80 [0.56-1.14],0.2192543093440924
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNAP29,Synaptosomal-associated protein 29,22677,169,0.96 [0.83-1.11],0.5839257886448659
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNAPIN,SNARE-associated protein Snapin,19643,140,0.90 [0.68-1.20],0.48036526650541
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNCA,Alpha-synuclein,19262,139,0.96 [0.83-1.11],0.574342575997102
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNCG,Gamma-synuclein,22459,168,1.03 [0.84-1.27],0.7723474167452875
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19177,139,0.81 [0.49-1.35],0.4201499079739613
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNRPB2,U2 small nuclear ribonucleoprotein B'',19633,140,1.02 [0.71-1.45],0.9260240825098788
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNU13,NHP2-like protein 1,19073,136,0.89 [0.67-1.18],0.426887906364528
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNX15,Sorting nexin-15,19262,139,0.90 [0.67-1.22],0.5051009610953574
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNX18,Sorting nexin-18,19573,142,1.05 [0.75-1.49],0.7624998202605675
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNX2,Sorting nexin-2,19568,141,0.92 [0.75-1.14],0.4581422032458223
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNX5,Sorting nexin-5,19177,139,1.41 [0.86-2.31],0.1716175615049986
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SNX9,Sorting nexin-9,22609,170,1.02 [0.84-1.24],0.8688208656074295
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOD1,Superoxide dismutase [Cu-Zn],22128,169,1.09 [0.83-1.44],0.5179597013579573
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOD2,"Superoxide dismutase [Mn], mitochondrial",22614,165,1.14 [0.79-1.63],0.4855486255641577
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOD3,Extracellular superoxide dismutase,19678,139,0.91 [0.68-1.23],0.5531193429863954
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SORBS1,Sorbin and SH3 domain-containing protein 1,19643,140,0.82 [0.52-1.30],0.3990422531331643
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SORCS2,VPS10 domain-containing receptor SorCS2,22099,164,0.84 [0.56-1.25],0.3900769395754724
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SORD,Sorbitol dehydrogenase,22700,166,0.92 [0.75-1.12],0.3982672819679754
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SORT1,Sortilin,22575,170,0.89 [0.61-1.30],0.5492519408937648
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOST,Sclerostin,22575,170,0.88 [0.62-1.25],0.4797227201260116
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19126,138,0.84 [0.58-1.22],0.3679652679330305
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOX2,Transcription factor SOX-2,19616,140,0.68 [0.33-1.39],0.2910753692313144
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SOX9,Transcription factor SOX-9,19126,138,0.59 [0.32-1.08],0.0854318881678161
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19643,140,0.51 [0.27-0.97],0.0404569195815016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPAG1,Sperm-associated antigen 1,19643,140,0.97 [0.74-1.29],0.8493543839454366
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPARC,SPARC,22677,169,0.91 [0.76-1.10],0.3321291954639925
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPARCL1,SPARC-like protein 1,22598,168,1.20 [0.74-1.93],0.4683103455206963
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPART,Spartin,19262,139,0.92 [0.74-1.14],0.4267970161525238
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPESP1,Sperm equatorial segment protein 1,19673,140,0.91 [0.51-1.63],0.7501897179568608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK1,Serine protease inhibitor Kazal-type 1,22614,165,0.96 [0.69-1.34],0.8135695682577679
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK2,Serine protease inhibitor Kazal-type 2,19262,139,0.97 [0.64-1.48],0.8845120532654465
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK4,Serine protease inhibitor Kazal-type 4,22569,167,1.05 [0.85-1.30],0.6313453923361436
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK5,Serine protease inhibitor Kazal-type 5,22614,165,1.26 [0.82-1.92],0.2899262840166973
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK6,Serine protease inhibitor Kazal-type 6,22809,167,0.87 [0.68-1.12],0.2758790213063069
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINK8,Serine protease inhibitor Kazal-type 8,19073,136,1.13 [0.78-1.63],0.5192742797762401
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINT1,Kunitz-type protease inhibitor 1,22550,165,1.31 [0.76-2.26],0.3237957302198291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINT2,Kunitz-type protease inhibitor 2,22709,169,0.88 [0.64-1.20],0.4224615134358892
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPINT3,Kunitz-type protease inhibitor 3,19573,142,1.04 [0.91-1.18],0.5672054928599551
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPOCK1,Testican-1,22459,168,1.17 [0.68-2.01],0.5745183348632639
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPON1,Spondin-1,22642,169,0.70 [0.45-1.07],0.1022792589560626
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPON2,Spondin-2,22507,167,1.22 [0.82-1.81],0.3383089053598349
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPP1,Osteopontin,22840,170,0.87 [0.65-1.15],0.3261940760758755
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19124,135,0.91 [0.62-1.34],0.627879761216648
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPRING1,SREBP regulating gene protein,18980,139,1.09 [0.85-1.40],0.4854786873746471
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPRR1B,Cornifin-B,19295,142,0.88 [0.71-1.09],0.2564952552092868
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPRR3,Small proline-rich protein 3,19633,140,0.91 [0.73-1.15],0.4392664267674422
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPRY2,Protein sprouty homolog 2,22181,166,0.98 [0.84-1.14],0.8015107107087107
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19065,134,0.79 [0.46-1.37],0.4083941155798819
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SPTLC1,Serine palmitoyltransferase 1,19633,140,0.82 [0.50-1.35],0.4404011743867663
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SRC,Proto-oncogene tyrosine-protein kinase Src,22637,168,0.98 [0.87-1.09],0.6744372050874967
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SRP14,Signal recognition particle 14 kDa protein,22505,169,1.06 [0.85-1.33],0.5758125373142637
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SRPK2,SRSF protein kinase 2,22569,167,0.99 [0.84-1.17],0.9133191135817792
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SRPX,Sushi repeat-containing protein SRPX,19673,140,0.95 [0.58-1.57],0.8454141107105533
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSB,Lupus La protein,22047,163,0.98 [0.77-1.24],0.8459255644112333
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19124,135,1.20 [0.79-1.81],0.3966998667031178
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22575,170,1.01 [0.89-1.15],0.8411421177334255
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22671,169,1.28 [0.93-1.77],0.1316267725785186
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSH3,Protein phosphatase Slingshot homolog 3,18980,139,0.84 [0.47-1.49],0.5483221028316746
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SSNA1,Sjoegren syndrome nuclear autoantigen 1,19573,142,1.08 [0.79-1.46],0.6280603064178256
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ST13,Hsc70-interacting protein,19262,139,0.94 [0.71-1.25],0.6820489222694326
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22505,169,1.15 [0.84-1.56],0.381152980002737
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22879,170,0.83 [0.52-1.35],0.4585350266834805
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19124,135,0.85 [0.57-1.26],0.4207772994513747
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAB2,Stabilin-2,19669,142,1.02 [0.58-1.79],0.9363703459124874
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAM,Signal transducing adapter molecule 1,19568,141,0.89 [0.58-1.37],0.59734741960159
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAMBP,STAM-binding protein,22411,168,1.02 [0.83-1.26],0.844911129820836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAT2,Signal transducer and activator of transcription 2,19124,135,0.95 [0.77-1.19],0.6786722350170664
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAT5B,Signal transducer and activator of transcription 5B,22505,169,0.97 [0.88-1.07],0.5598695762130645
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,18980,139,0.83 [0.63-1.09],0.1815633081719091
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STC1,Stanniocalcin-1,22808,168,0.83 [0.59-1.18],0.2985973179624196
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STC2,Stanniocalcin-2,22581,165,2.01 [1.17-3.46],0.0113885010452876
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STEAP4,Metalloreductase STEAP4,19065,134,0.92 [0.73-1.17],0.5084203816663051
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STIP1,Stress-induced-phosphoprotein 1,22584,165,1.05 [0.85-1.29],0.6579479506936907
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STK11,Serine/threonine-protein kinase STK11,22202,165,0.96 [0.80-1.17],0.7141717180353693
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STK24,Serine/threonine-protein kinase 24,22047,163,0.96 [0.77-1.21],0.7500076855691176
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STK4,Serine/threonine-protein kinase 4,22609,170,1.00 [0.85-1.16],0.956859992344123
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STOML2,"Stomatin-like protein 2, mitochondrial",18980,139,1.00 [0.84-1.20],0.9698396319578164
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX16,Syntaxin-16,22099,164,0.93 [0.72-1.18],0.5374048944583254
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX1B,Syntaxin-1B,19126,138,1.08 [0.76-1.54],0.6788824315280817
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX3,Syntaxin-3,19633,140,0.92 [0.60-1.41],0.6858261865736464
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX4,Syntaxin-4,22505,169,1.02 [0.82-1.27],0.8482416121710806
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX5,Syntaxin-5,19124,135,0.98 [0.65-1.46],0.9106655417808376
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX6,Syntaxin-6,22099,164,1.02 [0.84-1.24],0.845782892066742
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX7,Syntaxin-7,19124,135,1.00 [0.72-1.39],0.9918458457315084
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STX8,Syntaxin-8,22569,167,0.96 [0.73-1.27],0.7749880010777555
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STXBP1,Syntaxin-binding protein 1,19643,140,0.90 [0.73-1.10],0.3082076547831532
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",STXBP3,Syntaxin-binding protein 3,22099,164,0.88 [0.63-1.23],0.4416943252161568
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUGP1,SURP and G-patch domain-containing protein 1,19573,142,1.09 [0.74-1.60],0.6620787579069058
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUGT1,Protein SGT1 homolog,22099,164,0.98 [0.82-1.16],0.7947059510885929
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SULT1A1,Sulfotransferase 1A1,22808,168,1.01 [0.91-1.12],0.8352256759432961
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SULT2A1,Bile salt sulfotransferase,22569,167,1.02 [0.79-1.31],0.8849657008255453
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUMF1,Formylglycine-generating enzyme,19124,135,0.90 [0.69-1.18],0.4522050115246669
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22808,168,1.06 [0.82-1.37],0.6660009129636035
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUOX,"Sulfite oxidase, mitochondrial",19643,140,0.95 [0.73-1.24],0.7023354147664316
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUSD1,Sushi domain-containing protein 1,22202,165,0.84 [0.64-1.12],0.2328947672783291
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUSD2,Sushi domain-containing protein 2,22614,165,1.26 [0.79-2.01],0.3389919752440202
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUSD4,Sushi domain-containing protein 4,19568,141,0.80 [0.54-1.18],0.2573807369191728
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SUSD5,Sushi domain-containing protein 5,19147,138,1.21 [0.74-1.96],0.4481003922968911
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SV2A,Synaptic vesicle glycoprotein 2A,19126,138,0.85 [0.64-1.13],0.2583354940310858
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SWAP70,Switch-associated protein 70,19573,142,1.35 [0.95-1.93],0.0939548178482403
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SYAP1,Synapse-associated protein 1,19262,139,1.03 [0.77-1.38],0.8173615903185779
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19065,134,0.96 [0.72-1.29],0.79634421762574
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SYT1,Synaptotagmin-1,19633,140,0.91 [0.59-1.41],0.6777910757672511
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",SYTL4,Synaptotagmin-like protein 4,19673,140,0.94 [0.75-1.17],0.5686960665088754
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19295,142,0.94 [0.81-1.10],0.4358679826494076
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TACC3,Transforming acidic coiled-coil-containing protein 3,22505,169,0.97 [0.86-1.09],0.6100048178043378
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TACSTD2,Tumor-associated calcium signal transducer 2,20078,148,1.36 [0.83-2.25],0.2244548238672979
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TADA3,Transcriptional adapter 3,19568,141,0.94 [0.62-1.42],0.7703463584067173
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TAFA5,Chemokine-like protein TAFA-5,22505,169,0.74 [0.49-1.10],0.1356273664409401
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TAGLN3,Transgelin-3,18980,139,1.19 [0.96-1.48],0.1209370750728707
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TALDO1,Transaldolase,19586,142,1.09 [0.77-1.54],0.6247060629115628
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TANK,TRAF family member-associated NF-kappa-B activator,22181,166,0.87 [0.71-1.07],0.1798849993447217
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TAP1,Antigen peptide transporter 1,19295,142,0.97 [0.74-1.28],0.8405457906196367
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TARBP2,RISC-loading complex subunit TARBP2,22047,163,0.96 [0.80-1.14],0.6265497776660754
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19126,138,0.90 [0.72-1.14],0.3882416524764437
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19568,141,1.07 [0.70-1.63],0.7697406343583458
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TAX1BP1,Tax1-binding protein 1,19633,140,0.84 [0.65-1.10],0.2019041309877328
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBC1D17,TBC1 domain family member 17,22047,163,0.98 [0.72-1.33],0.9050906898315182
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBC1D23,TBC1 domain family member 23,22505,169,0.95 [0.82-1.11],0.5120877984357679
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBC1D5,TBC1 domain family member 5,22569,167,1.03 [0.87-1.22],0.7585458746521151
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBCA,Tubulin-specific chaperone A,19262,139,0.94 [0.78-1.13],0.5056193958222646
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBCB,Tubulin-folding cofactor B,22459,168,0.98 [0.86-1.12],0.7963693151540655
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBCC,Tubulin-specific chaperone C,22459,168,1.00 [0.84-1.18],0.9763117771564588
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBL1X,F-box-like/WD repeat-containing protein TBL1X,22099,164,0.95 [0.81-1.12],0.5273032456936959
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TBR1,T-box brain protein 1,19126,138,0.80 [0.54-1.20],0.2805181088449123
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCL1A,T-cell leukemia/lymphoma protein 1A,22420,167,1.02 [0.88-1.18],0.814604184570186
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCL1B,T-cell leukemia/lymphoma protein 1B,22202,165,1.08 [0.93-1.26],0.2849759065886064
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCN1,Transcobalamin-1,19269,136,0.88 [0.54-1.44],0.6140225575977432
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCN2,Transcobalamin-2,22840,170,0.80 [0.50-1.27],0.3449837854142041
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCOF1,Treacle protein,19673,140,1.08 [0.64-1.81],0.7686049148758525
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCP11,T-complex protein 11 homolog,19295,142,1.00 [0.77-1.32],0.9729336203943642
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TCTN3,Tectonic-3,19673,140,1.03 [0.59-1.80],0.9102292089161976
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TDGF1,Teratocarcinoma-derived growth factor 1,22047,163,0.98 [0.88-1.08],0.6422179799158951
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TDO2,"Tryptophan 2,3-dioxygenase",19126,138,0.80 [0.49-1.28],0.3465227412811283
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TDP1,Tyrosyl-DNA phosphodiesterase 1,19568,141,1.00 [0.79-1.25],0.9804600047255896
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TDRKH,Tudor and KH domain-containing protein,22047,163,1.02 [0.86-1.20],0.8315052538698575
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TEF,Thyrotroph embryonic factor,19073,136,1.02 [0.70-1.49],0.9213868931222244
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TEK,Angiopoietin-1 receptor,22677,169,0.71 [0.37-1.34],0.2859945423067735
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TERF1,Telomeric repeat-binding factor 1,19124,135,1.58 [0.99-2.54],0.0576978725327946
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TET2,Methylcytosine dioxygenase TET2,19259,141,1.00 [0.85-1.18],0.9753698373117689
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TEX101,Testis-expressed protein 101,19126,138,1.00 [0.66-1.51],0.9987144278001802
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TEX33,Testis-expressed protein 33,19295,142,1.19 [0.85-1.65],0.316524229792825
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TF,Serotransferrin,19703,139,1.17 [0.57-2.42],0.6685879230613503
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFAP2A,Transcription factor AP-2-alpha,19065,134,1.21 [0.97-1.52],0.0915456955527438
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFF1,Trefoil factor 1,22503,164,0.88 [0.73-1.07],0.2080876170552963
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFF2,Trefoil factor 2,22670,169,0.84 [0.65-1.08],0.164900722758097
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFF3,Trefoil factor 3,22566,167,0.99 [0.76-1.29],0.9345389982442912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFPI,Tissue factor pathway inhibitor,22525,166,1.45 [0.98-2.16],0.0640030473326949
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFPI2,Tissue factor pathway inhibitor 2,22605,167,1.05 [0.74-1.49],0.7872000722818224
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TFRC,Transferrin receptor protein 1,22683,169,0.75 [0.53-1.07],0.109441292207523
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TG,Thyroglobulin,19568,141,0.95 [0.83-1.09],0.4687020481487354
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFA,Protransforming growth factor alpha,22569,167,0.90 [0.67-1.22],0.5070303238619098
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFB1,Transforming growth factor beta-1 proprotein,22816,168,0.85 [0.59-1.22],0.3841576687557482
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFB2,Transforming growth factor beta-2 proprotein,19568,141,1.30 [1.01-1.67],0.0400125866282673
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFBI,Transforming growth factor-beta-induced protein ig-h3,22448,165,1.22 [0.73-2.02],0.4495952360965487
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFBR1,TGF-beta receptor type-1,19124,135,0.85 [0.39-1.84],0.674770421014919
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFBR2,TGF-beta receptor type-2,22677,169,1.14 [0.73-1.78],0.5599775429334098
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGFBR3,Transforming growth factor beta receptor type 3,22879,170,1.15 [0.76-1.75],0.5087737172000258
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGM2,Protein-glutamine gamma-glutamyltransferase 2,22578,169,1.16 [0.97-1.38],0.0967694298905282
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TGOLN2,Trans-Golgi network integral membrane protein 2,19678,139,1.00 [0.53-1.90],0.9950442182903242
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THAP12,52 kDa repressor of the inhibitor of the protein kinase,18942,139,0.98 [0.82-1.17],0.815786371932503
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THBD,Thrombomodulin,22609,170,1.28 [0.78-2.10],0.3256113449992854
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THBS2,Thrombospondin-2,22614,165,1.35 [0.94-1.95],0.1059544284746028
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THBS4,Thrombospondin-4,22594,169,1.10 [0.81-1.49],0.5461601405693868
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THOP1,Thimet oligopeptidase,22506,170,1.05 [0.68-1.63],0.82331501143639
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THPO,Thrombopoietin,22202,165,0.99 [0.69-1.43],0.9672180678793793
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THRAP3,Thyroid hormone receptor-associated protein 3,19073,136,0.99 [0.86-1.14],0.9196869105149564
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THSD1,Thrombospondin type-1 domain-containing protein 1,18981,135,0.95 [0.58-1.55],0.8336233552691776
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THTPA,Thiamine-triphosphatase,19541,141,0.91 [0.76-1.09],0.297317403627893
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",THY1,Thy-1 membrane glycoprotein,22808,168,1.10 [0.67-1.81],0.7176687746878866
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIA1,Nucleolysin TIA-1 isoform p40,21959,161,0.95 [0.84-1.06],0.3589387626875905
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIE1,Tyrosine-protein kinase receptor Tie-1,22879,170,1.01 [0.73-1.40],0.9318192036498972
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",21999,163,1.07 [0.80-1.43],0.631187579940347
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19295,142,0.78 [0.49-1.26],0.3135763085322595
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22671,169,1.30 [0.96-1.77],0.0893165744928257
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19673,140,0.98 [0.66-1.48],0.9406814845263022
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19633,140,0.97 [0.81-1.17],0.7751899860640351
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMP1,Metalloproteinase inhibitor 1,22334,163,1.22 [0.75-2.00],0.4250804078678036
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMP2,Metalloproteinase inhibitor 2,19673,140,0.68 [0.32-1.44],0.3156275187067693
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMP3,Metalloproteinase inhibitor 3,22709,169,0.97 [0.87-1.07],0.5107701372628928
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TIMP4,Metalloproteinase inhibitor 4,22614,165,0.96 [0.68-1.36],0.8305314201640006
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TINAGL1,Tubulointerstitial nephritis antigen-like,22534,170,0.88 [0.48-1.64],0.6943945540774277
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TJAP1,Tight junction-associated protein 1,22677,169,0.96 [0.82-1.14],0.6533335291305893
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TJP3,Tight junction protein ZO-3,19065,134,0.59 [0.37-0.94],0.0279041784701386
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TK1,"Thymidine kinase, cytosolic",19295,142,1.10 [0.78-1.54],0.5937275644107889
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TLR1,Toll-like receptor 1,19124,135,0.83 [0.44-1.58],0.5705754704782877
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TLR2,Toll-like receptor 2,19295,142,1.24 [0.63-2.48],0.5327801203604156
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TLR3,Toll-like receptor 3,22856,169,0.96 [0.77-1.19],0.7039065381233083
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TLR4,Toll-like receptor 4,19124,135,0.59 [0.32-1.07],0.0838048304130942
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19126,138,1.04 [0.78-1.40],0.7858819073079963
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMED1,Transmembrane emp24 domain-containing protein 1,19295,142,1.06 [0.80-1.41],0.6659308571372086
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMED10,Transmembrane emp24 domain-containing protein 10,19073,136,0.87 [0.59-1.27],0.4680082465102452
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMED4,Transmembrane emp24 domain-containing protein 4,19073,136,1.10 [0.84-1.43],0.4799961413161258
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMED8,Protein TMED8,19573,142,0.98 [0.84-1.14],0.7725976212633682
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMEM106A,Transmembrane protein 106A,19568,141,1.02 [0.81-1.28],0.891926616115256
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMEM132A,Transmembrane protein 132A,19177,139,0.98 [0.76-1.27],0.8933413606579999
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMEM25,Transmembrane protein 25,19643,140,0.85 [0.58-1.25],0.4148488784346188
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMOD4,Tropomodulin-4,18980,139,1.14 [0.78-1.66],0.4936512591367528
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMPRSS11B,Transmembrane protease serine 11B,19065,134,1.05 [0.85-1.28],0.661224201609854
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMPRSS11D,Transmembrane protease serine 11D,19592,140,0.93 [0.60-1.43],0.7348633061330214
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMPRSS15,Enteropeptidase,22505,169,0.93 [0.81-1.08],0.370239678850124
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMPRSS5,Transmembrane protease serine 5,22351,167,1.09 [0.76-1.57],0.6399323681381122
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TMSB10,Thymosin beta-10,22614,165,1.02 [0.85-1.23],0.8119769077809487
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNC,Tenascin,22671,169,1.12 [0.84-1.48],0.438632354271516
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNF,Tumor necrosis factor,22161,165,0.99 [0.69-1.42],0.9631771497475504
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19573,142,1.11 [0.80-1.54],0.5295282158939837
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22181,166,0.92 [0.63-1.35],0.6842939181690577
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19262,139,0.98 [0.75-1.26],0.854401231912498
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22459,168,0.83 [0.54-1.29],0.4161168371016697
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22459,168,0.71 [0.44-1.15],0.1605520671397145
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22642,168,1.02 [0.78-1.35],0.8605453454909875
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22856,169,0.76 [0.52-1.10],0.1473326248438818
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22600,169,0.82 [0.51-1.31],0.3997792422322153
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22677,169,1.17 [0.79-1.75],0.429079694030362
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22642,169,0.96 [0.61-1.49],0.8419414501234208
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22181,166,0.86 [0.61-1.22],0.3992613281068888
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22642,169,1.01 [0.63-1.62],0.9615786554925752
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19262,139,0.92 [0.61-1.39],0.6809963384943728
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22809,167,0.92 [0.58-1.46],0.7126792006396909
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22614,165,1.09 [0.67-1.80],0.7253380227986452
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22614,165,0.97 [0.65-1.45],0.8903090780584757
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22808,168,1.23 [0.74-2.04],0.4195917052954314
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22816,168,0.89 [0.61-1.29],0.5268933279899035
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22459,168,0.91 [0.70-1.19],0.4937672522305387
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22808,168,1.07 [0.79-1.44],0.6604671595550503
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22459,168,0.75 [0.52-1.09],0.1351944894312729
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF10,Tumor necrosis factor ligand superfamily member 10,22856,169,1.58 [0.94-2.65],0.0866137057498241
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF11,Tumor necrosis factor ligand superfamily member 11,22569,167,0.91 [0.72-1.13],0.3832700095277739
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF12,Tumor necrosis factor ligand superfamily member 12,22856,169,0.85 [0.54-1.36],0.5031134724534464
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF13,Tumor necrosis factor ligand superfamily member 13,22709,169,0.89 [0.53-1.50],0.6637523698178791
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22840,168,0.90 [0.53-1.52],0.6872309027898323
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF14,Tumor necrosis factor ligand superfamily member 14,22459,168,1.01 [0.80-1.28],0.915813804834638
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNFSF8,Tumor necrosis factor ligand superfamily member 8,19669,142,0.85 [0.54-1.34],0.4776398273376957
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNIP1,TNFAIP3-interacting protein 1,19633,140,0.92 [0.77-1.11],0.400571866446929
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNN,Tenascin-N,19669,142,1.09 [0.76-1.56],0.631835183309125
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNNI3,"Troponin I, cardiac muscle",22202,165,1.00 [0.85-1.18],0.9948874086752472
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNPO1,Transportin-1,19295,142,0.83 [0.52-1.32],0.4224749704738987
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNR,Tenascin-R,22459,168,1.19 [0.86-1.64],0.2924189143119101
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TNXB,Tenascin-X,22614,165,1.46 [0.86-2.49],0.1646689889404567
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19673,140,0.97 [0.78-1.19],0.7581620131170218
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TOP1,DNA topoisomerase 1,19573,142,1.01 [0.87-1.17],0.9141380600582498
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TOP1MT,"DNA topoisomerase I, mitochondrial",18980,139,0.98 [0.70-1.36],0.8923219943276537
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TOP2B,DNA topoisomerase 2-beta,19124,135,0.99 [0.80-1.22],0.93468255864268
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TOR1AIP1,Torsin-1A-interacting protein 1,19177,139,1.05 [0.78-1.41],0.7669711129735142
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TP53,Cellular tumor antigen p53,22099,164,1.07 [0.77-1.47],0.6963529188838016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TP53BP1,TP53-binding protein 1,19124,135,0.84 [0.69-1.02],0.0752396930020274
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TP53I3,Quinone oxidoreductase PIG3,18841,139,0.97 [0.72-1.33],0.8711537199860165
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TP53INP1,Tumor protein p53-inducible nuclear protein 1,22202,165,0.89 [0.56-1.40],0.6094784134789429
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TP73,Tumor protein p73,19126,138,0.74 [0.46-1.19],0.2115053388348514
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPBGL,Trophoblast glycoprotein-like,19126,138,0.91 [0.61-1.36],0.6402612798313079
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPD52L2,Tumor protein D54,19262,139,0.95 [0.82-1.10],0.4962036385663902
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPK1,Thiamin pyrophosphokinase 1,19673,140,1.27 [0.70-2.29],0.4351448099560052
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPM3,Tropomyosin alpha-3 chain,19073,136,0.77 [0.50-1.19],0.2374601364064813
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPMT,Thiopurine S-methyltransferase,22099,164,0.85 [0.70-1.03],0.1028987245920526
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPP1,Tripeptidyl-peptidase 1,22457,169,0.92 [0.67-1.26],0.6062443707825698
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPPP2,Tubulin polymerization-promoting protein family member 2,19295,142,1.03 [0.85-1.24],0.7988523796231238
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPPP3,Tubulin polymerization-promoting protein family member 3,22047,163,1.03 [0.73-1.44],0.8840958786118408
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPR,Nucleoprotein TPR,19073,136,0.98 [0.70-1.37],0.9201842327854516
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPRKB,EKC/KEOPS complex subunit TPRKB,18980,139,0.97 [0.75-1.26],0.8198382913243384
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPSAB1,Tryptase alpha/beta-1,22818,168,0.95 [0.74-1.23],0.7111148426797327
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPSD1,Tryptase delta,19643,140,1.10 [0.74-1.64],0.6333839449491608
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPSG1,Tryptase gamma,19124,135,1.08 [0.59-1.96],0.8089728328978301
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TPT1,Translationally-controlled tumor protein,22181,166,1.11 [0.92-1.33],0.2752373959110329
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRAF2,TNF receptor-associated factor 2,22569,167,1.07 [0.88-1.29],0.5047957974079593
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRAF3,"TNF receptor-associated factor 3, Isoform 2",19124,135,1.06 [0.69-1.63],0.7973819567345003
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19073,136,0.79 [0.53-1.18],0.2475459149110771
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19295,142,1.10 [0.92-1.31],0.2844742323163121
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TREH,Trehalase,19669,142,1.06 [0.85-1.31],0.6244110103882912
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TREM2,Triggering receptor expressed on myeloid cells 2,22600,169,0.83 [0.64-1.09],0.1875239482317627
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TREML1,Trem-like transcript 1 protein,19678,139,0.97 [0.72-1.32],0.8604940580204365
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TREML2,Trem-like transcript 2 protein,22614,165,1.01 [0.66-1.53],0.975953443309902
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIAP1,TP53-regulated inhibitor of apoptosis 1,22809,167,0.93 [0.74-1.15],0.4824876952696078
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM21,E3 ubiquitin-protein ligase TRIM21,22569,167,1.00 [0.84-1.19],0.9778565971878695
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM24,Transcription intermediary factor 1-alpha,19252,142,1.07 [0.84-1.35],0.6024122163710305
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19573,142,0.96 [0.83-1.11],0.5930697278560748
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM26,Tripartite motif-containing protein 26,18980,139,0.98 [0.73-1.30],0.8815298633574712
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM40,E3 ubiquitin ligase TRIM40,19126,138,0.95 [0.75-1.19],0.6538482734788542
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM5,Tripartite motif-containing protein 5,22569,167,1.07 [0.91-1.26],0.3924500080171503
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRIM58,E3 ubiquitin-protein ligase TRIM58,19568,141,0.90 [0.75-1.09],0.280009775347416
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TRPV3,Transient receptor potential cation channel subfamily V member 3,19073,136,0.80 [0.55-1.17],0.2526650487484718
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSC1,Hamartin,19124,135,0.92 [0.72-1.17],0.4768658357083971
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSC22D1,TSC22 domain family protein 1,19643,140,0.77 [0.59-1.00],0.0467764243429145
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSHB,Thyrotropin subunit beta,22609,170,0.99 [0.84-1.16],0.9066284484244962
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSLP,Thymic stromal lymphopoietin,22202,165,0.98 [0.78-1.23],0.8319567971014903
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSNAX,Translin-associated protein X,19073,136,0.82 [0.53-1.25],0.3459613457996505
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSPAN1,Tetraspanin-1,22202,165,0.84 [0.51-1.38],0.490159176578677
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSPAN15,Tetraspanin-15,19073,136,0.89 [0.63-1.26],0.5098638392930511
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSPAN7,Tetraspanin-7,19065,134,0.93 [0.77-1.13],0.4821610831086869
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSPAN8,Tetraspanin-8,19573,142,0.95 [0.82-1.11],0.5423572939011533
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TSPYL1,Testis-specific Y-encoded-like protein 1,19124,135,1.24 [0.85-1.81],0.2657055880170591
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TST,Thiosulfate sulfurtransferase,22009,161,1.02 [0.85-1.23],0.8488117939218988
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TTF2,Transcription termination factor 2,19126,138,0.58 [0.41-0.84],0.0037267543266341
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TTN,Titin,19073,136,0.95 [0.73-1.22],0.6697400189345569
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TTR,Transthyretin,19477,134,1.67 [0.87-3.21],0.1262963239049243
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TUBB3,Tubulin beta-3 chain,19065,134,0.75 [0.41-1.37],0.351688773787531
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TWF2,Twinfilin-2,19669,142,0.98 [0.81-1.19],0.868136551901127
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXK,Tyrosine-protein kinase TXK,19295,142,0.77 [0.59-1.00],0.0529705844691794
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXLNA,Alpha-taxilin,22459,168,0.99 [0.85-1.15],0.889929792146551
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXN,Thioredoxin,19336,138,0.95 [0.65-1.37],0.7652203732914459
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXNDC15,Thioredoxin domain-containing protein 15,22677,169,0.95 [0.58-1.57],0.8477182129991728
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXNDC5,Thioredoxin domain-containing protein 5,22808,168,0.98 [0.80-1.20],0.8691415309366592
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXNDC9,Thioredoxin domain-containing protein 9,19633,140,0.87 [0.64-1.20],0.4031146279436456
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXNL1,Thioredoxin-like protein 1,19028,133,0.90 [0.74-1.09],0.2739372713116984
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22614,165,1.05 [0.78-1.41],0.7279842723166311
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TYMP,Thymidine phosphorylase,22461,168,0.99 [0.81-1.21],0.9166864659118312
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TYRO3,Tyrosine-protein kinase receptor TYRO3,22609,170,1.17 [0.72-1.89],0.5251121371225782
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19124,135,1.09 [0.83-1.43],0.5173775022569707
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBAC1,Ubiquitin-associated domain-containing protein 1,22505,169,0.99 [0.68-1.45],0.9710193420880184
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBE2B,Ubiquitin-conjugating enzyme E2 B,19568,141,0.71 [0.40-1.26],0.2358086753692585
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19673,140,0.98 [0.75-1.27],0.8695702786922825
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19124,135,0.93 [0.70-1.25],0.6351867307778931
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBQLN3,Ubiquilin-3,19073,136,1.03 [0.72-1.48],0.8656498057822405
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UBXN1,UBX domain-containing protein 1,19262,139,0.93 [0.73-1.18],0.5325786624200055
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19573,142,0.98 [0.87-1.10],0.7429316584876877
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UGDH,UDP-glucose 6-dehydrogenase,19073,136,0.94 [0.78-1.12],0.4782518900534322
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UHRF2,E3 ubiquitin-protein ligase UHRF2,19073,136,0.69 [0.40-1.19],0.1861595487530379
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ULBP2,UL16-binding protein 2,22459,168,0.94 [0.65-1.36],0.7388671238762501
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UMOD,Uromodulin,22815,170,1.04 [0.81-1.34],0.7516794300074203
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UNC5D,Netrin receptor UNC5D,19124,135,0.94 [0.50-1.76],0.8473696001122955
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UNC79,Protein unc-79 homolog,18980,139,0.95 [0.71-1.27],0.7158024686992983
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UNG,Uracil-DNA glycosylase,19568,141,0.97 [0.60-1.56],0.8974542402555015
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UPB1,Beta-ureidopropionase,19673,140,1.09 [0.92-1.29],0.334188682163314
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UPK3A,Uroplakin-3a,19065,134,1.14 [0.84-1.57],0.4000121451327189
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UPK3BL1,Uroplakin-3b-like protein 1,19267,142,1.00 [0.75-1.34],0.976349697078197
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UROD,Uroporphyrinogen decarboxylase,19262,139,0.96 [0.76-1.21],0.7146161664483879
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UROS,Uroporphyrinogen-III synthase,19126,138,0.88 [0.68-1.13],0.3111230847058447
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",USO1,General vesicular transport factor p115,22505,169,0.94 [0.81-1.09],0.4061507870755416
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",USP25,Ubiquitin carboxyl-terminal hydrolase 25,19568,141,0.89 [0.71-1.11],0.2986522146231443
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",USP28,Ubiquitin carboxyl-terminal hydrolase 28,19633,140,1.10 [0.74-1.62],0.6349000160313008
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",USP47,Ubiquitin carboxyl-terminal hydrolase 47,19073,136,0.98 [0.80-1.19],0.8008257046067248
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",USP8,Ubiquitin carboxyl-terminal hydrolase 8,22202,165,0.95 [0.82-1.09],0.4556514604032359
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",UXS1,UDP-glucuronic acid decarboxylase 1,22099,164,1.02 [0.79-1.31],0.8887831835448073
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VAMP5,Vesicle-associated membrane protein 5,22202,165,0.99 [0.77-1.27],0.9504605988226952
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VAMP8,Vesicle-associated membrane protein 8,19124,135,0.99 [0.82-1.20],0.9397484741398862
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VASH1,Tubulinyl-Tyr carboxypeptidase 1,22569,167,0.96 [0.81-1.13],0.6043577057060862
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VASN,Vasorin,22222,164,1.32 [0.79-2.19],0.2866829526304226
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VASP,Vasodilator-stimulated phosphoprotein,19678,139,0.97 [0.78-1.22],0.8184786899121557
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22505,169,0.83 [0.42-1.64],0.5943120641311883
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VAV3,Guanine nucleotide exchange factor VAV3,19065,134,0.94 [0.79-1.11],0.4710366768908119
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VCAM1,Vascular cell adhesion protein 1,22634,169,0.97 [0.58-1.62],0.8945825639029952
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VCAN,Versican core protein,22808,168,0.82 [0.52-1.30],0.4065002417792249
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VCPKMT,Protein-lysine methyltransferase METTL21D,18980,139,0.98 [0.81-1.19],0.8479947268695901
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VEGFA,Vascular endothelial growth factor A,22786,168,0.91 [0.72-1.15],0.4104775799558855
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VEGFB,Vascular endothelial growth factor B,19124,135,0.80 [0.44-1.43],0.4452148073860444
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VEGFC,Vascular endothelial growth factor C,22677,169,0.94 [0.74-1.19],0.5994621096468999
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VEGFD,Vascular endothelial growth factor D,22816,169,1.41 [0.95-2.12],0.091231588710868
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VGF,Neurosecretory protein VGF,19643,140,0.81 [0.47-1.40],0.4579324784427369
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VIM,Vimentin,22202,165,1.10 [0.97-1.25],0.1222126742865326
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VIPR1,Vasoactive intestinal polypeptide receptor 1,19177,139,0.91 [0.47-1.75],0.7779216641460466
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VIT,Vitrin,19673,140,1.00 [0.65-1.55],0.9918464090917284
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VMO1,Vitelline membrane outer layer protein 1 homolog,22505,169,0.92 [0.76-1.11],0.375957032551611
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VNN1,Pantetheinase,19678,139,1.09 [0.87-1.37],0.4380199131553551
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VNN2,Vascular non-inflammatory molecule 2,22505,169,1.03 [0.77-1.39],0.8322679890666406
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VPS28,Vacuolar protein sorting-associated protein 28 homolog,19295,142,0.96 [0.75-1.22],0.718520502752828
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VPS37A,Vacuolar protein sorting-associated protein 37A,22505,169,0.93 [0.78-1.10],0.3862290464187321
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VPS4B,Vacuolar protein sorting-associated protein 4B,19568,141,0.95 [0.80-1.12],0.527798930591348
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VPS53,Vacuolar protein sorting-associated protein 53 homolog,22505,169,0.93 [0.77-1.11],0.4044177362594929
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSIG10,V-set and immunoglobulin domain-containing protein 10,19568,141,0.91 [0.57-1.45],0.687585979112682
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19073,136,0.86 [0.52-1.45],0.5796748451331903
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSIG2,V-set and immunoglobulin domain-containing protein 2,19568,141,1.14 [0.87-1.50],0.3441608045021673
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSIG4,V-set and immunoglobulin domain-containing protein 4,22581,165,1.09 [0.76-1.57],0.6425802419079192
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22574,170,0.89 [0.71-1.12],0.3114920133878177
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSNL1,Visinin-like protein 1,19633,140,1.12 [0.73-1.71],0.613184387214711
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSTM1,V-set and transmembrane domain-containing protein 1,22047,163,0.99 [0.74-1.32],0.9496574079782274
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSTM2B,V-set and transmembrane domain-containing protein 2B,19295,142,1.06 [0.74-1.51],0.7438964075280836
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22202,165,1.13 [0.91-1.40],0.2701873781688466
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22808,168,1.01 [0.84-1.22],0.8999125024155308
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VTCN1,V-set domain-containing T-cell activation inhibitor 1,22099,164,0.92 [0.59-1.43],0.7186319878418007
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19262,139,0.99 [0.75-1.31],0.9401362442724048
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VWA1,von Willebrand factor A domain-containing protein 1,22770,167,0.85 [0.62-1.18],0.3387703045619875
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VWA5A,von Willebrand factor A domain-containing protein 5A,18980,139,0.92 [0.73-1.15],0.452870239959861
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VWC2,Brorin,22376,168,0.79 [0.55-1.13],0.1994844799208613
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VWC2L,von Willebrand factor C domain-containing protein 2-like,19643,140,0.84 [0.57-1.25],0.3941930183630615
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",VWF,von Willebrand factor,22879,170,1.08 [0.89-1.29],0.4350535185825033
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WARS,"Tryptophan--tRNA ligase, cytoplasmic",22614,165,1.28 [0.89-1.84],0.1900237742856018
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WAS,Wiskott-Aldrich syndrome protein,22181,166,0.96 [0.78-1.17],0.6746149637438152
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WASF1,Wiskott-Aldrich syndrome protein family member 1,22202,165,0.90 [0.78-1.05],0.200450392178311
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WASF3,Wiskott-Aldrich syndrome protein family member 3,22047,163,0.94 [0.80-1.11],0.4542108788204847
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WASHC3,WASH complex subunit 3,19633,140,0.90 [0.73-1.13],0.36953840692932
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WASL,Neural Wiskott-Aldrich syndrome protein,19124,135,0.99 [0.76-1.30],0.955118591406854
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WDR46,WD repeat-containing protein 46,19568,141,0.84 [0.52-1.35],0.4695517890472612
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WFDC1,WAP four-disulfide core domain protein 1,19183,138,1.17 [0.92-1.48],0.193131310691602
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WFDC12,WAP four-disulfide core domain protein 12,22781,167,0.87 [0.70-1.08],0.2001214555867072
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WFDC2,WAP four-disulfide core domain protein 2,21445,161,1.10 [0.74-1.63],0.6536088207427526
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22396,167,0.94 [0.67-1.32],0.7310072963421286
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22642,169,0.98 [0.66-1.46],0.9239558835840808
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WIF1,Wnt inhibitory factor 1,22809,167,0.76 [0.51-1.14],0.1831344908981382
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WNT9A,Protein Wnt-9a,22181,166,0.80 [0.48-1.32],0.3760746286689452
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22459,168,1.07 [0.83-1.37],0.603966266249016
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",XCL1,Lymphotactin,22809,167,1.00 [0.79-1.28],0.9686320321991392
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",XG,Glycoprotein Xg,22765,166,0.89 [0.55-1.44],0.6385847268632837
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",XIAP,E3 ubiquitin-protein ligase XIAP,19124,135,0.97 [0.72-1.29],0.8286458169022384
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",XPNPEP2,Xaa-Pro aminopeptidase 2,22677,169,1.13 [0.97-1.32],0.1197816208361656
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",XRCC4,DNA repair protein XRCC4,22047,163,0.91 [0.62-1.34],0.646254367861197
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YAP1,Transcriptional coactivator YAP1,19633,140,1.02 [0.55-1.91],0.940015973931613
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19573,142,0.99 [0.89-1.10],0.8749306905599604
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YES1,Tyrosine-protein kinase Yes,22505,169,0.95 [0.85-1.08],0.4479222051521145
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YJU2,Splicing factor YJU2,19568,141,1.01 [0.62-1.67],0.9621621972454
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YOD1,Ubiquitin thioesterase OTU1,19073,136,0.96 [0.74-1.25],0.7663144538744027
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YTHDF3,YTH domain-containing family protein 3,22181,166,0.92 [0.78-1.09],0.3338764533268079
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YWHAQ,14-3-3 protein theta,19262,139,0.96 [0.77-1.20],0.7294299578827834
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",YY1,Transcriptional repressor protein YY1,19124,135,1.31 [0.76-2.28],0.3359293685673682
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZBP1,Z-DNA-binding protein 1,19124,135,0.90 [0.59-1.39],0.6395014424418954
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZBTB16,Zinc finger and BTB domain-containing protein 16,22099,164,0.96 [0.78-1.17],0.6770993629972011
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZBTB17,Zinc finger and BTB domain-containing protein 17,22202,165,0.88 [0.62-1.25],0.4744000919307971
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZCCHC8,Zinc finger CCHC domain-containing protein 8,19073,136,1.00 [0.76-1.30],0.9807487173382184
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZFYVE19,Abscission/NoCut checkpoint regulator,19573,142,1.02 [0.85-1.22],0.8231250607626489
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZHX2,Zinc fingers and homeoboxes protein 2,19633,140,0.92 [0.54-1.54],0.7387635082145327
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZNF174,Zinc finger protein 174,19124,135,0.98 [0.63-1.51],0.9162483921528096
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZNF75D,Zinc finger protein 75D,19295,142,0.87 [0.65-1.15],0.3296643119469048
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZNF830,Zinc finger protein 830,19568,141,0.97 [0.79-1.18],0.7334912214898609
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZNRD2,Protein ZNRD2,19573,142,1.03 [0.81-1.30],0.8189084286453946
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19568,141,0.73 [0.54-1.01],0.0554500041185556
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZP3,Zona pellucida sperm-binding protein 3,19177,139,0.99 [0.93-1.05],0.78496493156171
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZP4,Zona pellucida sperm-binding protein 4,18980,139,1.09 [0.70-1.71],0.6962419648002602
Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",ZPR1,Zinc finger protein ZPR1,19065,134,1.03 [0.87-1.21],0.748572347452749
